Carbohydrate metabolising enzymes in male and female rats by Mahmoud, Said Abdel Fattah
gk
M « i h
ISS.7^5
F t b . S o
CARBOHYDRATE METABOLISING ENZYMES IN MALE AND FEMALE RATS
A Thesis submitted by
SAID ABDEL FATTAH MAHMOUD




Department of Biochemistry 
Royal Holloway College 






INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest.
ProQuest 10097471
Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States Code.
Microform Edition ©  ProQuest LLC.
ProQuest LLC 
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106-1346
-  3 -
ACKNOWLEDGEMENTS
I would like to take this opportunity to express my sincere 
thanks and gratitude to Professor J.B. Pridham for his help, 
guidance, encouragement, support and interest during the course 
of this study.
I would also like to thank Dr. D.R. Davies for his interest, 
support and many helpful discussions.
I am obliged to Dr. P. Finch of the Chemistry Department for 
his interest and suggestions.
I also wish to thank all the staff and members of the 
Biochemistry Department of Royal Holloway College who have helped 
in many ways to make this thesis possible.
I would also like to thank the Ministry of Higher Education 
and Zagazig University (A.R.É.) for giving me full financial support 
during my study and Rank Hovis McDougalLResearch Ltd. for financial 
assistance.
Finally, to my wife Ragaa I would add, "Your encouragement and 
assistance is no small contribution to this work, the least I can 
say is that I hope to repay you in kind one day, until then, I will 
always be grateful to you".
-  4 -
ABSTRACT
It has been reported that the increase in the concentration 
of triglyceride in fasting serum is more likely to be induced by 
carbohydrates than by fats in the diet. This fact has focussed 
the attention of researchers on the possible role of dietary car­
bohydrates in the aetiology of ischaemic heart disease. Epidemio­
logical studies have also shown that there is a positive correlation 
between the incidence of atherosclerosis and (1), the amount of 
sucrose in diet and (2), the level of triglyceride in the fasting 
serum. Moreover, some epidemiological studies suggest that the 
increase in the death rate from ischaemic heart disease coincides 
with the increased consumption of sucrose in western countries.
Feeding sucrose has been reported to produce hypertriglyceri- 
daemia in man and experimental animals and this carbohydrate has a 
greater hypertriglyceridaemic effect than glucose or starch. Sucrose- 
or fructose-induced hypertriglyceridaemia is more marked in male 
animals than females.
These facts when considered together, suggested that an examin­
ation of sex differences in the metabolism of sucrose might throw 
some light on the different incidence of ischaemic heart disease in 
men and women. Hence the activities of a number of liver enzymes 
involved in fructose metabolism have been examined using male and 
female rats on normal and carbohydrate-supplemented diets.
Sex differences were observed in three cases: glycerol kinase 
((?>?), glycerol 3-phosphate dehydrogenase ( ? > 8 ‘) and sorbitol dehy­
drogenase but dietary factors modified or nullified these
differences. The conclusion was reached that glycerol 3-phosphate 
might be produced more readily in female rats than males because 
aldolase and glycerol 3-phosphate dehydrogenase activities were higher 
in the females.
The effect of sex hormones on the activity of glycerol kinase was 
examined using hepatocyte preparations. A rapid activation of this 
enzyme in cells from both male and female livers was observed when 
relatively high concentrations of dihydrotestosterone were used. 
E s t r a d i o l - 1 h a d  no effect. The activation was most marked with 
hepatocytes from castrated male rats and the phenomenon could only be 
demonstrated with intact cells. There was no evidence that the dihy­
drotestosterone effect was mediated through protein synthesis.
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Hormonal control of lipogenesis by estrogens, possibly mediated 
by insulin and glucagen, has been considered in the Discussion 
together with the role of lipoprotein lipase in maintaining serum 
triglyceride levels low in female animals compared with males.
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The study described in this thesis was initiated by a number 
of reports that dietary carbohydrate might be implicated, via blood 
serum triglycerides, in the development of the disease, athero­
sclerosis, which is the primary cause of death in western countries.
It was noted that the hypertriglyceridaemic response to some 
fructose-containing dietary carbohydrates in men and women (and in 
males and females of other animal species) was different and that, 
in addition, the incidence of atherosclerosis in men was greater 
than in women. These points are considered in detail in the text 
that follows.
The main purpose of the experimental work that is described 
was to investigate some possible sex differences in the way that 
fructose is converted to triglycerides. In one case, glycerol kinase, 
the mode of activation by sex hormones was investigated.
I. ATHEROSCLEROSIS
A. THE DISEASE
The most prevalent degenerative change observed in the cardio­
vascular system is atherosclerosis, which affects the main arteries 
and leads to ischaemic changes in the myocardium, brain and limbs (6).
The term arteriosclerosis (hardening of the arteries) describes 
the form of atherosclerosis characterized by accumulation of soft, 
amorphous, fatty material in the vascular wall.
A study group of the WHO defined atherosclerosis as, "a variable 
combination of changes of the intima of arteries consisting of focal 
accumulation of lipids, complex carbohydrates, blood and blood products, 
fibrous tissue and calcium deposits and associated with medial changes". 
(1). This definition emphasizes the pleomorphic character of the 
arterial lesion, which is often overlooked in studies on atherosclerosis, 
Paleopathologis.ts have found evidence of arteriosclerosis (probably 
atherosclerosis) in mummies from ancient Egypt (27), and medical 
historians have documented, extensively, reports on atherosclerotic 
disease over the centuries (3, 8, 28),
Current interest in the study of atherosclerosis is due to the 
fact that coronary heart disease, one of the complications of the 
atherosclerotic process, is today the leading cause of death in devel­
oped countries. Atherosclerosis of the coronary blood vessels, is a
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more frequent cause of death in the United Kingdom than any other 
disease of the circulatory system (2).
Atherosclerosis begins in childhood, proceeds rapidly in some 
arteries during adolescence and in others during early adulthood, 
undergoes a series of complex changes in subsequent decades and then 
begins to result in clinically manifest disease during early middle 
age (3).
The first structural abnormality that can be classified as 
atherosclerosis is the deposition of lipid in the subendothelial 
space of the arteries and this produces the so-called fatty streaks 
(4), the appearance of which normally begins in the aorta, in the 
first year of life, in the coronary arteries in the second decade 
and in the intracranial arteries in the third decade.
It is well established that fatty streaks chronologically pre­
cede fibrous plaques and more advanced lesions. Haemorrhage within 
the plaque with superimposed thrombosis will result in atheroma 
formation. The atheroma and complex lesions sometimes show evidence 
of calcification and/or ulceration (5).
These atheromatous lesions may reduce the size of the arterial 
lumen and produce partial or complete ischaemia. Ischaemia may then 
result in angina pectoris, myocardial infarction, cerebral infarction 
or peripheral gangrene.
Recognition of the importance of atherosclerosis as a cause of 
morbidity and mortality in industrialized countries has resulted in a 
great deal of research directed towards an understanding of the causes 
and the treatment of this disease (2).
B. MORPHOLOGY
Atherosclerosis is a disease characterized by the accumulation 
of lipids in the subendothelial space of the large arteries. From 
the pathological point of view, the earliest lesions found in children 
are those classified as fatty streaks, which appear to the naked eye 
as pale yellow, flat or elevated intimai lesions; microscopically, 
they consist of macrophages which are apparently filled with lipid 
droplets (4).
The second type of intimai lesion is the fibrous plaque. These 
are firm and appear as grey elevated areas of thickening which are 
composed of collagen and elastic fibres together with smooth muscle 
cells, but the fat content is less than that found in fatty streaks (4)
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The third type of intimai lesion is that which is referred to 
as atheroma and this consists of soft, fatty, raised lesions in 
which there may be evidence of intimai haemorrhage with superimposed 
thrombosis. Calcification and/or ulceration of the atheromatous 
lesion is a possible complication (5).
In the view of most investigators, the evolution of plaques of 
the adult type occurs mainly via the fatty streaks. This view is 
supported by the study of spontaneous and induced atherosclerosis in 
experimental animals (11). In man, it is difficult, to establish 
whether the fatty streaks are the precursors of the fibrous plaques. 
For example, evidence has been presented that the fatty streaks and 
fibrous plaques appear at different sites in the arterial tree in 
man (9). A similar conclusion has been drawn from studies on the 
chemical composition of the différant lesions (4). On the whole, 
however, the pathological evidence, favours the conclusion that 
atherosclerotic lesions of the adult type commonly evolve from fatty 
streaks.
C. AETIOLOGY
The aetiology of atherosclerosis has been the subject of con­
troversy for over a century. The mechanism of the arterial changes 
has been explained by a variety of theories (21). The thrombogenic 
theory is one of the oldest of these theories. It was proposed by 
Von Rokitansky (12) in the 19th century, when he described a typical 
atheroma and postulated that it resulted from degeneration of blood 
proteins (notably fibrin) deposited upon the arterial intima. This 
view was contested by Virchow (13) in 1856, who introduced the 
inflammatory theory and regarded the atheroma as an outcome of de­
generations that followed inflammatory processes within the intima 
and the fibrous thickening as a product of proliferation of intimai 
connective tissue cells in reaction to the pool of degenerative 
material. In 1941 Leary (14) considered that the atherogenic process 
was due to a type of fatty infiltration of the vessels, whilst Duguid 
(15) advanced an alternative explanation for the process of athero­
matosis. He revived interest in the theory of Von Rokitansky (12) 
and presented evidence for the existence of fibrin in arterial lesions, 
He also said that the fibrous thickenings were not caused by reaction 
to the process of degeneration, as proposed by Virchow (13), but that 
they resulted from surface deposits.
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In 1951 Wilens (16) drew attention to the slow increase in the 
thickness of the arterial intima in females relative to males, which 
proceeds throughout life. He suggested that this might help to 
explain the difference between the two sexes with regard to the 
development of atherosclerosis.
The occurrence of appreciable amounts of lipid in atherosclerotic 
lesions led to the theory of lipid infiltration. This states that the 
lipid contents of fatty streaks are the result of the deposition of 
lipids which infiltrate from the blood plasma to the intimai tissues 
(21). The theory is supported by the observations of BOttcher and Van 
Gent (10) who have found a similarity between the lipid composition of 
fatty streaks and that of blood plasma.
The long suspected relationship between the nature of the dietary 
intake and atherosclerosis was claimed by several investigators, on the 
basis of dietary studies, in the early years of this century (see also 
p. 18). In particular, Saltykow (18) emphasized the probable role that 
dietary cholesterol played in atherogenesis and shortly thereafter 
Anitschow and Chalatov (19) began to study the effects of excessive 
cholesterol feeding on rabbits. They showed that aortic, lipid- 
containing lesions appeared in these animals and they believed that 
the high level of cholesterol in the plasma initiated atherosclerosis 
and maintained that the origin of the disease might be traced to a 
general disorder of lipid metabolism. They further reasoned that in­
creased blood lipoproteins had the tendency to settle in the intima 
producing the changes typical of atherosclerosis, whereas all other 
factors (mechanical, chemical and pharmacological) were only of a con­
tributing nature.
In contradiction to this theory, however, the analysis of human 
arteries for plasma low density lipoprotein (LDL) content has indicated 
that, proportionally less cholesterol is bound as LDL in the fatty 
streak than in either normal intima or in advanced atheroma (25). 
Furthermore, the composition of cholesterol esters in fatty streaks 
differs considerably from that in adjacent normal intima or in plasma 
(26). These findings suggest that much of the lipid of the fatty streak 
is synthesized locally rather than being derived from the plasma.
Developing atheroma leads to the formation of fissures in the endo­
thelial blood vessel tissues overlying the atheromatous mass. These in 
turn damage blood platelets circulating in the vessel lumen which
-  15 -
accelerates platelet aggregation and thrombus formation. The 
existence of a thrombus can, of course, threaten blood circulation 
and thus result in partial or complete blockage of blood vessels 
often culminating in death if the coronary arteries are affected.
The biochemical factors involved in this phenomenon have reviewed 
(31, 32).
There are numerous other theories of the aetiology of athero­
sclerosis (21) many of which have not been generally accepted and 
some which have been subsequently incorporated into broader concepts 
or have proved to be invalid.
D. RISK FACTORS
Great efforts have been made this century to elucidate the 
pathogenesis of atherosclerosis, and several 'risk factors' for 
clinical manifestations of the disease have been identified. Risk 
factors are statistically associated with an increased risk of the 
development of ischaemic heart disease in an individual (35, 36, 37,
38, 39, 40).
1. Age and Sex
Coronary heart disease is rare in women before the menopause but 
is an increasing cause of death thereafter. It has been reported that 
the incidence of coronary occlusion increases with age in both men and 
women, but throughout all age classes there is a greater incidence 
for men than for women (7, 36, 43, 48, 80) (See also p . 23).
2. Familial Incidence
Attempts have been made to demonstrate a genetic disposition to 
coronary heart disease and in families of patients with myocardial 
infarctions, there is commonly a history of atherosclerotic cardio­
vascular disease and early death (41, 44). As pointed out by Rose (42), 
however, this cannot be taken as proof of genetic disposition, since 
family members often resemble each other with respect to dietary habits, 
physical activity and other factors.
3. Body Weight
In some studies, particularly with men, a greater prevalence of 
ischaemic heart disease was found in subjects who were over-weight (36, 
57, 61), whilst in other studies this was not the case (56).
4. Diabetes Mellitus
Diabetes mellitus is an important risk factor for atherosclerotic 
diseases - coronary, peripheral and cerebral (7) and there is agreement
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in most of the literature that there is a sex difference in the 
prevalence and incidence of diabetes with more women than men 
developing the condition (37, 60, 64). It has also been pointed 
out that atherosclerotic heart disease accompanied by diabetes 
results in higher mortality rates than atherosclerosis alone. It 
has been assumed that 'diabetic vascular disease' of the smaller 
arteries results in a poorer development of collaterals and, 
therefore, a greater number of fatal cases of arteriosclerotic 
occlusions (64).
Diabetes is also associated with a marked weight gain (60, 61) which 
itself predisposes to ischaemic heart disease. In addition, plasma 
insulin levels show a strong positive relationship with obesity and 
this is most pronounced in women who are commonly obese. In obesity, 
the uptake of glucose by the peripheral tissue is reduced, and this 
produces hyperglycaemia and compensatory hyperinsulinaemia (60, 61). 
Diabetes mellitus is considered to develop when the compensation is 
no longer effective.
5. Plasma Lipids
Serum lipids such as cholesterol and triglyceride are always 
bound to protein to form lipoproteins. In the fasting state, three 
major lipoproteins can be isolated by ultracentrifugation or electro­
phoresis: very low (VLDL), low (LDL) and high (HDL) density lipo­
proteins (72): these have different biochemical, metabolic and patho­
genetic properties. Fredrickson ejt aJ. (76) have correlated five 
electrophoretic lipoprotein patterns with clinical syndromes of 
various types (hyperlipoproteinaemias). Elevated serum LDL and VLDL 
(type II and type IV hyperlipoproteinaemias) relate to premature 
ischaemic heart disease and to diabetes and associated vascular 
disease, respectively. Both of these conditions are influenced by 
hereditary factors (44, 78). It has also been proposed that reduction 
in serum HDL (which contains mainly cholesterol, cholesterol esters 
and phospholipid) may hasten the development of atherosclerosis (29, 
75).
A number of epidemiological studies have established a relation­
ship between hypercholesterolaemia and ischaemic heart disease (36,
79, 80, 83) and an association between hypertriglyceridaemia and 
atherosclerotic heart disease has also been found (51, 84, 85, 86).
It is difficult, however, to relate these findings to the associations
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claimed for the lipoproteins because the latter all contain mixtures 
of different lipids and the information concerning hypercholesterol­
aemia and hypertriglyceridaemia refers to total serum cholesterol 
and total serum triglyceride, respectively.
Epidemiological studies are scanty in which serum cholesterol 
and serum triglyceride have been determined in both sexes but there 
is a good agreement in those studies which have been published.
Before the age of about 50 years a lower serum cholesterol level is 
found in women than in men, whilst the opposite occurs after this age 
(36, 78). Serum triglycerides are found to increase with age but 
decrease slowly after the age of 50 years with men having higher 
values than women in all age groups (76, 78, 89, 90).
6. Smoking
Recent incidence studies have shown that smokers, and particularly 
cigarette smokers, run the greatest risk of developing myocardial 
infarction (92, 93, 94, 96), this being so for both men and women (48). 
However, prevalence studies could not demonstrate with certainty, a 
relationship between ischaemic heart disease and smoking (97, 98).
The content of carbon monoxide in tobacco smoke has recently 
been proposed as significant factor in the development of athero­
sclerosis (101).
7. Hypertension
The cardiovascular consequences of elevated blood pressure have 
been demonstrated in many incidence studies (36, 38, 80, 102). The 
risk of atherosclerotic heart disease is higher the higher the blood 
pressure. There are also strong positive relationships in both sexes 
between blood pressure and serum triglycerides, obesity and carbohy­
drate intolerance, and hence maturity onset diabetes (80, 84).
8. Physical Activity
Many investigators assume that the changes which have taken place 
in the way of life of industrialized countries during this century 
contribute to the development of atherosclerotic heart disease. Amongst 
other causes, the decreased demands on physical activity have been 
blamed for this and regarded as a coronary risk factor (37, 103, 104, 
108) and it has been reported that exercise is effective in reducing 
serum triglycerides (107, 116). In addition, other risk factors such 
as cigarette smoking, obesity (but not high serum cholesterol levels 
and hypertension) appear to be positively related to inactivity (105, 
106).
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9. Serum Uric Acid
In 1951, Gertler ejb (109) published their observations that 
serum uric acid was significantly elevated in a group of young male 
patients with myocardial infarctions. Since then, numerous authors 
have reported a positive relationship between serum uric acid levels 
and atherosclerotic manifestations (110 , 115), as well as with hyper- 
uricaemia and hypertension, obesity and serum triglycerides (7, 66, 
115): a relationship of hyperuricaemia with serum cholesterol was 
denied (7).
All studies on the distribution of serum uric acid in the two 
sexes have shown that men have higher values than women and in addition 
the levels show only a slight age-dependence in men (114, 115).
E. DIET AND ISCHAEMIC HEART DISEASE
1. General Considerations
The DHSS report on "Diet and Coronary Heart Disease" (2) considers 
possible dietary risk factors in ischaemic heart disease (IHD) and in 
particular; (a), a general over consumption of food; (b), an excess of 
fat; (c), a low ratio of polyunsaturated to saturated fatty acids in 
the diet; (d), an excess of cholesterol; (e), an excess of sucrose;
(f), a high consumption of common salt; (g), a deficiency of dietary 
fibre and (h), softness of the water supply.
A consumption of food in excess of energy expenditure results in 
obesity and there is evidence that this 'disease* is becoming more 
prevalent in western countries (2). Obesity is associated with low 
physical activity, a high blood pressure and diabetes mellitus, each 
of which is considered to be an important risk factor for IHD. Some 
studies suggest that, in the absence of these associated factors, 
obesity alone may not contribute greatly to the total risk of IHD in 
an individual (2, 61).
In the United Kingdom, the amount of protein consumed, expressed 
as the average weight per person per day, has altered very little 
since the early years of this century. The consumption of total carbo­
hydrate, on the other hand, during the decade 1950-1960, started to 
fall and this fall continued into the 1970's. The consumption of 
sucrose has, however, shown a different trend. This rose from the 
1940's until 1958 and then declined slightly, although in 1971 sucrose 
still provided about 16% of the total available food energy (2, 125).
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Over the last decade about 11% of food energy has been avail­
able from protein. A comparison of total carbohydrate consumption 
with that of fat shows that since 1950, the proportion of food 
energy available from carbohydrate has steadily declined whilst 
that from fat has risen. In 1971, on average, 46-48% of food energy 
was supplied by carbohydrate and about 42% by fat (2).
There is some evidence to suggest a positive correlation between 
the average proportion -of food energy which is derived from fat and 
the death rate from ischaemic heart disease. This relationship is 
clearest when the proportion of food energy derived from combined 
saturated fatty acids is considered rather the proportion derived 
from total amount of fat in the diet (123). The interpretation of the 
evidence which conforms with the view that a diet rich in fat pre­
disposes to ischaemic heart disease is complicated by the fact that 
people who consume a high fat diet are often heavy cigarette smokers 
and tend to have a high sucrose intake (2, 117).
There appear to be strong interelationships in man between dietary 
fat and blood cholesterol and ischaemic heart disease (128). In some 
animal species a diet rich in cholesterol induces the appearance of 
arterial lesions which have some similarity to those seen in human 
subjects (11), and comparative studies of different human populations 
show that those which have a diet rich in cholesterol have a higher 
death rate from ischaemic heart disease (130). However, a diet rich 
in cholesterol is usually one which is also rich in saturated fatty 
acids.
2. Sucrose and Ischaemic Heart Disease
It has been claimed (104, 133) that sucrose is an important risk 
factor in the development of ischaemic heart disease in man. Although 
this view has been criticized in the scientific literature, it has 
received considerable public attention.
The hypothesis is based on four main points which can be summar­
ized as follows:
(a), there is a correlation between the rate of mortality from ischaemic 
heart disease and sucrose consumption in several countries;
(b), there was an enormous increase in the incidence of ischaemic heart 
disease over the last 30 years which was coincident with the marked 
rise in the sucrose consumption per capita in various countries;
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men with ischaemic heart disease commonly prove to be unusually 
heavy consumers of sucrose; and
(d), compared with starch, dietary sucrose leads to elevation of 
blood serum lipids, mainly triglycerides.
In 1957, Yudkin (104) postulated a relationship between sucrose 
consumption and the death rate attributed to ischaemic heart disease 
in 15 countries. The sucrose consumption per capita was calculated 
from sucrose production, export and import data; death rates were 
calculated from vital statistics. According to Walker (134) and 
Keys (132), these two sources of information do not give a true pic­
ture of either the actual sucrose consumption or the ischaemic heart 
disease mortality.
Keys (132) and Grande (129) have pointed to exceptions to Yudkin’s 
original data citing countries with a high sucrose consumption but a 
low incidence of ischaemic heart disease such as Cuba, Venezuela, 
Colombia and Costa Rica. Furthermore, in countries with similar 
sucrose consumptions, such as Sweden and Finland, the incidence of 
ischaemic heart disease may be different: in the case of the two 
Scandinavian countries the incidence is higher in the latter than 
the former (129). The dietary data obtained by Keys (130) in his 
population studies indicate a correlation between sucrose intake and 
ischaemic heart disease incidence rate of 0.78 and a correlation 
between saturated fatty acids and ischaemic heart disease incidence 
rate of 0.86. However, as noted also by Wretlind (135), there is also 
a high correlation (0.84) between the amount of sucrose in the diet 
and the saturated fatty acid content, which is adequate to explain the 
relationship between sucrose intake and the incidence of ischaemic 
heart disease in these studies (130, 132).
The view that increases in sucrose consumption and coronary mor­
tality have occurred concomitantly (Yudkin, 104) has been criticized 
by Keys (132). The data from the U.S. Department of Agriculture 
reported by Keys, shows that the yearly, per capita average for sugar 
consumption of 51.7kg in the 1920's and 51.2kg in the 1960's. On the 
other hand, the U.S. vital statistics show a considerable increase in 
coronary death rates between these two periods.
Ashton (136) has claimed correlations of 0.64 and 0.55 between 
death rates from ischaemic heart disease and fat consumption and death 
rates and sucrose consumption, respectively, in Britain.
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Yudkin and his colleagues (137, 138) reported that coronary 
patients had a higher sucrose intake than controls but Grande (129) 
and Keys (132), were unable to confirm these findings. It has also 
been stated by a working party of the Medical Research Council, U.K.
(139), that sucrose consumption by men with myocardial infarction is 
slightly higher than that of normal individuals but the difference 
was not statistically significant. Furthermore, the Medical Research 
Council stated that the increase in sucrose consumption amongst 
coronary patients was likely to relate to an association between
cigarette smoking and the intake of sucrose.
The general controversy in this field undoubtedly relates to the 
multifactorial nature of ischaemic heart disease.
The effect of dietary sucrose on human serum lipids has been the 
subject of many investigations and is of interest in view of claims 
that high levels of certain serum lipids can be correlated with a high
incidence of ischaemic heart disease (see p. 16).
The term "carbohydrate induced lipaemia" has been coined by Ahrens
(140) to signify the type of hypertriglyceridaemia which becomes more 
apparent following several days of a very high carbohydrate diet. In 
contrast to alimentary lipaemia, in which the triglyceride concentra­
tion is greatest 3-5 hours after a fat meal, in carbohydrate-induced 
lipaemia the serum triglyceride concentration reaches its highest value 
after an overnight fast. The elevation of serum triglycerides produced 
by dietary carbohydrate has been the subject of a review by Kaufmann
(141).
Since plasma triglyceride levels are doubled after a few days of 
carbohydrate-enriched food, persons with initially elevated triglycer­
ides will show a greater increase in triglyceride than will persons 
with normal triglyceride levels. In other words the effect will be 
more apparent in hypertriglyceridaemic than normoglyceridaemic indi­
viduals.
Many investigations suggest that dietary sucrose (or fructose) is 
a more marked hypertriglyceridaemic agent than starch or glucose in man. 
In a review, Grande (129) concluded that the hypertriglyceridaemic 
effect of sucrose, relative to starch, could not be demonstrated in 
normolipidaemic men under normal dietary conditions. However, with 
normolipaeraic subjects on diets with 12% of the calories present as fat 
(mainly animal fat) and 70% of the calories as carbohydrate, if sucrose
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replaces starch then higher serum lipid levels, especially trigly­
ceride, are produced (Macdonald and Braithwaite, 142; cf Antar et 
a_l. , 148). These latter findings for men and postmenopausal women 
(but not premenopausal women) were confirmed in later publications 
(143, 144, 145).
It has also been reported that substitution of sucrose for 
starch in the diet produces marked elevations of serum lipid levels, 
particularly the triglycerides, in hyperlipaemic individuals (149,
150, 151). However, not all hyperlipaemic individuals showed this 
effect. The response to this dietary exchange seems to be related 
to the degree of hyperlipaemia and to the fatty acid composition of 
the diet (149, 162). Antar et al. (149) found that sucrose was more 
hyperlipaemic in patients with hypertriglyceridaemia than in patients 
with hypercholesterolaemia.
In general, therefore, simple dietary carbohydrate appears to 
have a greater effect on serum triglycerides than on serum cholesterol 
or phospholipids. However, with normolipaemic subjects. Keys (147) 
and Grande and their collaborators (146) found that replacement of 17% 
of the total calories (present as carbohydrate in fruit, leafy veget­
ables and legumes) by sucrose or lactose produced significantly higher 
serum cholesterol values.
It has been clearly shown that sucrose produces hypertriglyceri­
daemia to a greater extent than glucose or starch not only in humans, 
but also in experimental animals (153, 154, 155, 156, 157, 158, 159), 
although this response may be modified by other dietary factors such 
as the presence or absence of fat (160, 162) and whether the carbo­
hydrate supplement is supplied to fasted or fed animals (154). The 
hypertriglyceridaemic effect of a sucrose-containing diet has also been 
found to be dependent on the age of the animal (154, 156), as well as 
the sex in both man (143) and laboratory animals (154, 155). Dietary 
studies with the latter are discussed in detail in Section III (p. 54) 
and the effect of sex in Section IV (p. 68).
It is evident that apart from the hypertriglyceridaemic effect, 
sucrose can also produce an increase in the adhesiveness of blood plate­
lets, an early stage of blood clotting (161) and an increase in the 
level of circulating insulin (161). High levels of insulin are assoc­
iated with peripheral vascular disease, obesity, hypertension and 
cigarette smoking - conditions that all predispose to ischaemic heart 
disease (133, 161).
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F. EXPERIMENTAL ATHEROSCLEROSIS
Until recently the rabbit and the chicken were the only common 
laboratory animals in which atherosclerosis could be demonstrated 
(168). It is now recognized, however, that there are a number of 
other species (rat, mouse, guinea pig, hamsters, monkey and the 
pigeon) which can be made to develop arterial lesions similar to 
those found in human blood vessels by dietary manipulations of lipid 
metabolism (171).
Atherosclerotic lesions have been produced in the rat by adding 
cholesterol, bile salts and thiouracil to semi-synthetic diets con­
taining the normal nutritional requirements. In addition, large 
amounts of dietary fat produce lesions and also thrombi (11, 171).
The morphological features of the lesions in rat, are said to be 
more similar to those of man than those found in other experimental 
animals (171).
More recently, Mahley £t (50) have succeeded in producing
hypercholesterolaemia with a distinctive hyperlipoproteinaemia and 
subsequent development of atherosclerotic lesion in swine by choles­
terol-fat rich diet.
G. SEX DIFFERENCES IN THE INCIDENCE OF ISCHAEMIC HEART DISEASE
It has been reported that, coronary heart disease, particularly 
myocardial infarction, is more common amongst men than women, at 
least during the middle decades of life (7, 22, 37, 80, 167). The 
mortality data from the United States reveal that throughout middle 
age, death rates attributed to ischaemic heart disease are several 
times higher in white males than white females (37, 165).
Kannel (80), in his Framingham studies, concluded that age, 
blood pressure, carbohydrate intolerance and serum lipid levels are 
linked to the rate of arterial atherogenesis in both sexes and with 
regard to the lipid factor, Hagerup (7) has found that serum choles­
terol levels are lower in the men than in the women before the age of 
about 50 years whilst the opposite is the case after this age. The 
most common lipid disorder amongst patients with ischaemic heart 
disease is type IV hyperlipoproteinaemia in which the serum levels of 
triglyceride-rich lipoprotein VLDL are raised. Salel et (74) have
found that type IV hyperlipoproteinaemia is 2.7 times more common in 
men than in women and they suggest that perhaps the type IV disorder 
is responsible for the sexual differences observed in the incidence
-  24 -
of ischaemic heart disease.
It has been shown that the administration of estrogens 
decreases the serum cholesterol level and this hormone has been 
used clinically as preventive treatment for atherosclerosis (23).
Many experiments with laboratory animals have been carried 
out to examine the effect of sex hormones on atherosclerosis.
For example, chickens on atherogenic diets containing significant 
amounts of cholesterol and fat were treated with estrogens (166).
This work showed that the diet itself induced hypercholesterolaemic 
hyperlipaemia and that estrogen therapy allowed the plasma choles­
terol zphospholipid (C/P) ratio to be maintained at or near normal 
levels (0.35-0.6) via enhancement of the phospholipid concentration. 
The authors believed that estrogen-induced inhibition of coronary 
lesions in these animals might be closely interlinked with mainten­
ance of C/P ratios below 0.75-0.80 (166). This tends to support the 
hypothesis that the human sex differential in susceptibility to 
ischaemic heart disease may be, at least in part, result from ovarian 
hormonal secretion (168).
In subsequent studies with chickens it was demonstrated that 
oral administration of estrogens was effective in producing the de­
cisive triad of hormone effects: feminization, altered plasma lipid 
patterns and prevention of coronary atherosclerosis (167, 168).
These studies reinforced the impression that inhibition of coronary 
atherogenesis was closely linked to the basic biological actions of 
the estrogens in Avian species at least.
Studies on estrogen-induced reversal of coronary atherosclerosis 
with animals on a high cholesterol/fat diet demonstrated that this 
effect was partially inhibited by administration of either thiouracil 
or insulin (168, 169). It has been clearly shown that egg-laying 
hens, in contrast to roosters of the same age, are remarkably resis­
tant to cholesterol-induced atherogenesis (169). This phenomenon of 
sex difference in chickens shows a parallelism to the human situation 
regarding susceptibility to coronary atherogenesis.
In addition to studies on estrogens, the effects of androgens 
and castration have also been explored in animals (167).
Using male and female rats, Uzunova e^ (172) have been able 
to increase the mortality rate from arterial thrombosis by the admin­
istration of testosterone to either sex. On the other hand, estradiol
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treatment decreased the mortality rate in both cases. These 
authors conclude that this may be the first significant experi­
mental evidence for an association between sex hormones and the 
development of arterial thrombosis.
It should be noted, however, that the protective effect of 
estrogen against coronary atherosclerosis is apparently .not uni­
versal with all animal species e.g. the rabbit (168). In addition, 
it has been claimed that administration of testosterone to choles- 
terol/fat-fed cockerels retards hypercholesterolaemia: the effect 
was not observed with castrated animals, however (170).
II. CARBOHYDRATE AND TRIGLYCERIDE METABOLISM
A. METABOLISM OF CARBOHYDRATES
The disaccharide, sucrose, which is totally derived from plant 
sources, has been a major and increasing source of dietary calories 
in western countries for the last 30 years and, hence, any attempt 
to relate diet to human disease must take this carbohydrate into 
account.
The evidence linking dietary sucrose with ischaemic heart disease 
through hypertriglyceridaemia has already been outlined (see p. 19). 
There is no significant correlation between dietary starch or glucose 
and ischaemic heart disease.
1. Intestinal metabolism of sucrose
Sucrose is a disaccharide of P-D-fructofuranose and a-D-gluco- 
pyranose with the glycosidic linkage joining the two anomeric carbon 
atoms. This rather unusual structure imparts chemical properties on 
the molecule which are not found with most other dietary carbohydrates 
It is a non-reducing sugar, which is stable in solutions of alkali 
but, because of the furanosyl moiety it is more easily hydrolysed by 
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Dietary sucrose passes through the alimentary tract to the 
small intestine where, before absorption, it is normally hydro­
lysed by an invertase (174), present in the intestinal mucosa, 
to glucose and fructose. Since sucrose is sensitive to acid 
hydrolysis, it was once suggested that hydrolysis of ingested 
sugar, catalyzed by the hydrochloric acid of the gastric juice, 
might start in the stomach (422), but this has recently been re­
futed by Dahlqvist (174).
Intestinal invertase is an a-glucosidase which can hydrolyse 
both sucrose and maltose; it appears in the human mucosa very early 
in fetal life much earlier than lactase (174). In the rat, the 
invertase activity varies with age, but not the sex, of the animal 
(175). Rats 23 days old have approximately two-thirds of the 
activity found in adult animals.
Dietary sucrose increases the activity of invertase in the 
jejunum of the rat (175, 176) and, some believe, in man (177, 199).
When Blair e^ (175) fed a high-sucrose diet (70%) to rats, the 
invertase activity increased and there was also enhanced fructose 
absorption as reported by Deren e_t (176). Rosensweig and Herman
(199), have demonstrated the adaptive nature of human disaccharidases; 
they concluded that the level of disaccharidase activity in human 
jejunum is controlled by dietary sugars. Specifically, sucrose and 
fructose are, they claim, capable of regulating invertase activity 
whilst lactase activity is not changed by these carbohydrates.
However, Dahlqvist (174) believes that sucrose has little effect on 
the invertase activity in humans.
The site of intestinal absorption of the components of sucrose 
has been studied in man by the use of both oral loading and infusion 
techniques (178). Both hydrolysis and absorption were found to occur 
mainly in the jejunum, furthermore, 'sucrose absorption' rates were 
observed to be considerably more rapid in jejunal segments than in 
ileal segments. It has been suggested by Gray and Ingelfinger (178) 
that considerable amounts of glucose and fructose are released into the 
lumen after the hydrolysis of sucrose by the bound mucosal enzyme and 
then these monosaccharides are absorbed i.e. the hydrolysis products 
are not directly absorbed from the mucosal cells. Other workers (179) 
claim that sucrose is absorbed in both the distal jejunum and in the 
ileum. In this connection it should be noted that the region of highest 
invertase activity is in the region of the villi i.e. in the ileum (179).
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It has been shown that glucose is absorbed by an active trans­
port system which involves a protein carrier and sodium ions (30,
180, 186). The brush border membrane is the site of action of sodium 
ions (180). It is assumed that the cell membrane contains a glucose- 
binding carrier substance which binds glucose at one site and sodium 
ions at a separate site (see Fig. 1). The sodium ions are assumed 
to be necessary for the binding of the glucose to the carrier by 
bringing about a conformational change. It has also been shown that 
potassium ions can bind at the sodium-binding site and alter the 
degree of glucose-binding through another conformational change in 
the carrier (30). Hence, an efflux of potassium ions through the 
membrane facilitates the release of the glucose by the carrier on 
the intracellular side of the membrane. The active transport of the 
sodium ions out from and potassium ions into the cell is believed to 
be handled by a separate system, via a brush border, Na*/K*-dependent 
membrane ATPase (118), thereby providing the sodium ions necessary 
for glucose transport.
Work by Honegger (131) very recently reported by Dahlqvist (126), 
suggests that there are actually two glucose carrier systems in 
hamster small intestine. They are both Na^-dependent and they can 
also carry galactose but they differ in sensitivity to phloridzin, 
the degree of specificity and values.
Although the bulk of the intraluminal sugars are absorbed into 
the portal venous blood a portion of these sugars are metabolized by 
the mucosal epithelial cells of the small intestine to maintain their 
viability and to enable the absorptive systems to function (30, 191). 
Absorption of glucose, however, occurs with little conversion of the 
hexose to other metabolites. Kiyasu ejt (182) for example, using
rats found that [^^cjglucose placed in a loop of intestine, isolated 
by ligatures, appeared in the blood collected from a vein draining the 
loop. The total radioactivity recovered in the blood was 97% of which 
80-90% was as glucose and the remainder as lactate and alanine.
Fructose is absorbed across and into the small intestinal epithe­
lial cells of man and other animal species at a slower rate than 
glucose (186). Recently, Guy and Deren (181) have shown that the 
epithelial cells of the rat small intestine have a special membrane 
mechanism that allows the rapid entry of fructose. This mechanism is 
not dependent on sodium ions and is not sensitive to phloridzin un­
like the process for glucose transport (121).
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Fig. 1. Hypothetical scheme for active transport of glucose
in the small intestine (30)
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In the rat small intestine about 10% of ingested fructose is 
converted to glucose (30, 122, 184), about 60% to lactate (122, 184) 
and the remaining 30% is absorbed unchanged into the portal venous 
blood. In the small intestine of guinea pig comparatively more (55- 
80%) of the fructose is converted to glucose (124, 184), 10% to lactate 
(124, 184) and the remainder passes into the portal circulation intact.
Man is very different from the other species mentioned in that up 
to 80-90% of ingested fructose is absorbed from the small intestine as 
fructose. However, the conversion of some fructose to glucose by the 
human intestine has been demonstrated (119).
The metabolism of fructose by the small intestine of several 
animal species has been reviewed by Herman et al. (191). They conclu­
ded that in the small intestinal epithelial cells, fructose is trans­
formed into either fructose 6-phosphate (hexokinase-catalyzed) (187) 
or fructose 1-phosphate (ketohexokinase-catalyzed) (185, 190, 193). 
According to Herman e_t (191) fructose, per se, can undergo either
reaction but fructose which arises from the invertase-catalyzed 
hydrolysis of sucrose will probably undergo the ketohexokinase reaction 
preferentially. The reason for this is that the liberated glucose will 
compete with fructose for hexokinase but not ketohexokinase. Sols (187) 
found that fructose (6mM) phosphorylation by rat intestinal hexokinase 
could be inhibited (90%) by the presence of glucose at the same concen­
tration.
Guinea pig small intestine appears to convert fructose to glucose 
to a greater degree than rat intestine (184, 191) because of the lower 
levels of ketohexokinase (214) and glucose 6-phosphatase (30, 180, 190) 
in the latter (see Fig. 2).
Intestinal ketohexokinase and fructose 1-phosphate aldolase can 
be regulated by the presence of fructose in the diet. A high fructose 
diet increases the activity of both enzymes in man (30, 192) and in the 
rat (30, 193). A glucose diet, on the other hand, lowers the activi­
ties of these enzymes (192, 193).
2. Metabolism of Glucose and Fructose in the Liver 
(a) General considerations
Glucose and fructose, after being absorbed from the small intestine, 
pass directly to the liver through the portal circulation. In the liver, 
however, about two-thirds of the free glucose enters the hepatocytes and 
is metabolized; the remainder of the glucose passes through the liver to 
the systemic circulation.
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1.Hexokinase 2.Hexose phosphate isomerase 3.Glucose 6-phosphatase
4.Phosphofructokinase 5.Fructose 1,6-diphosphate aldolase ô.Triose 
phosphate isomerase Y.Triokinase 8.Ketohexokinase 9.Fructose 1- 
phosphate aldolase 10.Fructose 1,6-diphosphatase.
*
These reactions may be slow in rat tissue; relatively fast in guinea 
pig tissue.
Fig. 2. Pathways of fructose metabolism by intestinal epithelium
- 31 -
Monosaccharides other than D-glucose, such as D-fructose,
D-mannose and D-galactose are all phosphorylated in the liver and 
can be further transformed into glucose and other products or oxi­
dized to CO^. Systemic blood contains essentially no free mono­
saccharides other than glucose and minor amounts of fructose.
Cahill and his associates in 1958 (205) believed that hexoses
entered the liver cells by free diffusion across the plasma membrane,
a view which was widely accepted for 10 years. However, in 1968
Williams ejt (33) found that D-glucose was taken up by perfused
liver more rapidly than L-glucose and that the uptake was inhibited
by phloridzin, a well known inhibitor of glucose transport in various
cells. These results were considered as evidence for the existence
of a specific transport system for glucose. Baur and Haldt (34) who
studied glucose transport using isolated hepatocytes also concluded
that there was a glucose carrier system (K 30mM and V 1lOumol
min g ) and that the rate of glucose uptake was much faster than
the rate of phosphorylation in the cell. Glucose penetration of liver
cells does not appear to be significantly controlled by insulin but
high levels of this hormone in the blood do enhance the entry of
glucose into extra hepatic tissues such as adipose and muscle (369).
Compared to glucose, fructose is taken up more slowly but, again,
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carrier system (K 67 mM and V 30pmol min g ) is involved (222, 
m max
232). The results obtained by Sestoft (222) using perfused rat liver, 
show that the affinity of fructose for its carrier system is lower 
than the affinity of the ketose for ketohexokinase, the enzyme cata­
lysing the initial phosphorylation stage. Sestoft, therefore, con­
cluded that the rate of carrier-mediated transport of fructose limited 
its metabolism under physiological conditions.
It has long been known that the routes for glucose and fructose 
metabolism in the liver are different (see Fig. 3).
In summary the initial step in fructose metabolism is phosphory­
lation to D-fructose 1-phosphate. This reaction is catalyzed by a 
specific ATP-dependent enzyme, ketohexokinase. Cleavage of fructose 
1-phosphate by liver aldolase yields D-glyceraldehyde and dihydroxy­
acetone phosphate; the latter may enter the glycolytic pathway and/or 
be used for triglyceride synthesis or gluconeogenesis.
Four enzymes are present in liver cells for the further metabolism 
of D-glyceraldehyde. These are: (1), triokinase which converts glycer­
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dehydrogenase which produces D-glyceric acid (which can be further 
phosphorylated to 2-phosphoglycerate by glycerate kinase) and (3),
NAD- and NADP-dependent alcohol dehydrogenases which can both reduce 
glyceraldehyde to glycerol (which in turn can be phosphorylated to 
sn-glycerol 3-phosphate by glycerol kinase). In different animal 
species the levels of these enzymes vary (214).
Glucose on the other hand, is phosphorylated to D-glucose 6- 
phosphate by hexokinase which exists in different isoenzymic forms; 
this is the first rate-limiting step in hepatic glucose metabolism 
(214). Glucose 6-phosphate can then be isomerized to D-fructose 6- 
phosphate which is catalyzed by glucose phosphate isomerase. Further 
phosphorylation of fructose 6-phosphate at C-1 is catalyzed by the 
allosteric enzyme phosphofructokinase. Aldolase-cleavage of the 
resulting D-fructose 1,6-diphosphate gives rise to dihydroxyacetone 
phosphate and D-glyceraldehyde 3-phosphate. After the formation of 
trioses by aldolase the metabolism of glucose and fructose is similar.
The path of carbon from both fructose and glucose is further 
regulated at the triose level by the allosteric enzyme, pyruvate 
kinase, which produces pyruvate for eventual entry into the Krebs 
cycle. The levels of some of the enzymes involved in both glucose 
and fructose metabolism are subjected to hormonal and dietary control.
The detailed characteristics of the specific enzymes in the path­
ways for fructose metabolism and the key regulatory enzymes for 
glycolysis can now be considered.
(b) Fructose metabolism in the liver
In most animal species the liver is the main organ for fructose 
metabolism and there are a number of hepatic enzymes which are specific 
for this purpose (45).
Although fructose can be phosphorylated by hexokinase (EC 2.7.1.1) 
to fructose 6-phosphate, the low activity of this enzyme in rat and 
other mammalian livers and the high (2-5mM) for fructose as com­
pared with the (O.ImM) for glucose makes it unlikely that the phos­
phorylation of fructose by this enzyme is at all significant under 
physiological conditions (214).
D-Fructose is chiefly phosphorylated to fructose 1-phosphate in 
hepatocytes by an ATP-dependent reaction catalyzed by ketohexokinase 
(ATP:D-fructose 1-phosphotransferase; EC 2.7.1.3) (214, 215, 216).
This enzyme is found in all mammalian livers (218, 219), in kidney (220)
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and in the small intestinal mucosa (214, 221). In the cell, the 
enzyme is localized in the cytoplasm (68).
Hepatic ketohexokinase has been purified by a number of
workers (215, 223, 224, 225, 226) and most recently from rat
liver by Sanchez ejt (227). Purified rat liver ketohexokinase
has an absolute requirement for K^ions (228) and has a K of 0.46mM
2+
for fructose and 1.56mM for the ATP-Mg complex at a K*ion concen­
tration of 0.4M (227). ADP, one of its reaction products, is a non­
competitive inhibitor towards fructose and competitive with respect 
to the ATP-Mg complex (228) and this latter inhibition is partially 
reversed by K ions. Inhibition of ketohexokinase by fructose 1- 
phosphate has been reported by Froesch et al. (217) but was not 
observed by Parks ejt (225) and by Sestoft (222). Ketohexokinase
is not specific for D-fructose it also catalyzes the phosphorylation 
of L-.sorbose and D-tagatose. The affinity of the enzyme for these 
ketoses depends on the concentration of K^ions (226, 227).
It has been shown (231) that ketohexokinase is absent from the 
fetal livers of rats, rabbits and guinea pigs and that the enzyme 
appears post-partum and reaches adult levels of activity 7-10 days 
later.
The complete absence of ketohexokinase from the human liver 
results in a condition called essential fructosuria (233). As a 
consequence, ingested fructose accumulates in the blood and is ex­
creted as such in the urine.
Ketohexokinase activity varies in different species of animals.
In rat liver it is 2.2 U/g and in human liver 1.7 U/g (218). In the
rat, the measured enzyme activity equates well with the rate of ex-
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traction of fructose from the medium (3pmol fructose min g tissue) 
during liver perfusion (222). In human liver, an extraction rate of 
1.5-2.3pmol fructose min” g” tissue (or an equivalent rate of 0.41- 
0.55g/min for a whole liver) has been calculated by Tygstrup et aT. 
(229) and Craig et al. (230). This again correlates well with the 
level of ketohexokinase in this tissue.
Ketohexokinase activity of rat liver is affected by diet and 
hormones. Adelman and co-workers (46) have shown that the specific 
activity of the enzyme, in terms of liver weight, does not change 
greatly when the diet is manipulated. However, there are marked 
changes in the total liver activity. This is decreased to about
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one-half of the normal level on fasting (48-72 hr) and is restored 
completely to normal after feeding fructose (70%) for 24 hr. With 
glucose feeding, the recovery is only partial. Heinz (198) has 
shown that feeding rats a diet enriched with fructose (65%) for 3 
weeks causes an increase in ketohexokinase activity in liver and 
in kidney. The level of ketohexokinase is unchanged in alloxan- 
diabetic rats. On the other hand, the enzyme activity of fed, 
adrenalectomized or hypophysectomized rats is at the fasting level 
of normal rats and neither fasting nor subsequent feeding of fructose 
or glucose affects the level (46).
The mammalian liver also possesses an enzyme, sorbitol dehydro- 
genase (L-iditol dehydrogenase; L-iditol, NAD oxidoreductase;
EC 1.1.1.14) which, in vitro, can catalyze the reduction of fructose 
to sorbitol (glucitol) by NADH. (The EC nomenclature for the enzyme 
is derived from early work where iditol was used as a substrate (437)).
This dehydrogenase was first partially purified in 1951 by Blakley 
(437) from rat liver. Since that time it has been shown to occur in 
various animal tissues (438, 440, 441, 442) where it is mainly located 
in the cytoplasm and also claimed to be present in the mitochondria of 
liver, kidney and prostate (439). In the liver the dehydrogenase has 
a specific activity five times greater than that found in the kidney 
or prostate (438). In human liver the activity is 25 U/g, and in rat 
liver 18.9 U/g (218).
The rat liver enzyme has a of 0.7mM for sorbitol (437) and a
K of 100-200mM for fructose (439).
m
The main fate of fructose 1-phosphate is an aldolase-catalyzed 
cleavage leading to trioses. The products of the reaction are dihy­
droxyacetone phosphate and D-glyceraldehyde. The hepatic isoenzyme 
(aldolase IB; ketose 1-phosphate aldolase; EC 4.1.2.7) can cleave 
fructose 1-phosphate at nearly the same rate as fructose 1,6-diphos­
phate. The isoenzyme is also found in the kidney and the small 
intestinal mucosa but at lower activities than in the liver (214).
A specific fructose 1,6-diphosphate aldolase (aldolase 1A) is present 
•in skeletal muscle, which cleaves fructose 1,6-diphosphate more than 
100-fold faster than fructose 1-phosphate (214). In human liver the 
fructose 1-phosphate aldolase activity is 2.08 U/g and in rat liver,
1.63 U/g (214, 218).
Aldolase IB of human liver has a. of 7.5 x 10" M for fructose
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1-phosphate and 1 x 10 M for fructose 1,6-diphosphate (214).
It has been shown by Adelman et (46) that rat liver
aldolase is also regulated by diet and hormones. The activity 
decreases to about one-third of the normal activity if the animals 
are fasted for 48-72 hr: the activity is restored completely to 
normal in 24 hr by fructose feeding. The same authors (46) have 
shown that with fed, adrenalectomized or hypophysectomized rats, 
the activity is normal but that it decreases sharply on fasting 
and does not recover on subsequent glucose or fructose feeding.
Hereditary fructose intolerance is a disorder of fructose 
metabolism where the activity of liver aldolase is greatly depressed. 
Hers and Joassin (234) showed that, in patients with this disorder, 
the ability of liver aldolase to split fructose 1-phosphate is al­
most completely lacking. It is assumed, therefore, that the toxic 
effects of ingested fructose are related to the accumulation of 
fructose 1-phosphate (234).
D-Glyceraldehyde, derived from fructose 1-phosphate, can in 
theory be acted upon by four different enzymes. Triokinase (ATP: 
D-glyceraldehyde 3-phosphotransferase; EC 2.7.1.28) can phosphorylate 
the aldehyde by an ATP-dependent reaction, producing D-glyceraldehyde 
3-phosphate. This enzyme can also phosphorylate dihydroxyacetone 
(214). Triokinase is present in soluble fraction of liver (214), 
kidney (220) and the small intestinal mucosa (221). The enzyme has 
been partially purified from guinea pig liver (113), beef liver (112) 
and, recently, from rat liver (111).
The rat liver enzyme has a for D-glyceraldehyde of O.OImM and 
0.77mM for ATP-Mg^* (111, 236). Free ATP, ADP and ADP-Mg^* are com­
petitive inhibitors with respect to ATP-Mg^* and non-competitive in­
hibitors with respect to D-glyceraldehyde (111).
Triokinase activity in human liver is 2.07 U/g, and in rat liver, 
1.65 U/g (218). It has been shown (198) that feeding fructose-enriched 
diets to rats increases the liver and kidney enzyme activities. With 
normal rats fasting produces a marked decrease in total hepatic 
activity of the kinase which is completely restored to normal in 24 hr 
by fructose feeding (46). With fed, adrenalectomized or hypophy­
sectomized rats, the activity is normal but it decreases sharply on 
fasting and does not recover on subsequent glucose or fructose feeding.
NADP-dependent alcohol dehydrogenase (glycerol dehydrogenase or
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aldehyde reductase or alcohol: NADP-oxidoreductase; EC 1.1.1.2) 
is an enzyme which is highly specific for the reduction of D- 
glyceraldehyde to glycerol (214). It is found in the liver and 
in lower activities in the kidney and small intestinal mucosa (214).
Alcohol dehydrogenase has been purified from rat liver (95) 
and from the skeletal muscles of rabbit (99) and the rat (100).
The is 0.15mM for D-glyceraldehyde arid 0.63M for glycerol with
the liver enzyme (95, 214). The level of the enzyme is 3.6 U/g in 
human liver and 0.38 U/g in rat liver (218). A second alcohol dehy­
drogenase which is NAD-dependent (glycerol dehydrogenase or alcohol; 
NAD-oxidoreductase; EC 1.1.1.1) can also reduce D-glyceraldehyde to 
glycerol (214). In human liver the activity of this dehydrogenase 
is 3.1 U/g and in rat liver four times more active (1.64 U/g) than 
the NADP-dependent dehydrogenase (218). The rat hepatic enzyme has 
a of 3 X 10 for D-glyceraldehyde which is high and for this 
reason, the physiological role of the dehydrogenase is in doubt (218) 
(see also p. 63).
Any glycerol produced vivo from glyceraldehyde (or from lipo- 
lysis or dietary sources) can be converted to sn-glycerol 3-phosphate 
by glycerol kinase (L-triokinase or ATP: glycerol phosphotransferase; 
EC 2.7.1.30). The tissue distribution of glycerol kinase has been 
studied in detail in rats. The liver is the chief source of the 
enzyme and in kidney the activity is mainly concentrated in the 
cortex (214). Significant activities are also present in the brain 
(248), adipose tissue (247), heart (247) and the small intestinal 
mucosa (214).
The activity of the enzyme has also been studied in tissues of 
guinea pigs (214), hamsters (214), mice (250), rabbits (214) and man 
(218, 249).
Glycerol kinase has been purified from rat (251, 253, 254),
pigeon (252), beef and human-(253) livers. The purified enzyme from
rat has a K of 3.2 x 10"^M for glycerol (254). Dihydroxyacetone and 
m
L-glyceraldehyde are also phosphorylated by this enzyme (214).
Glycerol 3-phosphate, ADP and AMP are inhibitors of the kinase (254, 
255) and raising the Mg^^ion concentration increases inhibition by the 
latter two compounds (254). Inhibition by AMP is prevented by free 
ATP (254).
In human liver, the activity of glycerolkinase is 0.62 U/g tissue
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and in the rat it was found to be 2.08 U/g (214, 218).
The enzyme level in rats was observed to decrease in response 
to starvation and in alloxan diabetic animals and after adrenal­
ectomy. The first three days of feeding fat to normal animals also 
lowered the level. On the other hand, the activity of the kinase 
was increased after longer ( ^ 3  days) periods of feeding fat, after 
insulin substitution of alloxan diabetic rats and after cortisol 
replacement of adrenalectomized animals (256). Feeding unsaturated 
fatty acids to rats also led to an increased activity of glycerol 
kinase, whilst glycerol had no effect (257).
In adult animals, but not the newborn, glycerol kinase activi­
ties show sex differences: males have higher levels in the liver than 
females (241, 258) and the reverse appears to be true in the case of 
the kidney (239, 241).
Aldehyde dehydrogenase (D-glyceraldehyde dehydrogenase or alde­
hyde: NAD-oxidoreductase; EC 1.2.1.3) oxidizes D-glyceraldehyde to D- 
glyceric acid using NAD as a hydrogen carrier (214).
In rat liver, 60% of the aldehyde dehydrogenase activity is 
localized in the cytosol and 40% in the mitochondria; the overall 
activity is 1.4 U/g tissue. In human liver, the enzyme possesses a 
similar activity of 1.04 U/g (214, 218).
Aldehyde dehydrogenase isolated from rat liver has a of 4 x 
10~^M for D-glyceraldehyde. Therefore, oxidation of D-glyceraldehyde 
to D-glyceric acid is a physiological possibility (88, 214).
Aldehyde dehydrogenase in the liver is accompanied by D-glycerate 
kinase (ATP: D-glycerate 2-phosphotransferase; EC 2.7.1.31) which can 
phosphorylate glyceric acid to 2-phosphoglycerate, an intermediate in 
glycolysis.
In human liver, the level of activity of this enzyme is low (0.13 
U/g); in rat liver, significantly higher (3.2 U/g) (214, 218).
An enzyme capable of oxidising sn-glycerol 3-phosphate, sn-glycerol 
3-phosphate dehydrogenase (sn-glycerol 3-phosphate: NAD-oxidoreductase;
EC 1.1.1.8),'is widespread in animal tissues. It is NAD-dependent and 
can readily catalyse the formation of dihydroxyacetone phosphate in vitro. 
However, at physiological pH values, the equilibrium favours glycerol 
3-phosphate formation. ^  vivo the enzyme is thought to be important 
for the production of glycerol 3-phosphate from dihydroxyacetone 
phosphate (a product of the aldolase reaction), the former being an 
acyl acceptor for triglyceride and phospholipid synthesis (267, 272).
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Glycerol 3-phosphate dehydrogenase is present in the cytosol. The 
tissue distribution of glycerol 3-phosphate dehydrogenase has been 
studied in rats; significant activities are present in the liver 
(262, 263), skeletal muscle (260, 262), brain (261), heart and 
adipost tissue (264), but the highest enzyme level is found in the 
muscle (239).
The enzyme has been purified from various tissues and several 
different animals (206, 238, 243, 244, 259, 260, 261, 262, 263, 265).
The rabbit liver enzyme has values of 0.91mM, 0.075mM, 0.083mM 
and 0.022mM for glycerol 3-phosphate, dihydroxyacetone phosphate,
NAD and NADH, respectively (243).
There is some evidence to suggest that the liver enzyme has two
allosteric sites, one for glycerol 3-phosphate and the other for NAD.
The binding of glycerol 3-phosphate to its allosteric site lowers the
K for this substrate but increases the K for dihydroxyacetone phos- 
m m
phate. The case is similar with NAD (265). The effects of sugar 
phosphates, nucleotides and other phosphorylated compounds on glycerol 
3-phosphate dehydrogenase from rabbit liver have also been studied.
Lee ejt (210) found that glucose 6-phosphate, fructose 1,6-diphos­
phate and 3-phosphoglycerate inhibited the oxidation of glycerol 3- 
phosphate, competitively, with respect to both glycerol 3-phosphate 
and NAD. On the other hand, glyceraldehyde 3-phosphate was competi­
tive with glycerol 3-phosphate and non-competitive with NAD. Further­
more, nucleotides (AMP, ADP and ATP) and pyrophosphates were found to 
inhibit both the forward and reverse reactions in a competitive manner 
with respect to NAD.
It has been shown by Fitch and Chaikoff (266) that feeding 
glucose- or fructose-enriched diet (60% for 7 days) to rats, resulted 
in a significant increase in the activity of glycerol 3-phosphate 
dehydrogenase. There are claims that glycerol 3-phosphate dehydrogen­
ase is under the control of adrenal and pituitary function via gluco­
corticoids in rat brain but not in muscle (268).
(c) Glucose metabolism in the liver
The catabolism of glucose to trioses and eventually acetate, is 
well documented and differs, in the main, from fructose metabolism in 
the initial phosphorylation reaction and the subsequent aldolase- 
catalysed reaction which yields different products. Furthermore, whilst 
glucose metabolism to acetate is controlled by four rate—limiting 
enzymes; glucokinase, phosphofructokinase, pyruvate kinase and pyruvate
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dehydrogenase, conversion of fructose to acetate would appear to 
be only controlled by the latter two enzymes.
The first step in glucose metabolism in the liver is phosphory_ 
lation which yields glucose 6-phosphate. This is achieved by hexo- 
kinases and the process requires ATP and Mg^* ions (214). In mam­
malian tissues, two types of hexokinases have been detected the 
group of, so-called, low (for glucose) hexokinases (ATP:D-glucose 
6-phosphotransferases; EC 2.7.1.1.) which have a low substrate 
specificity and a single high form, present only in the liver, 
which is normally termed glucokinase (ATP:D-glucose 6-phosphotrans­
ferase; EC 2.7.1.2) and which is specific for glucose (208).
Using DEAE-cellulose column chromatography and starch gel- 
electrophoresis Katzen (211) resolved hexokinase activity in rat 
tissues into different forms. He detected three isoenzymes which 
were designated hexokinases I, II and III. An additional form, 
type IV hexokinase, was also found and this is the form which is now 
commonly known as glucokinase. All four isoenzymes have been detected 
and purified from livers of several different animal species (163,
194, 211, 213).
In the livers of both man and rat, hexokinases are localized in 
the epithelial cells of the bile ducts and glucokinase is present in 
the hepatocytes (209). The hexokinases of rat liver can phosphory­
late fructose but it is unlikely, under physiological conditions, that 
fructose is a substrate for these kinases (see p.33). Glucokinase 
cannot catalyze the phosphorylation of fructose (207, 208).
The distribution and kinetic data for the multiple forms of rat 
hexokinases are summarized in Table I (211). Hexokinases are inhibited 
by their reaction products, glucose 6-phosphate and ADP (208, 214). 
Glucokinase, on the other hand, is not inhibited by these compounds but 
acetyl-CoA and phosphoenol pyruvate are inhibitors (200).
In the liver of several mammals and man, the hexokinase activity 
is approximately the same, i.e. 0.4 U/g tissue. A high glucokinase 
activity (1.35 U/g) in rat liver compared to human liver (0.08-0.2 
U/g) has been reported (214, 218). Rat liver glucokinase is an adap­
tive enzyme and its activity is increased by a glucose-enriched diet 
(346). The hexokinases of rat liver, however, are much less subject 
to dietary modification (346). Sharma et. il- (347) found that fasting 
or alloxan diabetes markedly depressed glucokinase activity without
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TABLE I. Kinetic properties and distribution of multiple 








I Brain 3.0 X IQ-S 3.1 X 10“^
Liver 2.5 X 10-3 -
Muscle 2.4 X 10-3 5.0 X 10"^
II Muscle 2.0 X 10-4 2.4 X 10"^
Epididymal 
fat pad
1.4 X 10-4 3.0 X 10"^
III Liver 5.0 X 10-3 2.2 X 10"^
IV Liver 1.6 X 10-2 *
(Glucokinase)
* Fructose is not a substrate at concentrations up to 0.1M.
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affecting the activity of hexokinase. Glucokinase activity was 
restored when glucose was refed to fasted animals or when insulin 
was administered to diabetic rats. Furthermore, it has been 
suggested that the responsiveness of liver to dietary glucose in 
maintaining a high activity of glucokinase requires the action of 
both insulin and glucose (347). '
With regard to the hexokinases, however, there are reports 
(163, 196) that type II which is predominantly found in insulin- 
sensitive tissues (heart and skeletal muscles and adipose tissue) 
but at low levels in liver and other insulin-insensitive organs, 
is reduced in diabetic or starved rats. Insulin injection and/or 
refeeding raises the level of type II hexokinase. Glucokinase 
activity in aged, fasted rats is not restored to normal by glucose 
feeding. Administration of large amounts of insulin appears to 
overcome the age-dependent deterioration of the regulatory capacity 
(201).
Glucose 6-phosphate, produced by the kinases, is isomerized in 
the glycolytic pathway to fructose 6-phosphate (see Fig. 3) and 
after this stage the path of carbon from glucose to acetate is 
further regulated by the allosteric enzyme, phosphofructokinase 
(ATPzD-fructose 6-phosphate 1-phosphotransferase; EC 2.7.1.11).
This enzyme phosphorylates fructose 6-phosphate to fructose 1,6- 
diphosphate and it is present in most tissues but the levels vary 
greatly. The liver, for example, possesses a much lower specific 
activity than muscle (214). The kinase has been purified from tissues 
from several animal species including muscle (212), brain (242), 
kidney (245), heart (282, 283) and liver (197, 202, 203). Phospho­
fructokinase exists in two forms: the M-type is localized in skeletal 
muscle, heart and brain and the L-type in liver, kidney and adipose 
tissue (214). These two isoenzymes exhibit different kinetic proper­
ties. A comparison of rabbit liver and muscle phosphofructokinases 
shows similarities in their pH optima and at pH 8.2, cation activa­
tion and substrate affinity. On the other hand, differences in the 
two latter properties were observed when reactions were carried out 
at pH 7.0. In the presence of 0.75mM ATP, the values for fructose 
6-phosphate for the muscle and liver enzymes were 0.056mM and 0.052mM, 
respectively, and using 1mM fructose 6—phosphate, the values for 
ATP were 0.050 and 0.043mM, respectively (202).
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The activity of phosphofructokinase is regulated by a variety 
of metabolites. It has been shown that ATP and citrate are potent 
inhibitors of the enzyme (197) and that ADP, AMP, inorganic phos­
phate and fructose 6-phosphate are activators (197, 246). The 
liver enzyme is more strongly inhibited by ATP than the muscle-type 
and it is not sensitive to reversal of inhibition by AMP. Further­
more, the hepatic phosphofructokinase is less inhibited by citrate, 
phosphoenolpyruvate and other phosphates than muscle enzyme (202,
246). ^n vitro, inhibition of rat liver phosphofructokinase activ­
ity by long chain fatty acids has also been reported (17, 285, 286).
The effect of insulin and glucagon on the activity of hepatic 
phosphofructokinase has been investigated in rats (20, 349, 350, 351).
The enzyme activity has been shown to decrease in the liver of alloxan 
diabetic rats and during starvation and the activity can be restored 
after insulin replacement or refeeding normal diet, respectively, in 
these animals (20). Insulin and glucagon injected intravenously into 
normal rats produces rapid reciprocal changes in the activity of phos­
phofructokinase (349, 351): insulin induces an increase whilst glucagon 
effects a decrease. It is believed that the glucagon-effect is mediated 
through the action of cyclic AMP on a cyclic AMP-dependent protein 
kinase as the effect of this peptide hormone on the enzyme activity is 
preceded by a significant increase in cyclic AMP levels which occur 
immediately after hormone injection (351). The effect of epinephrine 
on phosphofructokinase activity has also been investigated in the rat 
(352). Infusion of the hormone into rat portal vein results in a rapid 
decrease in the activity of the kinase in liver. Insulin administered 
5 min after epinephrine partially reverses the epinephrine effect.
The epinephrine effect is also associated with a significant increase 
in hepatic cyclic AMP concentrations. According to Stifel ejt (352)
the epinephrine effect appears to be mediated through the action of 
cyclic AMP, but on a cyclic AMP-independent protein kinase as was 
demonstrated by Garrison (373). Pretreatment of rats with actinomycin 
D or puroraycin does not alter the response of the enzyme to insulin, 
glucagon or epinephrine, indicating that de novo protein synthesis is 
not responsible for the change in enzyme activity (351).
The enzyme pyruvate kinase (ATP: pyruvate phosphotransferase;
EC 2.7.1.40) catalyzes the transfer of the 'energy-rich' phosphate
group from phosphoenolpyruvate to ADP producing enolpyruvate and ATP (214)
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During gluconeogenesis, phosphoenolpyruvate is produced from 
pyruvate via oxalacetate in two steps which are catalyzed by 
pyruvate carboxylase (EC 4.6.1.1) and phosphoenolpyruvate car- 
boxykinase (EC 4.1.1.32), respectively. High levels of these 
two gluconeogenic enzymes are present in liver and kidney i.e. in 
tissues capable of catalyzing glucose formation from trioses at 
a relatively high rate (306).
In the cell, pyruvate kinase is localized in the cytosol (214). 
At least three different isoenzymic forms of the kinase are present 
in higher animals (353). The L-type is found as a major component 
in the liver and a minor constituent in the kidney. The M-type is 
found in muscle, brain and heart; the third, A-type, occurs in 
adipose tissue and kidney and to a lesser extent in liver (353, 355). 
The L- and A-types share a number of regulatory properties; for 
example, both exhibit sigmoidal kinetics with respect to the concen­
tration of phosphoenolpyruvate and both are allosterically inhibited 
by citrate and activated by fructose 1,6-diphosphate. They differ, 
however, with regard to allosteric inhibition by ATP which occurs 
with the L-type but not the A-type. The M-type pyruvate kinase has 
none of the above mentioned regulatory properties (353). Pyruvate 
kinase has been purified from the livers of rats (309, 332, 356) and 
other animal species (338, 339, 343). More recently human liver 
pyruvate kinase has been purified (354). The M-type pyruvate kinase 
(rat muscle) has a K of 0.7 x 10~^M for phosphoenolpyruvate and 
0.3 X 10"^M for ADP whilst the L-type (rat liver) has values of 
0.8 X 10” \  and 0.3 x 10"^M, respectively (214, 344). Rat liver 
pyruvate kinase is allosterically inhibited by ATP and alanine and 
inhibition by ATP is reversed by fructose 1,6-diphosphate and high 
concentration of phosphoenolpyruvate (355). Tanaka et al. (344) have 
shown that fructose 1,6-diphosphate (O.ImM) can activate purified 
L-type pyruvate kinase from rat liver at a low concentration of phos­
phoenolpyruvate and it also reverses inhibition of the enzyme by. ATP. 
Furthermore, in the absence of fructose 1,6-diphosphate the curve of 
the enzyme activity plotted against the phosphoenolpyruvate concen­
tration is sigmoidal whilst in the presence of fructose 1,6-diphos­
phate the enzyme follows Michaelis Menten kinetics with a low for 
phosphoenolpyruvate (0.08mM) (344, 355). Activation of rat liver 
pyruvate kinase by fructose 1-phosphate has been reported (277) with 
most marked activation occurring at low phosphoenolpyruvate
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concentrations (0.05 - 0.25mM). At a higher phosphoenolpyruvate 
concentration (O.SmM), however, no activation by fructose 1-phosphate 
occurred. Acetyl-CoA has also been shown to inhibit rat liver 
pyruvate kinase activity (345).
The effects of diet and hormones on hepatic pyruvate kinase 
have been investigated in rats. Cohen ejt (335) have shown that
the activity of liver pyruvate kinase increased 4- to 6-fold, in 
rats fed a sucrose-enriched diet (72%) for 12 months, as compared to 
animals fed chow. An increase in the activity of liver enzyme has 
also been demonstrated by Yudkin and Krauss (197) in rats fed a 60% 
sucrose diet for 10 days. In alloxan diabetes and during starvation 
pyruvate kinase activity decreases but it can be restored by insulin 
treatment or refeeding normal diets (20). Insulin and glucagon 
injection into normal rats have been shown to raise and lower, re­
spectively, the activity of rat liver pyruvate kinase (349, 351). 
Glucagon and cyclic AMP have been shown to stimulate gluconeogensis 
in the liver and to increase the ratio of phosphoenolpyruvate concen­
tration to that of pyruvate (357, 358). Herman and co-workers (349,
351) found that rapid decrease in rat liver pyruvate kinase activity 
occurred a few minutes (2-10min) after an intravenous injection of 
glucagon. As with phosphofructokinase, the glucagon effect is believed 
to involve a cyclic AMP-dependent protein kinase which phosphorylates 
pyruvate kinase and inactivates it (355). Rat liver pyruvate kinase 
has been purified and found to be a substrate for cyclic AMP-stimu­
lated protein kinase (355). At low phosphoenolpyruvate concentrations 
the activity of pyruvate kinase is inhibited by phosphorylation (be­
cause of an increase in the apparent for phosphoenolpyruvate, from
0.3mM to O.SmM (in the absence of fructose 1,6-diphosphate) at pH 7.3). 
Cyclic AMP-stimulated phosphorylation of enzymes and other proteins 
is reversible, because of the existence of phosphoprotein phosphatases. 
Thus, the metabolic regulation of liver pyruvate kinase via a phosphory­
lation-déphosphorylation mechanism is possible. Epinephrine when 
injected into rats has been shown to produce an effect similar to that 
of glucagon (352) but in this former case a cyclic AMP-independent 
protein kinase mediates (373).
The conversion of pyruvate to acetyl-CoA, a precursor of fatty 
acids, is catalyzed by the pyruvate dehydrogenase complex (EC 1.2.4.1). 
This oxidative decarboxylation reaction requires three different 
enzymes and five different coenzymes organized together into a
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multienzyme complex (see Fig. 4): in animal tissues it is localized 
in the mitochondria. In skeletal muscle, heart, kidney, liver and 
adipose tissue (214) the pyruvate dehydrogenase complex consists of 
dihydrolipoyl transacetylase, as a core, to which pyruvate dehy­
drogenase, dihydrolipoyl dehydrogenase and two regulatory enzymes, 
pyruvate dehydrogenase kinase and a -phosphatase, are attached (359). 
The activity of the complex is inhibited competitively by the products 
of pyruvate oxidation, acetyl-CoA and NADH, and these inhibitions are 
reversed by coenzyme A and NAD, respectively (360). Furthermore, the 
transacetylase and flavoprotein components of the complex are the 
sites of acetyl-CoA and NADH inhibition, respectively.
Pyruvate dehydrogenase is under metabolic and hormonal regulation 
and a regulatory mechanism, involving phosphorylation and dephosphory­
lation of the complex has been demonstrated (359, 361, 362). Phos­
phorylation (inactivation) of the complex is catalyzed by pyruvate 
dehydrogenase kinase and dephosphorylation (activation) by pyruvate 
dehydrogenase phosphatase.
This control mechanism has been demonstrated with preparations of 
pyruvate dehydrogenase from mammalian liver and other tissues (359).
The kinetic and regulatory properties of the purified pyruvate dehy- 
drogenase-kinase and -phosphatase from bovine kidney and heart have 
been described (362). Both ADP and pyruvate are competitive inhibitors 
of the kinase and they compete with ATP. Recent studies indicate that 
Ca^* is required in addition to Mg^^ for pyruvate dehydrogenase phos­
phatase activity (363, 369). Activation of pyruvate dehydrogenase is 
enhanced by conditions that decrease the ATP/ADP molar ratio or increase 
the intramitochondrial pyruvate concentration. These observations are 
consistent with inhibition of pyruvate dehydrogenase kinase by pyruvate 
and ADP, respectively.
Regulation of the interconversion of the phosphorylated and the 
non-phosphorylated forms of rat adipose tissue pyruvate dehydrogenase 
by insulin has been reported (37 0, 371) and by long chain fatty acids 
(372) with rat heart, liver and kidney enzymes. Insulin, increases 
the proportion of the non-phosphorylated form of the dehydrogenase and 
this effect is antagonized by epinephrine. Metabolic states (diabetes 
and starvation) associated with increased concentrations of plasma free 
fatty acids result in an increase in the proportion of the phosphory­
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Fig. 4. The reaction steps involved in the oxidative decarboxylation 
of pyruvate to acetyl-CoA
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B. TRIGLYCERIDE SYNTHESIS
A major metabolic fate of glucose and fructose in animals in 
a positive calorie balance is conversion to triglyceride. The 
mammalian biosynthetic pathways to triglycerides from hexoses 
mainly involves ^  novo synthesis of long chain fatty acid esters 
which are then used to esterify sn-glycerol 3-phosphate. In out­
line, this occurs as follows. The first step to long chain acyl- 
CoA derivatives is the addition of CO to acetyl-CoA with the pro­
duction of malonyl-CoA. This reaction is catalyzed by the biotin- 
requiring enzyme, acetyl-CoA carboxylase (EC 4.6.1.2) (326):
Enzyme-biotin + HO-CO^ + ATP ^ — ► enzyrae-biotin-CO^ + ADP + P^
Enzyme-biotin-CO^ + acetyl-CoA------------- ►enzyme-biotin + malonyl-CoA
Allosteric activation of this enzyme by citrate and inhibition 
by palmityl-CoA (a major product of fatty acid synthesis) can occur 
(326). Possible control of acetyl-CoA carboxylase by phosphorylation 
and dephosphorylation of the enzyme has been reported (328, 330). A 
rat liver protein fraction inactivated the enzyme vitro with con­
comitant incorporation of ^^P from [Y-^^p] ATP and the phosphoryla­
tion was reversed by a phosphatase fraction (328). Cyclic AMP has 
also been shown to inhibit acetyl-CoA carboxylase activity in rat 
liver slices (331). However, ^  vivo regulation of the enzyme by 
phosphorylation-déphosphorylation and the role of cyclic AMP has been 
questioned (391).
The second step in fatty acid synthesis is the conversion of 
malonyl-CoA to palmityl-CoA which is catalyzed by a fatty acid synthase 
multienzyme complex consisting of six enzyme proteins and an acyl 
carrier protein. In essence the reaction consists of the transfer of 
C^ units from malonate to acetyl-CoA and reduced pyridine nucleotide, 
NADPH, is required (326).
Acetyl-CoA + 7 malonyl-CoA + 1 4  NADPH + 14 H ^ -------------------- -
palmitic acid + 14 NADP + 7 CO^ + 8 CoA + 6 H^O
Fatty acid synthase of pigeon liver is stimulated by phosphory­
lated sugars, especially fructose 1,6-diphosphate (397) and with the 
rat liver complex inhibition by palmityl-CoA has also been reported 
(328). Fatty acid synthase activity has been shown to increase when 
rats are fed a fat-free diet and decrease when fed a high-fat diet or
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on fasting. It has been demonstrated (397) that the high hepatic 
fatty acid synthase activity accompanying a fat-free diet returns 
to normal after gastric intubation of linoleate and linolenate but 
not after administration of palmitate or oleate.
The adaptive synthesis of fatty acid synthase in the liver of 
rats fed a fat-free diet following a 48 hr fast has been studied 
using immunochemical methods (327). The synthesis of the active 
synthase occurs 3 hr after feeding whereas the synthesis of in­
active material which can be precipitated by anti-fatty acid syn­
thase serum, occurs within 1 hr. Furthermore, incorporation of 
radioactive pantothenate into the synthase during the adaptive syn­
thesis follows the same pattern as the development of enzyme activity, 
indicating that the inactive butimmunochemically identical precursor 
of fatty acid synthase may represent an apoenzyme which is converted 
to enzymically active holoenzyme by the incorporation of the 4'- 
phosphopantetheine prosthetic group.
Fatty acid synthase in the developing liver has been studied in 
rat (397): the hepatic activity rises dramatically at the time of 
weaning when animals change their diet from high fat milk to lower 
fat chow. Synthase activity is also reduced in livers of alloxan- 
diabetic rats (397, 401) and administration of insulin to these rats 
restored the activity.
Two molecules of NADPH are needed for every complete sequence of 
reactions catalyzed by fatty acid synthase and this reduced coenzyme 
is derived from glucose 6-phosphate in two stages involving two 
separate dehydrogenases. In the first stage glucose 6-phosphate is 
oxidized to 6-phosphogluconate by the action of glucose 6-phosphate 
dehydrogenase (EC 1.1.1.49) as follows:
Glucose 6-phosphate + NADP ►6-phosphogTuconolactone + NADPH + H^
LciC to r ic is G
6-phosphogluconolactone + H^O ------------ ►6-phosphogluconate
Rat liver glucose 6-phosphate dehydrogenase has been crystalized 
by Matsuda and Yugari (408) who investigated some of the molecular 
properties of the enzyme (409). The enzyme is inactivated by free 
fatty acids and this process is facilitated by ATP. Although no effect 
of ATP itself on the enzyme has been reported by these authors (409), 
Avigad (410) has described inhibition of the rat liver dehydrogenase by 
ATP. NADP antagonizes the effect of fatty acids and this relationship
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is shown to be of a competitive type (409). Rat liver glucose 6- 
phosphate dehydrogenase has a of 1.3 x 10"^ M for both NADP and 
glucose 6-phosphate. The specific activity of glucose 6-phosphate 
dehydrogenase in rat liver is 46 ± 3U/g liver (at pH 7.6) in male 
rats although the level is higher in females (ca 104 ± 12U/g liver) 
(384).
There is some evidence to show that liver glucose 6-phosphate 
dehydrogenase is under long term dietary regulation. Clock and 
McLean (98) first reported a marked reduction in the activity of 
the dehydrogenase in the livers of starved rats. This finding has 
been confirmed and extended by other workers who observed that re­
feeding starved animals led to an increase in the levels of activity 
(183, 188, 237, 266, 407). Administration of a high-fat diet follow­
ing starvation does not induce recovery of the enzyme activity (237).
A 3-fold increase in activity was observed, however, when a balanced 
diet was given to fasted rats; the increase was more pronounced (10- 
12-fold) if the rats were fed with a carbohydrate-enriched diet 
particularly if the carbohydrate used was fructose (183, 266). There 
is some evidence that ^  novo synthesis of glucose 6-phosphate dehy­
drogenase occurs in response to diets rich in carbohydrate (188, 407). 
The activity of glucose 6-phosphate dehydrogenase has been shown to 
decrease in diabetic rats (183) and insulin injection together with a 
carbohydrate enriched diet raises the activity of the dehydrogenase 
(416) by increasing the rate of synthesis (80-fold) of the enzyme: 
the rate of degradation is also increased (5-fold). The rate of 
synthesis increases in proportion to the caloric consumption of car­
bohydrate and Rudack and co-workers (416) have concluded that insulin 
'induces' glucose 6-phosphate dehydrogenase synthesis, by stimulating 
the appetite of the animal. Glucagon and cyclic AMP have been shown 
to prevent the induction of rat liver glucose 6-phosphate dehydrogenase 
which normally occurs when fasted rats are fed a high carbohydrate 
diet (418). The hormone decreased the rate of enzyme synthesis without 
altering the rate of enzyme degradation (417). The effects of sex 
steroid hormones on this dehydrogenase are considered later (see p. 72).
The second enzyme involved in glucose 6-phosphate catabolism and 
the regeneration of NADPH is 6-phosphogluconate dehydrogenase (EC 1.1. 
1.44). In this reaction 6-phosphogluconate undergoes oxidation and 
decarboxylation to form D-ribulose 5-phosphate.
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6-phosphogluconate + NADP ---------—► ribulose 5-phosphate + NADPH +
The dehydrogenase from rat liver has been purified (419): the 
values for 6-phosphogluconate and NADP are 7.1 x 10~^M and 1.3 x 
10 respectively. The specific activity of 6-phosphogluconate 
dehydrogenase in male rat liver is 59 ± 8U/g tissue and in female 
rats this level is, again, higher (ca 130 ± 12 U/g tissue) (384).
Evidence has been presented that both ATP and NADPH act as competi­
tive inhibitors of the dehydrogenase with respect to NADP (384, 419) 
and that the NADPH concentration ijn vivo may be a sensitive regulator 
of the activity of the enzyme (419). Diet regulates the dehydrogen­
ase in rat liver; a high-fat, carbohydrate-free diet significantly 
decreases the activity (237). In normal rats, the substitution of 
glucose or fructose (60% for 7 days) for a stock diet resulted in an 
increase in the activity of 6-phosphogluconate dehydrogenase (266).
When the same dietary substitution was made with diabetic rats, the 
change in enzyme activity was less than that found with normal rats.
The activity of the dehydrogenase was reduced in diabetic rats regard­
less of the diet fed (183). Glucagon does not appear to be able to 
regulate the enzyme level (417).
The relative rates of synthesis and degradation of rat liver 6- 
phosphogluconate dehydrogenase have been studied in animals under 
different dietary conditions (420). With rats fed a high-carbohydrate, 
fat-free diet the rates of synthesis were 3.7- and 5.6- times greater 
than that with animals fed a normal diet or fasted rats, respectively.
No significant differences in the rates of degradation of the enzyme 
in all three nutritional states have been noticed.
The long chain acyl-CoA derivatives synthesized from acetate and 
malonate are ultimately used as acyl donors for triglyceride formation. 
The initial acceptor for these acyl groups can be sn-glycerol 3-phosphate 
or dihydroxyacetone phosphate. The relative importance of the, so- 
called, dihydroxyacetone phosphate and glycerol 3-phosphate pathways 
for the synthesis of acyl glycerols has been studied in several dif­
ferent laboratories (272, 273, 297, 304, 305, 307). The two pathways 
which both produce phosphatidic acids, are illustrated in Fig. 5.
In the first step in the glycerol 3-phosphate pathway a NAD- 
dependent, reduction of dihydroxyacetone phosphate catalyzed by glycerol 
3-phosphate dehydrogenase occurs followed by mono-acylation by glycerol 
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E N Z Y M E S
1. Sn-glycerol 3-phosphate acyltransferase (EC 2.3.1.15)
2. Dihydroxyacetone phosphate acyltransferase (EC 2.3.1.42)
3. 1-Acyl sn-glycerol 3-phosphate acyltransferase
4. Phosphatidate phosphohydrolase (EC 3.1.3.4 )
5. Diacyl glycerol acyltransferase
6. Sn-glycerol 3-phosphate dehydrogenase (EC 1.1.1.8 )
7. Acyl didydroxyacetone phosphate reductase (EC 1.1.1.101)
Fig. The de novo synthesis of triglyceride
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this transferase are found in the adrenal gland, liver and adipose 
tissue (267). Studies reported by Lloyd-Davies and Brindley (300) 
and Lamb and Fallon (301) suggest that glycerol 3-phosphate acyl- 
transferase is a rate-limiting reaction in phosphatidate formation 
in microsomal fractions of rat liver. After the introduction of a 
second acyl group by acyl glycerol 3-phosphate acyltransferase which 
yields phosphatidate, diacyl glycerol is then formed by hydrolysis 
catalyzed by the enzyme phosphatidate phosphohydrolase (EC 3.1.3.4)
(301). Lamb and Fallon (301) believe that this may be a rate con­
trolling reaction for diacyl glycerol and triacyl glycerol formation 
in liver cells. In the final stage of the process the third acyl 
group is introduced by diacyl glycerol acyltransferase (326). In this 
pathway where glycerol 3-phosphate is an intermediate a further con­
tribution to the pool of this phosphate comes from glycerol derived 
from lipolysis and, possibly, the reduction of glyceraldehyde.
Glycerol can be converted directly to glycerol 3-phosphate by glycerol 
kinase (see p. 37).
In the dihydroxyacetone phosphate pathway, dihydroxyacetone 
phosphate is converted to acyl derivatives and this can occur in 
both mitochondria and microsomal fractions (273, 304, 305): acylation 
is catalysed by the enzyme dihydroxyacetone phosphate acyltransferase 
(EC 2.3.1.42). NADPF[-dependent acyl dihydroxyacetone phosphate 
reductase (EC 1.1.1.101) can then reduce the carbonyl groups of the 
acyl derivatives to hydroxyls and the resulting acyl glycerol phos­
phates are then further acylated to phosphatidates as previously 
described (326).
The relative contributions of the two pathways for acyl glycerol 
synthesis have been compared in homogenates of different tissues.
Pollock ejt (297) have shown that dihydroxyacetone phosphate enters
phosphatidate more rapidly via acyl dihydroxyacetone phosphate pathway 
than via glycerol 3-phosphate in those tissues which are deficient in 
glycerol 3-phosphate dehydrogenase. In liver ^  vivo it was suggested 
that the glycerol 3-phosphate pathway to acyl glycerols was more 
active than the acyl dihydroxyacetone phosphate pathway because the 
activities of glycerol 3-phosphate acyltransferase and glycerol 3- 
phosphate dehydrogenase were greater than that of dihydroxyacetone 
phosphate acyltransferase.
Rat liver slices were used to study the relative rates of incor­
poration of a mixture of [2-^h ]- or [l,3-^H]glycerol with [l-^^c]glycerol
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into lipids. Here, Manning and Brindley (272) showed that 40-50% 
of the glycerol incorporated into lipid by rat liver slices pro­
ceeded via the glycerol 3-phosphate pathway and 50-60% was incor­
porated via dihydroxyacetone phosphate. This contrased with studies 
where isolated hepatocytes were incubated with [u-^^C, 2-^n]glycerol 
which produced glycerolipids with ^H/^^C ratios similar to those 
found in the intracellular glycerol 3-phosphate and in the original 
labelled glycerol. This suggested that, in this case, the acyl dihy­
droxyacetone phosphate pathway did not contribute significantly to 
the total glyceride synthesis from glycerol since the conversion of 
glycerol 3-phosphate to dihydroxyacetone phosphate would have resulted
3
in loss of H and a change in the isotopic ratio (307).
III. EFFECTS OF DIETARY CARBOHYDRATES ON SERUM 
AND LIVER TRIGLYCERIDES 
The role of dietary carbohydrate, particularly sucrose, in pro­
ducing hypertriglyceridaemia leading to ischaemic heart disease has 
already been outlined (see p. 19).
In humans, two types of lipaemia are recognized, one of which is 
induced by fatty meals and the other by carbohydrate in the diet (140, 
141). Fructose or sucrose feeding, in comparison with glucose or 
starch, has been reported by many investigators to increase the serum 
triglyceride levels in man (143, 144, 145, 149), rat (52, 53, 63) and 
other animal species (155, 164). It is apparent that it is the fruc­
tose moiety of sucrose which is hypertriglyceridaemic (22).
The biochemical mechanisms underlying the hypertriglyceridaemic 
effect of carbohydrates is poorly understood. It has been postulated 
that sucrose and fructose cause an increase in plasma triglyceride con­
centration through: (1), an increased rate of hepatic synthesis of tri­
glyceride (324, 329) and/or (2), a decreased rate of clearance of plasma 
triglyceride (325).
The male rat has been the main experimental animal used to investi­
gate the effect of dietary carbohydrates on triglyceride levels in 
blood serum and in the liver from which most of the serum triglyceride 
is derived. Much of this work is often difficult to compare in detail 
because of the different concentrations of carbohydrates used in diets 
and the different times and ways of administration (solid or in solu­
tion). In addition, other components accompanying the carbohydrate 
supplements have often been varied.
These nutritional studies can be divided into short-term 
feeding (up to 4 weeks) and long-term (from over 4 weeks to 1 
year).
Zakim e_t al. (47), for example, observed that the concen­
tration of triglycerides in serum and liver increased when fasted 
(48 hr) rats were fed for a short period (48 hr) on glucose- or 
fructose-enriched diets (70% of calories) in comparison with chow. 
Fructose produced a higher serum triglyceride concentration than 
glucose but the liver triglyceride levels were very similar with 
these two hexoses. Bar-on and Stein (53) carried out a similar 
investigation and found that with rats, fructose feeding (10% 
solution for 6-19 days) significantly increased the serum trigly­
ceride levels compared to animals on glucose or chow diets. In 
comparison to chow, the liver triglyceride levels increased when 
rats were fed a glucose- or fructose-enriched diet. On the other 
hand, with guinea pigs in which fructose is known to be converted 
to glucose in the intestine (184), the serum triglyceride level 
was not affected by supplements of fructose or glucose to the diet 
(53). The feeding of a synthetic diet containing 60% sucrose for 
8-14 days to rats by Shiff ejt (424) also resulted in a signifi­
cant increase in serum and liver triglyceride level compared to 
animals on chow diets and Mukherjee e^ a^. (340) showed that rats 
ingesting diets containing 12% sucrose or fructose for 30 days, had 
raised the serum and liver triglyceride levels compared to those 
animals fed on glucose or starch. Serum triglyceride levels in rats 
on a glucose regimen were, however, lower than the control animals 
receiving starch. Nikkila and Ojala (63) reported that both glucose 
and fructose supplementation of chow diet (10% solution in the drink­
ing water for a period of 2 - 4 weeks) caused an increase of serum 
triglyceride concentration in rats but the effect of fructose was 
more marked than that of glucose. Also, the liver triglyceride 
content was raised by both hexoses although the fructose fed animals 
did not apparently differ significantly from the control. High (72%) 
and low (32%) sucrose supplement diets were shown by Lin and Anderson 
(65) to produce the same raised levels of triglyceride in both the 
serum and liver of rats. However, the two diets had different fibre 
and vegetable oil contents.
The age-dependent response of serum triglyceride to dietary 
fructose has been demonstrated with rats. Hill (154) found that
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feeding fructose (10% in the drinking water for 21 days) to rats 
compared to a chow diet, increased the serum triglyceride and caused 
an accumulation of liver triglyceride after 24 hr in mature rats.
In young animals, however, the serum triglyceride was not affected 
whilst the liver triglyceride was significantly increased after 
24 hr but decreased after 10 days of fructose feeding. Similarly, 
when Chevalier et al. (156) fed young and mature rats on diets (70% 
carbohydrate diet for 3 weeks) enriched with sucrose, fructose, 
glucose or starch, the serum triglyceride levels were significantly 
increased in the mature rats ingesting sucrose or fructose compared 
to those given glucose or starch diets. The levels of serum tri­
glycerides remained unaffected in young animals, however.
In conclusion, it is apparent that in short-term feeding experi­
ments with rats under a variety of conditions, the serum triglyceride 
levels are increased by sucrose- or fructose-enriched diets compared 
to glucose or starch. With the liver triglyceride concentrations, on 
the other hand, there is not the clear distinction between glucose 
and sucrose/fructose feeding that is seen with the serum triglycerides.
The effect of long-term feeding of carbohydrates on hepatic and 
serum triglycerides has again shown an association between sucrose or 
fructose and elevated serum triglyceride levels in a number of differ­
ent animal species. Coltart and Macdonald (155), using male baboons, 
have demonstrated an increase in the fasting serum triglyceride con­
centration after feeding sucrose (75%) for 17 weeks in comparison with 
a control chow diet. Palafox (77) has fed white leghorn hens (from 
20-76 weeks of age) a diet containing either raw sugar (7.9%) or corn­
starch (7.9%) and similarly found that the serum triglyceride levels 
of the birds ingesting raw sugar were significantly higher than those 
feeding on starch. When Tuovinen and Bender (55) fed rats with sucrose, 
fructose or starch (60% for 26 weeks) the hepatic triglycerides were 
increased significantly in the case of both the sucrose- and fructose- 
rich diets in comparison with starch. Likewise, Laube et ad. (157) 
found that rats fed on a diet supplemented with sucrose (68% for 15 
weeks) or an equimolar mixture of glucose and fructose exhibited an 
increase in total liver lipid and in serum triglyceride and free fatty 
acids in comparison with rats on a high starch diet. There was no sig­
nificant difference between the effects of the sucrose and glucose plus 
fructose diets on these animals. In contrast, studies by Bruckdorfer 
and Yudkin (333) suggest that carbohydrate induced hypertriglyceridaemia
- 57 -
does not occur with male pigs given a diet in which 50% of the dry 
weight was either sucrose or starch for one year.
The inclusion of sucrose in the diet not only affects liver 
triglyceride levels but in the long-term, it also produces changes 
in the composition of the bound fatty acids. Casal et al. (336) 
fed young rats (6 weeks) fat-free diets containing either starch, 
sucrose or glucose (74%) as a carbohydrate source and then the fatty 
acid composition of the liver triglyceride was analysed. They found 
that the fatty acids in livers of animals fed on glucose or sucrose 
containing larger proportions of palmitic, palmitoleic and oleic 
acids and a smaller proportion of linoleic acid than those fed on 
starch.
Macdonald (334) has shown that administration of sucrose (18-68% 
of total calories) to rabbits for 16 weeks increases the hepatic lipid 
levels compared to animals on starch or glucose diets. However, in 
this case a study of the fatty acid composition of liver triglyceride 
revealed that, with dietary sucrose, the proportions of palmitic and 
palmitoleic acids rose with increasing sucrose intake but with glucose 
they tended to fall and with starch there seemed to be no change. 
Dietary sucrose was associated with a more rapid drop in the propor­
tion of combined linoleic acid than was dietary starch or glucose. 
Recently, Macdonald and his associates (337) have given young rats 
diets containing 70% of either glucose, sucrose or fructose until they 
reached 200g body weight. They were then transferred to a chow diet 
for a further 4 weeks. Other control rats received a chow diet through­
out the whole experimental period. The amount of liver triglyceride 
was found to be significantly greater in the ’fructose group', compared 
with the other three dietary groups at the end of the period on a high- 
carbohydrate diet. In the group of animals on the fructose diet there 
was a significant fall in total liver triglyceride 4 weeks after re­
turning to the control diet: this did not occur with the sucrose- or 
glucose-fed rats. In these experiments the combined palmitic, palmito­
leic and oleic acids in the liver triglycerides after the period of the 
high carbohydrate diet (glucose, fructose or sucrose) was significantly 
greater than the levels in the fat from animals ingesting chow. In the 
case of linoleic acid, however, the reverse was found.
Glycerol (a possible metabolite of fructose) feeding has also been 
shown to produce hypertriglyceridaemia in rats (82). When male rats
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fed on chow diets supplemented by either glycerol or glucose (15% 
solution in the drinking water for 2 weeks) the serum triglyceride 
was significantly greater with the glycerol- than with the glucose- 
supplement. The liver triglyceride content was also increased in 
both glycerol- and glucose-fed animals as compared to control diet. 
Macdonald (316) also reported that dietary glycerol was hypertri­
glyceridaemic in men.
Incorporation of carbon from [U-^^c]glucose or [U-^^c]fructose 
into lipids has also been investigated with several different animal 
species and the results tend to confirm the normal dietary studies. 
Macdonald and Roberts (164) found that with 48 hr fasted baboons, the 
ingestion of 40g of glucose, sucrose or partially hydrolysed starch 
all equally labelled with carbon-14, produced serum triglycerides with 
higher levels of radioactivity in the case of the sucrose-fed animals 
than with the baboons fed hydrolysed starch or glucose. Gale and 
Crawford (91) studied the different rates of incorporation of carbon 
from [U-^^c]fructose and [u-^^c]glucose into lipids in guinea pigs
after oral or intraperitoneal administration of the sugars. They
)se 
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found that the contribution of [U-^^c]fructos to the serum trigly­
ceride was 4-6 times higher than that of [U- cjglucose. Nikkila and 
Ojala (63) injected [l-^^c]palmitic acid intravenously into rats 
previously fed on chow diets supplemented with either glucose or 
fructose in the drinking water for 2-4 weeks. They found that the 
radioactivity present in the serum triglyceride of the fructose-fed 
animals 60 min after injection was 2-4 times greater than that in the 
serum triglyceride of the control or glucose-fed animals. In the 
glucose-fed group, however, the radioactivity of serum triglyceride 
was similar to that in the control animals. Zakim ejt al^ . (47) com­
pared the conversion of [6-^^c]glucose and [6-^^c]fructose to tri­
glyceride fatty acids and CO^ in liver slices of rats which had been 
fed a chow diet then fasted for 48 hr and, finally, fed glucose or 
fructose diets (70% of calories) for 48 hr. These workers showed that 
the incorporation of.label from [6-^^c]fructose into the combined fatty 
acids was always greater than the incorporation from [6-^^c]glucose in 
all dietary groups. Both the glucose- and fructose-fed rats showed 
higher incorporation into combined fatty acids than the chow-fed animals 
Bar-on and Stein (53) have reported that when [U-^^c]glucose or [U-"*^c] 
fructose is injected intravenously into rats, significantly more 
fructose- than glucose-carbon is recovered in both liver and serum
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triglycerides 1 hr after injection. Chevalier and co-workers (348) 
have studied lipogenesis from [u- ^c]glucose, [U-^^c]fructose and
r ^ -j
[1- Cjacetate in liver slices from rats fed fructose- or glucose-
enriched (70%) diets for 2-3 weeks. They found that with liver
slices from glucose-fed rats more glucose than fructose was converted
to combined fatty acids. Dietary fructose, when compared to glucose,
enhanced lipogenesis from [U-^^c]fructose but it had no effect on
lipogenesis from [U-^^c]glucose or [l-^^c]acetate. Cohen and Teitelbaum
(52) fed rats starch-, glucose- or fructose-enriched diets (72% for
65 days), and then measured the rate of incorporation of intraperiton- 
r 14 I
eally injected |_1- Cjacetate into lipids. Their results demonstrated 
that animals fed glucose or fructose showed a significantly higher 
incorporation of labelled acetate into fatty acids and triglycerides 
in the liver and serum triglycerides compared with rats on a starch 
diet. There was no significant difference between glucose- and 
fructose-fed animals in this instance, however. Maruhama and Macdonald 
(425) using rats on diets low in fat and high in glucose or fructose 
(11 weeks), demonstrated that after intragastric administration of 
[U-"*^c]glucose or [U-^^c]fructose the incorporation of radioactivity 
into the glycerol moieties of liver and plasma triglycerides was higher 
than into the fatty acid moieties after both fructose and glucose feed­
ing with fructose contributing more label than glucose.
Using patients who had had a myocardial infarction, Maruhama (341)
r 14 -|
compared the incorporation of carbon from orally administered |_U- Cj 
glucose or [u-^^c]fructose into serum triglyceride-glycerol and tri- 
glyceride-fatty acids over a period of 4 hr. He found that the increase 
in the specific activity of the triglyceride-glycerol and triglyceride- 
fatty acids after [u-^^c]fructose administration was significantly 
greater in comparison with [U-^^c]glucose ingestion. The radioactivity 
of the triglyceride-glycerol was 10 times greater than that of the tri­
glyceride-fatty acids after both glucose and fructose administration.
r 1 4 - 1
Periera and Jangaard (49) have studied the rate of conversion of [U- Cj 
fructose and [U-^^c]glucose into various intermediates of carbohydrate 
and lipid metabolism in rat liver slices. They found that fructose was 
converted to pyruvic acid and triglyceride-fatty acid 3 times faster 
than was glucose and 19 times faster than glucose into triglyceride- 
glycerol.
In conclusion, it appears that the rate of incorporation of carbon 
from [U-^"^c]fructose into serum triglyceride is much higher than from
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[U- cjglucose and this difference is further exaggerated in animals 
that have received fructose-enriched, rather than glucose-enriched 
diets, prior to administration of the labelled carbohydrates. In 
most cases in which glucose and fructose have been compared, the 
transfer of label from [U-^^c]glucose to serum triglyceride-glycerol 
is substantially less than from [u-^^c]fructose and also the amount 
of the labelled carbon in triglyceride-glycerol is greater than that 
found in the fatty acid moieties of the triglycerides no matter which 
labelled hexose is administered. The incorporation of carbon-14 from 
[U-^^c]fructose and [U-^^c]glucose into liver triglyceride sometimes 
equates with the serum triglycerides but this may be modified by the 
dietary regimen proceeding the experiment so that both hexoses behave 
similarly (cf 348).
The association of dietary fructose, in comparison with glucose, 
with elevated serum triglyceride levels may relate to different rates 
of hepatic synthesis and secretion and/or different rates of lipolysis 
(clearing) of the triglycerides.
The liver is the major source of serum triglycerides and a rapid 
conversion of fructose to triglyceride, here, could relate directly 
to high serum triglyceride levels. In the liver, fructose is metabo­
lized as far as aldolase products by a pathway which is distinct from 
that for glucose but after these trioses the routes for the conversion 
of glucose and fructose to triglyceride are similar. All of these 
pathways have already been outlined (see p. 31 and Fig. 3).
The greater capacity for fructose metabolism than glucose metabolism 
by the liver relates largely -to the initial phosphorylation stages.
The activity of hepatic ketohexokinase in rat, for example, exceeds 
the combined activities of hexokinase and glucokinase (and in man the 
difference is even more marked (214)) no matter what dietary carbohydrate 
supplements are given to the animals (47). In addition, ketohexokinase 
is particularly sensitive, in rats, to fructose in the diet which leads 
to a very significant increase in its activity (46).
The hexokinase (hexokinase I, II and III and glucokinase)-catalyzed 
phosphorylation of glucose is a rate-limiting step in glycolysis (214). 
These enzymes are subjected to a number of controls not found with keto­
hexokinase. The hexokinases which are constitutive enzymes are at very 
low levels, in rat and human livers (218) and are inhibited by their 
products, glucose 6-phosphate and ADP. Although this is not true for
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glucokinase this enzyme, with a high for glucose, is under the 
control of insulin (and dietary glucose-containing carbohydrates) 
although this is a relatively long term effect.
In rat liver, a phosphorylation rate of 3.0 pmol fructose/g 
tissue/min and 1.98 pmol glucose/g tissue/min has been calculated 
based on the levels of ketohexokinase and hexokinase and glucokinase 
in the tissues under optimal conditions. Thus, fructose could be 
phosphorylated faster than glucose in rat liver, a fact that has also 
been established for human liver (218). In vivo, these rates would 
of course, be influenced by the rates of transport of the two hexoses 
across cell membranes (cf 173) although differential rates of fructose 
and glucose phosphorylation are presumably maintained in view of the 
results obtained by 'feeding* these compounds (see p. 54).
Further apparent evidence for the rapid phosphorylation of fructose 
in the liver comes from studies where the fructose 1-phosphate levels, 
following a fructose load, have been assayed. The level of hepatic 
fructose 1-phosphate has been shown to increase following fructose 
infusion of rats (271, 274, 279) and perfusion of rat liver (232). 
However, the biochemical mechanism which results in this increase is 
reported to involve the rapid decrease in the intracellular concen­
trations of ATP, as a result of fructose phosphorylation, and subse­
quent increasing AMP levels and degradation of this nucleotide to IMP 
(see Fig. 3). IMP inhibits fructose 1-phosphate aldolase activity 
and, hence, favours the accumulation of fructose 1-phosphate (232). 
Lamers and Hulsman (270) were unable to demonstrate a marked increase 
in hepatic fructose 1-phosphate concentration or decrease in ATP 
10 min after intraluminal loading of fructose, in contrast to the 
large effects on the levels of these metabolites observed by the 
other workers (271, 274, 279) after parenteral administration.
Other enzymes, aldolase 1-B and triokinase, supporting the 
metabolism of fructose are also at levels high enough to account for 
the rapid rate of fructose metabolism in rat liver (46). These latter 
two enzymes also reach maximum levels in response to dietary fructose 
(46, 198).
A further control of the path of carbon from glucose (but not 
fructose) to triose occurs at the phosphofructokinase-catalyzed stage 
of conversion of fructose 6-phosphate to fructose 1,6-diphosphate.
This enzyme is subjected to glucagon and epinephrine inhibition and 
insulin activation and to the influence of a variety of other effectors 
(see p. 43).
- 02 -
There is no evidence to suggest that the pathways for the 
metabolism of the trioses produced from fructose and glucose, 
which are different, play any major role in the more rapid conver­
sion of fructose than glucose to triglyceride. Dihydroxyacetone 
phosphate is produced from both hexoses but D-glyceraldehyde and 
D-glyceraldehyde 3-phosphate are the other products from fructose 
and glucose, respectively. D-glyceraldehyde 3-phosphate and dihy­
droxyacetone phosphate are interconvertable via triose phosphate 
isomerase and, hence, all the glucose carbons and C-1, C-2 and C-3 
of fructose pass to pyruvate via the glycolytic pathway and this 
triose in turn leads to acetate and triglyceride-fatty acid. Like­
wise the same carbons from glucose and fructose may find their way 
to triglyceride-glycerol. D-glyceraldehyde, however, derived from 
C-4, C-5 and C-6 of fructose could conceivably be further metabo­
lized by four different enzyme-catalyzed reactions (see p. 31).
The high activity of triokinase in both human and rat livers and the 
low of this enzyme for D-glyceraldehyde makes it a strong candidate 
for the major role in D-glyceraldehyde metabolism via the formation 
of the 3-phosphate derivative. This view is supported by Hue and 
Hers (235) who examined the conversion of [4-^H, 6-^^c]fructose to
liver glycogen (but not triglyceride) in mice and showed that the
14
glucose was labelled at C-1 and C-6 with C, with the tritium re­
maining at C-4. On the basis of the kinetic properties of the various 
enzymes involved in the metabolism of D-glyceraldehyde in the rat, 
Sillero e^ a^. (236) came to the same conclusion as Hue and Hers (235) 
that triokinase is the main enzyme involved in the metabolism of D- 
glyceraldehyde to glucose. Frandsen and Grunnet (111) have speculated 
that, in the rat, triokinase is mainly involved in the conversion of 
glyceraldehyde to glucose. These authors support this assumption by 
two observations: (1), that the amount of fructose converted to glucose 
in rat liver slices corresponds closely to the activity of triokinase 
in rat liver (447) and (2), that the enzyme possesses a relatively 
high for ATP. The latter could mean that glyceraldehyde phosphory­
lation is regulated to a significant degree by the ATP level vivo 
and that triokinase would, then, only be effective when the ATP con­
centration was high which would also favour other gluconeogenic 
processes and inhibit glycolysis and acetate formation. At low ATP 
levels Frandsen and Grunnet (111) suggest that the glycerate and/or 
glycerol pathways may operate.
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The possibility of D-glyceraldehyde metabolism by oxidation 
to D-glyceric acid does exist, because the levels of aldehyde 
dehydrogenase are high in both human and rat livers and because 
of the low value for the substrate. However, the hepatic 
glycerate kinase level in man is very low and it probably plays a 
minor physiological role in human liver. The situation could be 
different in the rat: here the glycerate kinase activity is signi­
ficantly higher than that of aldehyde dehydrogenase which means 
that the pathway of glyceraldehyde to 2-phosphoglycerate via gly­
cerate could operate but this was not detected by Hue and Hers
(235).
The levels of NAD- and NADP-dependent alcohol dehydrogenases 
in human liver are high but the affinity of the enzymes for D- 
glyceraldehyde are low which means that the reduction of D-glycer­
aldehyde to glycerol in human liver may be unimportant. In rat 
also the evidence does not altogether favour a glycerol pathway.
In this animal, NADP-dependent alcohol dehydrogenase activity is 
low and although the NAD-dependent enzyme appears to be at a similar 
level to triokinase the for glyceraldehyde in this case is about 
30mM. In addition, isotope studies, have shown that the liver gly­
cogen isolated from rats after administration of [ô-^^c]fructose (58) 
or [l-^^c]fructose (189) is labelled only at C-1 and C-6 of the 
glucose moieties. The reduction of D-glyceraldehyde to glycerol, its 
conversion to glycerol 3-phosphate by glycerol kinase followed by 
gluconeogenesis would shift the labelling to positions 3 and 4 of the 
glucose molecule but this was not observed. However, Landau and 
Merlevede (58) found that injection of D-[3-^^c]glyceraldehyde into 
rats did give rise to the glucose labelling pattern expected for 
conversion of glyceraldehyde to glycerol. This latter result could 
be explained by assuming that direct administration of D-glyceralde­
hyde raises the intracellular concentration of the aldehyde to levels 
high enough for the NAD-dependent alcohol dehydrogenase to function
(236) and raised aldehyde levels are said to occur in response to 
fructose loading (97).
In summary, the possible fate of D-glyceraldehyde in human liver 
is its conversion to D-glyceraldehyde 3-phosphate by triokinase whereas 
the situation in the rat is less clear. There is a possibility of 
reduction of D-glycerladehyde to glycerol or oxidation to glycerate 
in this animal.
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As it has been shown with rats that more carbon from 
fructose than [U- ^cJglucose is incorporated into the glycerol 
moiety of triglyceride (which in both cases is also higher than the 
incorporation into triglyceride-fatty acid) (see p. 58) it has been 
suggested that there is a more rapid synthesis of sn-glycerol 3- 
phosphate from fructose than from glucose. There is, however, a 
lack of general agreement: with both vivo and vitro studies, 
there are conflicting results regarding which of the two hexoses is 
the better precursor of glycerol 3-phosphate (47, 81, 270, 342).
The path of carbon from both glucose and fructose to acetate 
after the aldolase reaction is further controlled by the two enzymes, 
pyruvate kinase and pyruvate dehydrogenase, as described earlier 
(see p. 43). A rapid phosphorylation of fructose in the liver may 
also indirectly influence the activities of these two enzymes as 
fructose 1-phosphate, a product of the phosphorylation reaction, has 
been reported to activate pyruvate kinase (277) and a decreased con­
centration of ATP would activate pyruvate dehydrogenase (275), hence, 
acetyl-CoA formation would be favoured on both counts.
A high-fructose diet (47), as well as addition of the ketose to 
perfused liver (423), both in comparison with glucose, increases the 
hepatic concentration of acetyl-CoA by 40-60%. This effect could be 
attributed to: (1), the higher rate of fructolysis as compared to 
glycolysis which increases the supply of pyruvate; (2), the activation 
of pyruvate dehydrogenase resulting from a lowering of ATP levels 
caused by fructolysis (97). As regards (1), however, it is interest­
ing that studies by Tay (431) did not show increased levels of hepatic 
pyruvate in rats on a sucrose-enriched diet: in comparison with chow 
the concentration was lowered. The tissue concentration of a metabo­
lite of fructose need not relate directly to the rate of fructolysis 
and the level of acetyl-CoA, however. In this connection Tay (431) 
showed that hepatic pyruvate and lactate levels were not necessarily 
directly related. With reference to (2), a two- to three-fold increase 
in the proportion of hepatic pyruvate dehydrogenase in the active form 
has been demonstrated after injection of fructose into rats (275), as 
well as after administering fructose to perfused livers (276).
The more marked hypertriglyceridaemic effect of fructose than of 
glucose may then be merely a function of the greater rate of conversion 
of the ketose to both acetyl-CoA and glycerol 3-phosphate in the liver. 
The role of insulin in these pathways offers no apparent explanation
—  05 —
for this difference: glucose stimulates insulin production to a 
much greater degree than fructose (312) and on this basis one might 
perhaps expect the path of carbon to triglycerides to be greater 
from glucose as insulin should promote the conversion of glucose to 
the immediate products of the aldolase-catalysed reaction more 
rapidly than the conversion of fructose. In reality, it must be 
assumed that insulin stimulation of glucose metabolism does not com­
pensate for the rapid initial phosphorylation of fructose. A further 
possible contributory factor which remains to be investigated is that 
some product of glycolysis or fructolysis may influence the rate of 
conversion of acetate to long chain fatty acids and/or the estérifi­
cation reactions. For example a product of fructolysis could con­
ceivably serve as a positive effector of one of the stages in lipo­
genesis.
Intermediate between hepatic triglyceride synthesis and the 
appearance of triglyceride mainly as VLDL in the plasma is the process 
of secretion. Liver perfusion experiments have shown that the release 
of triglyceride can be directly correlated with the rate of fatty 
acid synthesis (308, 310). Therefore, secretion in response to a 
fructose load would be expected to be higher than in the case of 
glucose. An increase in the rate of secretion in response to fructose 
in liver perfusion studies has been reported (311) but no comparative 
studies with glucose appear to have been carried out. If the liver 
donors are fed sucrose-enriched diets the secretion response to the 
ketose in the perfusate is even greater (311). Heimberg £t ad. (302) 
have shown that in alloxan diabetic rats the release of triglyceride 
from perfused livers is inhibited. When livers from fed rats were 
perfused with blood containing insulin the secretion of VLDL-trigly- 
ceride was enhanced (310). Glucagon has the opposite effect to 
insulin. It has been suggested that glucagon acts by increasing the 
concentration of cyclic AMP which activates a hormone-sensitive lipase 
acting on the small precursor pool of VLDL-triglyceride which, in 
turn, results in a decrease in the output of triglyceride from the 
liver (303).
A further important or perhaps most important factor which regu­
lates the level of serum triglyceride is 'clearing* which is achieved 
by the enzyme lipoprotein lipase (glycerol ester hydrolase; EC 3.1.1.3). 
This enzyme is a triglyceride lipase present in adipose and many other 
tissues; it requires lipoprotein-bound triglyceride as a substrate (293)
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Lipoprotein lipase is located on the surface of endothelial cells 
of adipose tissue and skeletal and heart muscles (292). The liver 
enzyme is predominently associated with the hepatocyte outer mem­
brane (296). Lipoprotein lipase activity is barely detectable in 
fasting human plasma, on the other hand, activity can be demonstra­
ted in the plasma compartment a few minutes after the injection of 
heparin (293, 294).
The mechanism whereby heparin releases lipoprotein lipase from 
its binding site is unknown. It is believed that the enzyme is 
present as a membrane bound complex with a glycosaminoglycan and 
that exogenous heparin (which is also a glycosaminoglycan) either 
may bring the enzyme into solution by combining with it, or may dis­
place the enzyme from the binding site. In this connection there is 
some evidence that heparin and related substances have an affinity for 
an uncharacterized constituent of the blood vessel wall (278). In 
addition, Malakhova £t (269) have demonstrated, i^ i vitro, that lipo­
protein lipase forms a ternary complex with heparin and chylomicrons and 
this complex is able to prevent intravascular blood coagulation.
Post-heparin released lipoprotein lipase comes mainly from two 
sources, adipose tissue and liver (293, 295). The two enzymes differ 
in their response to inhibition by protamine and concentrated NaCl 
solutions and activation by specific apoproteins present in chylo­
microns and VLDL (281, 284). They also differ in their activity towards 
their substrates with the liver enzyme only having a limited capacity 
for hydrolysing lipoprotein-bound triglyceride (294).
Adipose tissue lipoprotein lipase activity has been reported to 
be markedly enhanced by the presence of HDL in the incubation medium, 
on the other hand, the liver enzyme is inhibited in the presence of 
HDL (293). In this connection it is interesting to note that HDL has 
been implicated as a protective factor in the aetiology of ischaemic 
heart disease (313).
Little is known about the interaction of triglyceride-rich lipo­
proteins and the lipoprotein lipase, situ, i.e. attached to the 
endothelial lining of the capillary wall. There is evidence to suggest, 
that the hydrolysis of the triglyceride by the enzyme occurs at, or 
close to, the luminal surface of the capillary endothelial cells of 
extrahepatic tissues (where the chylomicrons and VLDL are sequestered) 
and that the free fatty acids released after the triglyceride hydroly­
sis then pass across the endothelial cells into the tissues (289)^
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The activity of lipoprotein lipase is generally considered to 
be essential for a normal rate of clearance of triglycerides from 
the plasma, and hence, hypertriglyceridaemia occurs in animals with 
a low level of this enzyme such as occurs in familial type I hyper- 
lipoproteinaemia (281) and hypertriglyceridaemia of pregnancy in 
rats (287). In familial type I hyperlipoproteinaeraia there is a 
complete absence of the extrahepatic lipoprotein lipase; the activity 
of the liver enzyme, however, seems to be at normal levels (281).
Types III and IV hyperlipoproteinaemias are also conditions where 
plasma triglyceride levels are raised and, again, these diseases are 
believed to be caused mainly by decreased clearing rates and not 
increased rates of triglyceride synthesis (290). Plasma lipoprotein 
lipase activity has been studied in 50 patients with ischaemic heart 
disease within the age group 30 to 50 years. Dutt (291) found that 
post-heparin lipoprotein lipase activity in the serum was depressed 
in ischaemic heart disease cases. Here again, it seems possible that 
the clearance of triglyceride by lipoprotein lipase may be an import­
ant factor in the development of ischaemic heart disease.
Epinephrine, norepinephrine, adrenocorticotrophic hormone, gluca­
gon,thyroid and thyroid-stimulating hormones have each been shown to 
have an inhibitory effect on adipose tissue lipoprotein lipase activity 
in vitro (292). Moreover, most of these effects have been shown to be 
inhibited by insulin (292).
Starvation of rats results in a decrease of lipoprotein lipase 
activity in adipose tissue, whereas insulin or glucose administration 
has been reported to increase the activity (288, 289, 292). Cryer and 
his associates (315) fed equicaloric amounts of glucose, sucrose and 
fructose to starved rats and correlated lipoprotein lipase levels with 
the resulting insulin levels. Administration of glucose significantly 
raised both the insulin and enzyme levels beyond the levels obtained 
with sucrose and fructose. Garfinkel ejt (288) have shown that the
stimulation by insulin of epididymal adipose lipoprotein lipase 
activity ^  vivo is abolished by cycloheximide treatment. Stimulation 
•of the enzyme activity by insulin has also been demonstrated in the 
presence and absence of cycloheximide and in this case it was assumed 
that there was a direct activation of the enzyme by the hormone (280).
Hence, the appearance of more triglyceride in the serum in response 
to a fructose load than to glucose may well, in part, be explained by 
the poorer insulinogenic properties of fructose which results in lower
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lipoprotein lipase activities and a slower clearing rate. When 
the relative responses of lipoprotein lipase activity to fructose 
and glucose loads are considered together with the high rate of 
conversion of fructose to triglyceride, as compared with glucose, 
the result is a rational explanation for the hypertriglyceridaemic 
properties of fructose in comparison to glucose.
IV THE ROLE OF SEX HORMONES IN CARBOHYDRATE AND 
TRIGLYCERIDE METABOLISM
A. GENERAL CONSIDERATIONS
The greater hypertriglyceridaemic response to dietary fructose 
than to dietary glucose is well established in a number of animal 
species. However, in addition, a sex-dependent hypertriglyceridaemia 
in response to fructose or sucrose loads has also been reported (143, 
154, 155, 392, 396). These two dietary carbohydrates are, in general, 
associated with higher serum triglycerides in male animals than in 
female. This association does not apparently hold for glucose- or 
starch-enriched diets (143, 144, 314).
These observations are of interest because the incidence of 
ischaemic heart disease in men is greater than in premenopausal women 
and, in addition, the former have higher fasting serum triglyceride 
levels (an ischaemic heart disease risk factor (see p. 16)) than the 
latter. In the case of postmenopausal women fasting serum trigly­
ceride levels are higher than in premenopausal women (143) and the 
incidence of ischaemic heart disease in the older group is also sig­
nificantly higher (7).
This raises the question of whether diets rich in sucrose play 
any part in the aetiology of ischaemic heart disease and in particular, 
are sucrose and fructose metabolized differently by men and post­
menopausal women in comparison with women of a younger age group. If 
such a difference existed this might be equated with the varying serum 
triglyceride levels and, hence, the incidence of ischaemic heart 
disease. The possible role of the sex steroid hormones in the bio­
chemistry of sucrose or fructose and triglycerides is, therefore, of 
interest.
Sex steroid hormone secretion is controlled by releasing factors 
derived from the hypothalamus which promote the formation of gonado­
trophic hormones by the anterior pituitary gland. These hormones then 
stimulate the gonads, the major sources of sex steroids (Fig. 6). Sex
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hormones are produced in a cyclical manner in the female but at a 
constant rate in the male (323). Once secreted by the gonads the 
steroid hormones, bound to specific hormone-binding proteins, pass 
via the blood stream to reach their target cells. The responsive 
target cells contain specific hormone receptors which are membrane- 
bound proteins capable of binding the hormone molecule with very 
high specificity and affinity. In the target cells, the sex hormones, 
which are lipid-soluble, pass through the cell membrane to the primary 
receptors which are located within the cell. The binding of the 
hormone to its specific receptor causes the formation of an intra­
cellular messenger molecule, which stimulates (or depresses) some
characteristic biochemical activity of the target tissue and as a
consequence the metabolic pathways of the cell are modified. These 
theories will be discussed further in section V, p. 128.
Tissues other than the primary sex organs also appear to be 
targets for sex steroids. Androgen uptake by peripheral organs has, 
for example, been investigated by Gustafsson and Pousette (368) after 
intraperitoneal administration of tritiated testosterone to castrated 
male rats. They showed that a relatively high accumulation of this 
steroid occurred in pancreas, adrenals, spleen, muscles, kidneys and 
liver in addition to the sex organs. A similar treatment of castrated 
male rats also resulted in appearance of a [^Hjandrostenedione-protein 
complex in the liver cytosol and this complex is believed to be in­
volved in androgen action in the liver (367).
A cytoplasmic sex hormone receptor has been identified in male 
rat liver (364) and this receptor binds both androgens (5a-dihydro- 
testosterone and testosterone) and estradiol-17^. At a saturating 
concentration of either dihydrotestosterone or estradiol the receptor 
binds dihydrotestosterone and estradiol in a molar ratio of 3 : 1. 
Estradiol inhibits the uptake of dihydrotestosterone by the receptor 
whereas the presence of dihydrotestosterone only weakly interferes 
with estradiol binding. The level of the androgen receptor activity 
in the liver cytosol closely follows the level of the urinary output 
of a^^-globulin, an androgen-dependent protein of hepatic origin.
Roy et al. (366) have shown that the hepatic synthesis and urinary 
excretion of a^^-globulin in male rats is dependent on the production 
of androgens. Castration of male rats reduces the urinary excretion 
of a^^-globulin by 50% and subsequent replacement therapy with testos­





















Fig- 6. The major naturally occurring mammalian sex hormones,
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increases the excretion of a^^-globulin to normal levels (365).
Immature and senile males as well as adult female rats, all of 
which do not produce urinary a^^-globulin, lack hepatic androgen 
receptor activity and androgen treatment of these rats does not 
induce a^^-globulin (364). However, administration of androgens 
to ovariectomized female rats induces the urinary a^^-globulin.
An estrogen receptor has also been demonstrated in the liver 
cytosol of adult female rats (319, 320). Similar estrogen-binding 
sites have been identified in the liver cytosol of adult male rats 
(318). The presence of these receptors in liver presumably means 
that sex hormones are involved in the regulation of a number of 
metabolic pathways in this organ.
Differences in the metabolism of male and female animals must 
be mediated by differences in enzyme activities and, in general, 
there have been few studies in this area of biochemistry. However, 
it is not surprising to find that there are sex differences in the 
levels of some enzymes which metabolize steroids (379, 394, 395).
In addition, male/female differences in the levels of some trans­
aminases (389), glutamate dehydrogenase (389, 390), malate dehydro­
genase (390), aryl hydrocarbon hydroxylase (378), acetylcholine 
esterase (374), P-glucuronidase (375) and tryptophan oxygenase (376,
377) have all been reported. The latter enzyme, which is higher in 
female rat liver than male has been studied in detail and the effects 
of exogenous sex hormones both in vivo and in vitro have been investi­
gated. Ovariectomy, adrenalectomy and testosterone propionate in­
jections were all found to reduce the levels of tryptophan oxygenase 
in female rats. The injection of estradiol benzoate into intact 
females increased the levels after 14 days whilst similar treatment 
given to intact male rats raised the level of the enzyme above that 
of the untreated females. Castration of males had no effect on the 
level of tryptophan oxygenase but subsequent injections of estradiol 
to castrated males caused an increase in the activity of this enzyme 
to that of similarly treated, intact female rats. Braidman and Rose 
(377), however, found that several estrogenic steroids at relatively 
high concentrations inhibit the activity of tryptophan oxygenase 
in vitro by 10-25% but testosterone was without effect. The levels of 
hormones used were much higher than physiological levels but the authors 
suggested that some in vivo studies may produce similar levels.
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B. EFFECT OF SEX STEROIDS ON ENZYMES OF CARBOHYDRATE AND
TRIGLYCERIDE METABOLISM.
The great majority of work on the major pathways of carbohy­
drate metabolism in animals has been carried out with tissues from 
male animals and sex differences have not usually been investigated.
As regards fructose metabolism, the specific activity of 
hepatic ketohexokinase was originally reported to be greater (ca 100%) 
in adult male rats than in females (380). In addition, testosterone 
injections were observed to increase the activity of this kinase in 
livers from both sexes. Estradiol, on the other hand, decreased the 
level in males but increased it in females. Similar results were 
obtained when liver slices were incubated with these hormones (380).
C. Pollard in later work in this Department (unpublished results) was 
unable to confirm these findings. No sex differences in the levels 
of either glucokinase or hexokinase appeared in results published by 
Walker and his co-workers (382, 383) who examined rat livers.
Fathipour and Pridham (258) (cf Vernon and Walker (241)) confirmed 
that the level of glycerol kinase was higher in the livers from male 
than from female rats and they also showed that in male animals sub­
cutaneous injection of testosterone stimulated the activity and 
estradiol decreased the level. On the other hand, testosterone 
administration to castrated male rats increased the activity of the 
enzyme beyond the level of the control animals. No sex difference 
was found by these authors (258) in the activities of either NAD- or 
NADP-dependent alcohol dehydrogenases.
The activity of glycerol 3-phosphate dehydrogenase in the kidney 
but not liver has also been found to be significantly greater in 
female rats (241). Sex differences (?>5') have also been found with 
rat jejunal phosphofructokinase and pyruvate kinase (386) and liver 
pyruvate kinase (20). Oral administration of either testosterone or 
estradiol-17P increased the levels of the former two enzymes in both 
sexes but estradiol was more effective in the female than the male 
and the reverse was true for testosterone (386). These data may suggest 
that the response of the jejunal enzymes to sex hormones is determined 
in part by the sex of the animal. In this work it was noted (387) 
that the route of hormone administration affected the results; intra­
muscular injections of sex hormones produced no change in the two 
kinases. Testosterone and estradiol decreased the levels of jejunal 
fructose diphosphatase but had no effect on fructose 1,6-diphosphate
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aldolase or hexokinase activity in both male and female rats (386). 
Lufkin ejt (388) have observed that testosterone-deficient adult
human males have low activities of certain jejunal glycolytic enzymes 
(pyruvate kinase, fructose 1,6-diphosphate aldolase and fructose 1- 
phosphate aldolase). These levels can be raised by the administration 
of oral or intramuscular testosterone.
Inconsistent sex differences in the levels of lactate dehydro­
genase, which were age dependent, were observed by Kerr and Frankel 
(390) who examined rat livers. These workers did, however, find a 
significant difference in liver coenzyme levels with female rat liver 
possessing a higher concentration of NADPH than male. This observa­
tion can be related to the activities of glucose 6-phosphate dehydro­
genase and 6-phosphogluconate dehydrogenase which are more active in 
female rat liver than male (384). The activity of glucose 6-phosphate 
dehydrogenase was reported to be reduced following ovariectomy (385) 
and subsequent replacement of estradiol restored the activity to the 
level of the intact animals. The activity of acetyl-CoA carboxylase 
and fatty acid synthase has also been shown (322) to be significantly 
higher in the livers of female rats than in those of males. Estrogen 
injection raises the levels of both enzymes in female animal (403,
421).
C. EFFECT OF SEX STEROIDS ON PLASMA AND LIVER TRIGLYCERIDE LEVELS
In the rat, the activities of acetyl-CoA carboxylase, fatty acid 
synthase and the supply of NADPH should favour a more rapid production 
of triglyceride from carbohydrate in the female liver than in the male 
although analysis of liver tissues does not always show this probably 
because of other factors such as secretion and clearing rates and 
different dietary regimens.
Takemoto (160) found, for example, that with rats fed on fat-free, 
fructose-enriched (70%) diet for 30 days the hepatic triglyceride con­
centration in females was significantly increased compared with male 
rats. In contrast, however, Touvinen and Bender (55) have reported 
that feeding rats with fructose (20%) or sucrose (40%) dietary supple­
ments for 26 weeks increases the hepatic triglyceride levels in both 
sexes to approximately the same degree and Hill (154) stated that liver 
triglyceride levels were higher in male than in female rats fed on 10% 
fructose for 10 days.
The effect of exogenous sex hormones on the levels of triglyceride
- 74 -
in liver tissues appears to be complex. Groener and Macdonald (399), 
for example, have shown that with female rats fed on a high fructose 
diet (70% for 11 weeks) subcutaneous injections of estradiol decrease 
the hepatic triglyceride concentration. On the other hand, proges­
terone administration increases the triglyceride levels in liver. 
Similarly, Jefferys and White (398) have shown that with male rats 
fed on sucrose-supplemented diet (75%), subcutaneous injections of 
estradiol appear to decrease the triglyceride concentration in the 
liver whilst progesterone has no effect. When these hormones are 
given together, however, the liver triglyceride levels are raised.
Liver perfusion studies, unlike dietary investigations, clearly 
indicate that female rat liver can produce more triglyceride than 
male. Watkins £t (321) have found that in isolated perfused livers,
the output of triglyceride by female rats exceeds that of male rats by 
a factor of 3. Ovariectomy reduced the secretion of triglyceride from 
livers of female rats whilst intramuscular administration of estradiol 
to ovariectomized animals tended to return the output to control levels. 
Weinstein and co-workers (400) have also demonstrated that livers from 
normal female rats released more triglyceride into the perfusate than 
did livers from male animals. Orchidectomy had no effect upon the 
release of triglyceride from livers of male rats whilst ovariectomy 
reduced the triglyceride released from the livers of female animals. 
Livers from female rats also synthesize and secrete more triglyceride 
than do livers from male animals when both organs are provided with 
equal quantities of oleate (402). The female rat liver takes up and 
estrifies fatty acids to triglyceride at a faster rate than male rat 
liver. There is also a slower rate of oxidation of fatty acids by the 
female rat liver compared to the male (402).
Further evidence that sex hormones play a role in triglyceride 
synthesis comes from the work of Hosotani and Yoshida (406) who have 
shown that the accumulation of fat in the liver, induced by a protein 
deficient diet, is significantly greater in female rats than in male 
animals. Farber (404) found that the accumulation of fat due to ethio- 
nine treatment occurred only in livers from female rats and administra­
tion of testosterone propionate to intact female animals prevented 
ethionine-induced fatty livers in these animals. Cycloheximide, another 
protein synthesis inhibitor, also caused a more pronounced accumulation 
of lipids in the liver of female than in male rats (405).
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Sex differences in serum triglyceride levels in humans, 
baboons and rats associated with dietary sucrose or fructose have 
also been reported. Hill (154) has demonstrated that the serum 
triglyceride levels are higher in male than female rats and that 
feeding 10% fructose for 10 days raises these levels with the 
differential being maintained. In immature rats, the serum tri­
glyceride levels are the same in both sexes before and after feed­
ing fructose for 21 days. Bruckdorfer et. (396) have shown that 
the concentration of serum triglyceride is higher in male than 
female rats fed on sucrose-enriched (68%) diets for 16 weeks. Kim 
and Kalkhoff (412) found that with rats fed on chow diet, injections 
of estrogen alone or in combination with progesterone elevated serum 
triglyceride levels, whereas progesterone by itself did not alter 
this parameter.
Coltart and Macdonald (155) showed that dietary sucrose (75%) 
raised the level of fasting serum triglyceride in male baboons over 
a 3 week period by 50% in comparison with the initial value. During 
the next 14 weeks on the disaccharide supplement the triglyceride 
concentration slowly decreased until it was about 18% higher than 
the initial value. Estrogen injections prevented this increase.
When female baboons were given a similar diet there was no significant 
change in fasting serum triglycerides and testosterone injection had 
no effect. The incorporation of label from [U-^^c]sucrose into serum 
triglycerides was similar in animals of both sexes prior to admini­
stration of the sucrose-enriched diet but following the diet, incor­
poration into triglycerides was significantly higher in the case of 
the male rats. Sex hormones appeared to have no significant effects 
on the incorporation of label, however, Coltart and Macdonald (155) 
inferred that the different triglyceride response between male and 
female animals was due to the inhibitory effect of estrogen and was 
independent of androgen and that the estrogen might regulate tri­
glyceride levels by influencing triglyceride synthesis and/or clearing.
Sex differences in fasting serum triglyceride levels have also 
been reported in humans with men always having higher levels than 
women (see p . 17). An increase in serum triglyceride levels in men 
and postmenopausal women, compared with premenopausal women, has also 
been demonstrated after sucrose or fructose loads (143). Macdonald 
(143) found that whereas diets containing sucrose or fructose raised 
the fasting serum triglyceride level in men, the reverse effect seemed
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to occur in premenopausal women. Postmenopausal women responded 
to fructose-containing diets in a similar manner to men. Macdonald 
(392) has shown that sex differences (human and baboons) in the con­
version of fructose to serum triglycerides are not due to differences 
in the rates of absorption of the hexose.
Although the studies on factors affecting serum triglycerides 
so far described all suggest that estrogen is associated with low 
levels there are reports that are contradictory. For example,
Groener and Macdonald (399) claimed that female rats feeding on a 
fructose supplement had raised serum triglycerides after an estradiol 
injection (399). In addition, oral contraceptives are associated 
with raised serum triglycerides in women (24, 393).
In conclusion, it is well established that the perfused female 
rat liver has a greater capability for triglyceride production than 
the male organ and that estrogen controls the output in the female 
liver. However, administration of estrogen to intact female animals 
lowers rather than raises hepatic triglycerides unless progesterone 
is present. There is further controversy in the case of serum tri­
glycerides here the level ( ^ > ? )  in three animal species (143, 154, 
155, 396) does not reflect the increased output of fat by the female 
rat liver shown in the perfusion experiments. In addition the work 
of Coltart and Macdonald (155) shows that injected estrogen lowers 
serum fats in male baboons. However, there are the two reports (399, 
412) that serum triglycerides in female rats are raised by injection 
of estrogen and that the contraceptive ’pill' has the same effect in 
women although here estrogen is normally accompanied by progesterone 
which may modify the action of estrogen (c£ 398).
D. EFFECT OF SEX STEROIDS ON PLASMA TRIGLYCERIDE CLEARANCE
There are at present, therefore, no clear relationships between
hepatic production of triglycerides and the level of these lipids in 
the sera of male and female animals. Although the rate of synthesis 
of liver fat must relate to the amount in the serum there is the 
second process, clearing by lipoprotein lipase, which must be con­
sidered.
Higher fasting serum triglyceride levels in men than in women
(both on normal and sucrose- or fructose-supplemented diets) can be
inversely correlated with reported post-heparin lipolytic specific 
activities ( 24, 411, 413). The levels of this enzyme have been shown
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to decrease with age but normally the activity in men is always less 
than in women (411). Sex differences in the levels of lipoprotein 
lipase have also been reported in rats (415) and again the levels are 
always higher in females than in males. Nikkila and Kekki (413) 
studied the kinetics of triglyceride clearing and found that there 
was a definite difference between normal men and women. The enzyme 
from women exhibited a lower than that from men and, hence, it was 
concluded that the former possessed a more efficient triglyceride 
clearing system which could be correlated with a lower plasma tri­
glyceride level.
The effects of female sex hormones on the activities of lipo­
protein lipase have also been investigated. In the rat, Hamosh and 
Hamosh (415), for example, found that intraperitoneal injections of 
e s t r a d i o l - 1 ( 5 0 p g / w e e k  for 8 weeks) into male rats significantly 
lowered adipose tissue lipoprotein lipase activity. On the other 
hand, ovariectomy increased the level of the enzyme to almost twice 
that found in adipose tissue of control animals: subsequent admini­
stration of estradiol (25pg daily for 7 days) to ovariectomized 
females caused a marked decrease in the enzyme activity. Progesterone 
administration did not affect adipose tissue lipoprotein lipase acti­
vity in either male or ovariectomized female rats. Kim and Kalkhoff 
(412) also found that intramuscular injections of estradiol (5pg/day 
for 21 days) to female rats significantly decreased the adipose tissue 
lipoprotein lipase activity and, unlike Hamosh and Hamosh (415), that 
administration of progesterone (5ijig/day for 21 days) increased the 
level of this enzyme in female animals. Kekki and Nikkila (24) have 
reported an increased triglyceride-clearing efficiency in normal women 
using mixed estrogen-progesterone oral contraceptives and they suggested 
that the progesterone component of the oral contraceptive was respon­
sible for increasing the triglyceride clearance but that this was over­
balanced by an estrogen-induced increment in the synthesis of fat 
resulting in elevated serum VLDL-triglyceride.
In summary, the observation that premenopausal women have a higher 
lipoprotein lipase activity than men (411) must be an important factor 
in keeping serum triglyceride levels relatively low in the former.
The hormonal basis of this difference is not clear, however, since 
exogenous estrogen does not enhance the fractional removal rate of 
plasma VLDL-triglyceride (24, 414) and in experiments with rats, estro­
gen appears to decrease the adipose tissue lipoprotein lipase activity 
(415).
R E S U L T S  A N D  D I S C U S S I O N
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The greater hypertriglyceridaemic response of male animals 
compared with females to dietary sucrose or fructose is a function 
of the relative rates of hepatic triglyceride synthesis and/or 
'clearing'. The present investigation has been concerned mainly 
with the former in an attempt to establish a clearer picture of 
triglyceride formation from fructose in male and female rats.
Reported sex differences in the activities of some of the enzymes 
likely to be involved in lipogenesis from fructose have been dis­
cussed (see section IV. B, p.72) and that which follows is a descrip­
tion of an investigation of other enzymes involved in the conversion 
of fructose to trioses which had not been previously investigated or 
had only been examined superficially with respect to sex differences.
In addition, the possibility that different dietary regimens might 
differentially influence enzyme activities in males and females was 
investigated. Finally, in the case of glycerol kinase, an attempt 
was made to establish a link between the activity of this enzyme and 
sex hormones.
• For this investigation male and female wistar rats with approxi­
mately the same initial body weight (50 - 5g) were used. In order to 
investigate possible effects of diet on sex differences in enzyme 
activity groups of 4 rats of the same sex were caged together and fed 
on a chow diet together with water or solutions of carbohydrates, all 
ad lib. (Dixon CDd[r] diet and sometimes Dixon 86 diet) with water to 
drink and Dixon CDD[r] diet supplemented with either 5% (w/v) sucrose 
or glucose in the drinking water). The levels of supplementary carbo­
hydrates used were significantly lower than in most previous studies.
The composition of the two commercial chow diets are shown in 
Tables XVa, b. In general, relative terms, Dixon 86 is a low-fat 
diet compared with Dixon CDD[r ] and although the digestible carbohydrate 
content of 86 is only about 20% greater than that of CDD[r ] a signifi­
cant proportion (about 5%, w/w) is molasses which is largely composed 
of sucrose. The temperature in the animal house was kept at 22° and 
the light switched on for 12hr daily (08.00 to 20.00hr). The duration 
of the feeding experiments was 110 days after which the rats were 
sacrificed by cervical dislocation, between 09.00 and ll.OOhr, and the 
livers excised within 45 sec after death. They were then washed with 
ice-cold saline and dried between filter paper. Tissues were stored 
at (-70°) until needed for preparations of soluble supernatants for the 
enzyme assays.
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A relatively large number of animals were used for these 
studies in order to be able to make a meaningful, statistical 
analysis of the enzyme levels. As a consequence, no attempt was 
made to measure the intake of chow by the animals because of a 
lack of suitable large scale facilities in the animal house.
However, the consumption of the carbohydrate supplements by 
groups of animals was measured and this was shown to be similar 
for both sexes (7-8g/rat/day) in the case of glucose and sucrose. 
Unpublished results obtained by C. Pollard in this Department, 
where a Dixon CDD[r ] diet, with water to drink, was fed ad lib. to 
male and female rat litter-mates for 18 days showed that the male 
animals consumed approximately 20% more chow than females. This 
intake of food closely correlates with the difference in final body 
weights of animals of the two sexes. Studies by Takemoto (160) 
indicated that for a smaller difference (8%) in consumption of a 
commercial diet there was a somewhat larger difference (29%) in 
body weights between males and females after 30 days. It should be 
noted, however, that Takemoto used a virtually fat-free diet unlike
c d d [r ].
Although it seems probable that the intake of a chow diet is 
roughly proportional to the increase in body weight in male and 
female rats the effects of glucose or sucrose supplements on the 
consumption of the chow diet are unknown. So although in the present 
work the supplement consumption was approximately the same for glucose 
and sucrose with animals of both sexes the two sugars may have differ­
entially influenced the intake of chow. For example, although animals 
may eat isocaloric amounts of sucrose and glucose the greater sweet­
ness of the former may result in a decreased consumption of chow (cf 
Allen and Leahy, 452). Mukherjee and his associates (340), however, 
claimed that addition of starch, glucose, fructose or sucrose supple­
ments to a basic diet had little effect on the total daily food intake 
of male rats. Mukherjee ejt (340), however, only fed supplements
which were 12% of the diet and the animals consumed about 1g of supple­
ment/day (cf 7-8g/day in the present study) and the experiment was 
only continued for 30 days (cf 110 days in the present work). In 
addition, there may be a sex difference in the effect of the two 
carbohydrate supplements on chow consumption. Finally, it should be 
noted that any biochemical comparison of male and female animals under 
physiological conditions will always bê problematical because of the 
normal sex differential in food consumption (430).
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In view of these feeding problems it has generally not been 
possible to state unequivocally in this study what the specific 
effects of the glucose and sucrose supplements on enzyme levels 
have been. However, it will be clear that carbohydrate-rich diets 
sometimes affect the male/female sex differentials.
In order to establish whether any gross physiological changes 
had occurred in response to the diets the body and liver weights 
of the animals were monitored. This data is also needed in order 
to understand the full significance of changing hepatic enzyme 
activities in relation to the whole animal. The capacity for a 
particular hepatic metabolic function is dependent on the total 
activities of all of the liver enzymes involved. The relationship 
between the total activity of a liver enzyme and the body size may 
change because: (1), the body weight/liver weight ratio changes but 
not the specific activity or (2), the ratio may remain constant but 
the specific activity may change.
The effect of different dietary regimens on body and liver 
weights is shown in Table Ila. Statistical treatment (Student t- 
test) of the data (Table lib) indicates that male animals always had 
significantly greater body and liver weights than female rats when 
commercial CDD[r ] diet or CDD[r ] diet supplemented with sucrose or 
glucose was used. However, these sex differences were not as evident 
in rats fed on Dixon 86 diet. Male rats on Dixon CDD[r ] had a signif­
icantly greater body weight than males on Dixon 86. There were no 
statistically significant differences, between body weights, with 
male animals on any diet containing CDD[r ]. A sucrose-supplement 
compared with CDD[r ] alone did, however, produce significantly heavier 
livers in the case of males. With female animals body and liver 
weights were similar using both commercial diets. On the other hand, 
those rats on CDD[r ] diet supplemented with sucrose had significantly 
greater liver weights than those females on CDD[r ] alone or CDD[r ] 
supplemented with glucose. The body weights of female animals on 
CDD[r ] supplemented with glucose were significantly lower than those 
females on CDD[r ] diet alone or CDD[r ] supplemented with sucrose.
It is generally believed that body weights and food intake are, 
at least in part, controlled by steroid hormones. It would seem that 
estrogens decrease both of these factors in mature female rats (426, 
427, 428). Testosterone, on the other hand, appears to have opposite 
effects (429, 430).
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TABLE lia. The effect of different dietary regimens on total
body and liver weights of male and female rats







MALE (n=8) 331 ± 35 10.7 ^ 1.8 31
FEMALE (n=8) 305 i 40 8.4 ± 3.7 36
Dixon CDD[r ]
MALE (n=8) 418 ± 40 11.9 i 2.4 35
FEMALE (n=8) 287 ± 29 8.8 ± 1.2 33
Dixon CDD[r ]
+ Sucrose
MALE (n=5) 440 ± 44.1 15.02 ± 2.1 29
FEMALE (n=5) 308 i 29.5 10.06 ± 0.09 31
Dixon CDD[r ]
+ Glucose
MALE (n=5) 436 ± 8.22 13.17 ± 1.8 33
FEMALE (n=5) 250 ± 14.1 8.85 ± 0.8 28
Figures in parenthesis represent the number of animals
Values are means i S.D. The statistical significance of the data is 
given in Table Ilb
Rats (initial body weight 50 - 5g) were fed for 110 days W  lib, on 
Dixon 86 or Dixon CDD[r ] diets with water to drink and with CDD[r ] 
diet supplemented with either 5% (w/v) sucrose or glucose in the 
drinking water. Water and carbohydrate solutions were also available 
ad lib.
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Body weight Liver weight
86 dr vs. ? 16 NS NS
CDD[r ](? vs. ? 16 PC^.OI p<6.oi
c d d [r ]+s ^ vs. ? 10 P<0.01 P(0.01
CDD[r ]+G(? vs. ? 10 P<0.01 P<p.01
86 vs. CDD[r ]8' 16 P<0.01 NS
86 ? vs. c d d [r ]? 16 NS NS
c d d [r ]^ vs. CDD[r ] + S5' 13 NS P<0.05
c d d [r ]j' vs. c d d [r ]+g <? 13 NS NS
CDD[r ] + S8' vs. CDD[r ]+G8' 10 NS NS
c d d [r ]? vs. c d d [r ]+s ? 13 NS P<p.02
c d d [r ]? vs. c d d [r ]+g ? 13 P(0.02 NS
c d d [r ]+s ? vs. c d d [r ]+gî 10 P<0.01 p<p.oi
Dixon 86 = 8 6 ;  Dixon CDD[r ] = CDD[r ]; Sucrose = S
Glucose = G; Not significant = NS
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In the present studies although the total intake of food by male 
rats probably exceeded that consumed by the females (c_f 160 and 
the results of C. Pollard p. 80) the body weight/liver weight ratios 
were, in general, similar.
In Tables Ilia, b it can also be seen that the protein concen­
trations in all the 100,000 x g soluble supernatants from liver 
homogenates are similar. It would appear that CDD[r ] with a glucose- 
supplement gives rise to higher protein contents than the chow with
sucrose in both males and females but the differences are not statis­
tically significant. Tay (431) has shown that under similar dietary 
regimens there is no significant change in the total liver protein 
content.
Ketohexokinase is the first enzyme in the pathway of fructose 
metabolism in the liver. Its occurrence and properties have been re­
viewed (p.33). In the cell, ketohexokinase is localized in the cytosol 
(214, 380) and 100,000 x g supernatant fractions from liver were used 
to measure activities in the present study.
Three basic methods have been described for the assay of keto­
hexokinase. In the spectrophotometric assay (226, 227) the formation 
of ADP is measured by coupled reactions involving pyruvate kinase and 
lactate dehydrogenase:
Fructose + ATP  ketohexokinase ^fructose 1-phosphate + ADP
ADP + phosphoenolpyruvate  pyruvate  ^kinase ^  + pyruvate
pyruvate + NADH . lactate dehydrogenase ^ + NAD*
A second method which has been employed by Adelman ejt (226) is
based on the conversion of [U-^^c]fructose to [U-^^c]fructose 1- 
phosphate. The product is then separated from the labelled fructose 
using DEAE-cellulose paper chromatography and its radioactivity 
measured. A third method for measuring the ketohexokinase activity 
is based on the estimation of the loss of fructose from reaction 
mixtures (432): the ketose is estimated using a resorcinol/HCl reagent 
(434, 435).
In this project it was first decided to try to use the spectro­
photometric method of Adelman et (226). Several problems with
this assay had been reported by these authors and these were examined 
in an initial study (which is not reported in detail in this thesis). 
One problem is that the soluble supernatants from liver contain a very
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TABLE Ilia. The effect of different dietary regimens on liver





MALE (n=8) 155.23 ± 25.2
FEMALE (n=8) 163.13 ± 20.67
Dixon CDD[r ]
MALE (n=8) 158.94 ± 16.59
FEMALE (n=8) 160.0 ± 15.95
Dixon CDD[r ] 
+ Sucrose
MALE (n=5) 155.01 ± 30.03
FEMALE (n=5) 155.44 ± 20.20
Dixon CDD[r ] 
+ Glucose
MALE (n=5) 168.47 ± 24.79
FEMALE (n=5) 166.93 ± 29.96
Figures in parenthesis represent the number of animals
Values are means ± S.D. The statistical significance of the data 
is given in Table Illb
Rats (initial body weight 50 ± 5g) were fed for 110 days W  lib, 
on Dixon 86 or Dixon CDD[r] diets with water to drink and with 
CDD[r] diet supplemented with either 5% (w/v) sucrose or glucose 
in the drinking water.
Water and carbohydrate solutions were also available ^  lib.
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86 S' vs. ? 16 NS
CDD[r] S v s. ? 16 NS
CDD[r]+S S v s. ? 10 NS
CDD[r]+G S v s. ? 10 NS
86 J v s . CDD[r] S 16 NS
86 ¥ vs. CDD[r ] ¥ 16 NS
cdd[r] s vs. cdd[r]+s S 13 NS
cdd[r] s v s . cdd[r]+g S 13 NS
cdd[r]+s s v s . cdd[r]+g S 10 NS
CDD[r ] ¥ vs. CDD[r ]+S ¥ 13 NS
CDD[r ] ¥ vs. CDD[r ]+G ¥ 13 NS
CDD[r ]+S ¥ vs. CDD[r ]+G ¥ 10 NS
Dixon 86 = 86; Dixon CDD[r ] = CDD[r ]; Sucrose = S 
Glucose = G; Not significant = NS
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active sorbitol (glucitol) dehydrogenase wliich reduces fructose 
in the presence of NADH, to sorbitol. Secondly, the addition of 
ATP alone to the liver preparation results in rapid ADP formation 
presumably due to the activity of ATPase.
It had been suggested by Adelman et al. (226) that both acid
and heat treatments of the soluble supernatants could be used to
completely destroy sorbitol dehydrogenase and ATPase. These workers
also suggested that the effect of the dehydrogenase would be minimized
if the concentration of the fructose was kept at about ImM. The
explanation for this is that the K of ketohexokinase is ca 0.5mM
m —
whereas for sorbitol dehydrogenase it is 100-200mM. A low fructose 
concentration would also prevent interference from hexokinase which 
also has a high (2-5mM) for fructose. However, in this study, 
after preliminary investigations, it was felt that it would be wise 
to avoid the acid and heat treatments where comparisons of ketohexo­
kinase activities in a number of samples were required. Hence, the 
method of Hers (432) was eventually adopted where the loss of fructose 
from the incubation mixtures is measured. In this assay procedure 
N-acetyl D-glucosamine was added to the reaction mixture: this inhibits 
hexokinase activity without affecting ketohexokinase (436).
The specific activities of ketohexokinase from livers of adult 
male and female rats were examined after feeding the various dietary 
regimens already described. The results are expressed in terras of mg 
protein and it should be noted that, for comparative purposes, this 
is satisfactory as there were no indications of changes in the protein 
contents of the livers as a result of the different diets. (Specific 
activities of other enzymes in this study are expressed in the same 
way although in Appendix I all results are given in an alternative 
form in terms of liver weight). The specific activity of the enzyme 
obtained from rats on the unsupplemented chow diet (Table IVa) are in 
good agreement with those obtained by Heinz (214), Heinz e_t (218),
Heinz and Weiner (219), Walker (231) and Stifel ejt (193). It is
also clear that supplementation of chow with carbohydrate significantly 
raises the specific activity of ketohexokinase. This finding is 
supported by the short term studies of Stifel £t (193) and of
Adelman et al. (46). Both of these groups also report that ketohexo­
kinase activity rises more sharply in response to dietary fructose 
than other sugars. The results in Tables IVa, b also show clearly
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TABLE IVb. Statistical analysis (Student t-test) of the data
in Table IVa
Group comparison No. of 
Animals
Significance
CDD[r] S v s. ? 16 NS
CDD[r]+S S v s. ? 8 NS
CDD[r ]+G <? v s. ¥ 8 NS
cdd[r] s v s. cdd[r]+s S 12 P <0.01
cdd[r] s v s. cdd[r]+g S 12 P <0.01
cdd[r]+s s v s. cdd[r]+g S 8 NS
CDD[r ] ¥ vs. CDD[r ]+S ¥ 12 P <0.01
CDD[r ] ¥ vs. CDD[r ]+G ¥ 12 P <0.01
CDD[r ]+S ¥ vs. CDD[r ]+G ¥ 8 P <^0.05
Sucrose = S; Glucose = G; Dixon CDD[r ] = CDD[r ] 
Not significant = NS
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that tliere is no sex difference in hepatic ketohexokinase specific 
activities no matter which diet is considered. This result differs 
from that reported by Hay and Pridham (380) who claimed that the 
activity was at a higher (ca 100%) level in males than in females. 
However, the latter workers only used animals which were maintained 
on Dixon 86, the high-carbohydrate, low-fat diet but C. Pollard 
(unpublished) who also fed rats on Dixon 86 diet (for 100 days) was 
unable to confirm the report by Hay and Pridham (380). This anomaly 
remains unexplained. As regards hepatic metabolism it is of interest 
to note that Tay (431) could find no difference in the concentrations 
of fructose 1-phosphate in male and female rat livers. This might 
be expected if the ketohexokinase activities were similar although 
the level of the ketose phosphate would also be determined by the 
rates of further metabolism.
The specific activity of sorbitol dehydrogenase is, interestingly, 
one of the highest (i.e.18.9 U/g) of all the carbohydrate-metabolizing 
enzymes in rat liver. The enzyme catalyzes the interconversion of 
fructose and sorbitol and, in theory, under conditions of high fructose 
concentration, it could be involved in metabolism of the ketose in vivo. 
A literature search revealed no information on sex differences in the 
levels of the enzyme and, hence, this was investigated, again using 
animals on different dietary regimens.
For this project, the spectrophotometric method adopted by 
Gerlach and Hiby (439) for sorbitol dehydrogenase was employed where 
the reduction of fructose by NADH is followed spectrophotometrically 
at 340nm:
Fructose + NADH sorbitol + NAD*
The results (Table Va)firstly show that the specific activity of 
the enzyme in male animals fed on chow is 1.4 times higher than that 
reported by Heinz, Lamprecht and Kirsch (218). Secondly, in the case 
of the unsupplemented diet the specific activity of the dehydrogenase 
is significantly higher in the livers of the female rats than of males. 
Supplementation by either glucose or sucrose appears to lower the 
activity in both sexes but the effect is more marked with the glucose- 
supplement. In addition, both carbohydrate-supplements nullify the 



















0) QJ d eu p
•H •H C/J > ü eu
cd QJ O o p
e -P O +1 +i QJ p cd
QJ O 3 1—1 cd
<4-1 P T—t d
eu O O' O cd dû"d CO M- H Pd G
ü ■H




eu H O •H
«—1 W ü P
cd M m m QJ g d
6 1 Q II II > OG e: •H X eu
U •H txû p d




(U "—1 Q sO o •H Ü a ü
CO O e; QJ CO •H o ■H
cd u C/J cd e
a O P cd d  1 QJ
QJ iz; P +1 +1 cd X p enÜû X o (J d QJ »—( 1 o
o ■p X es oW •H M 00 00 o QJ C/J d | es
d > e8 d p cd| P
•H 'Cf in p cd WJ
x i •P 00 S en
QJ U rg p •H X p




«H O C/J P
eu
O •H •H O
+-> P Cfl O o
•H •H X p
d O •—1 P u
W QJ 00 00 cd QJ p es
O eu p II II a d o enU) co e:QJ
d cd ees
p







in eu lO M- •H dQJ eu CM CO P p QJ•H :3 C/J P
+-> oo •H p QJ in
•H +1 -H P c
> o cd QJ p
•H % P m QJ+-> \0 M- C/J QJ bû d
O O' p lO p




•H O d<4-, e8 CO en p
•H •H •H
U 00 en p
QJ QJ d
eu +f d OJD din p •H euC/J ü QJ p

























X C/J P cd G es
QJ QJ cd en •H en
cd 00 P S co eu
> cd QJ QJ p en
S PU 3 ;] en p
W p bJJ p QJ
H-1 cd •H cd •H
CQ > PU d d
<
H
-  V  4b -
TABLE Vb. Statistical analysis (Student t-test) of the data
in Table Va
Group comparison No. of 
Animals
Significance
CDD[r] S v s .  ? 16 P <^.01
CDD[r]+S S v s .  ? 10 NS
CDD[r]+G S vs. Î 10 NS
cdd[r] s vs. cdd[r]+s S 13 NS
CDD[r] o' v s .  CDD[r]+G S 13 P <0.01
cdd[r]+s s vs. cdd[r]+g S 10 P <0.01
CDD[r ] ? vs. CDD[r ]+S ? 13 P <0.01
CDD[r ] ? vs. CDD[r ]+G ? 13 P <0.01
c d d [r ]+s ? vs. c d d [r ]+g  ? 10 P <0.01
Dixon CDD[r ] = CDD[r ]; 
Sucrose = S;
Glucose = G;
Not significant = NS
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The physiological significance of the presence of very higli 
levels of sorbitol dehydrogenase in liver has not been explained.
In other tissues, e.g. seminal vesicles, this enzyme appears to 
function together with aldose reductase (EC 1.1.1.21) to produce 
fructose from glucose (443).
NADPH NADP NAD NADH
Glucose ---^ --------- ». sorbitol ------ ^  ____ ►fructose
aldose reductase sorbitol dehydrogenase
In the liver, however, there is little evidence to suggest 
that this complete pathway is operative in either direction and 
the activity of the aldose reductase in this tissue appears to be 
low (457). The metabolism of sorbitol by rat liver slices has 
been examined (437, 444) and the hexitol was shown to be converted 
mainly to glucose and to a lesser extent fructose. This was 
explained (437) by the assumption that sorbitol was first oxidized 
to fructose by NAD and sorbitol dehydrogenase and that the ketose 
product was then converted to glucose via fructose 6-phosphate and 
glucose 6-phosphate. (This has also been assumed to occur, in 
human liver (445)). This study did not, however, rule out the 
direct conversion of sorbitol to glucose via aldose reductase and 
NADP and the explanation by Blakley (437) also required fructose in 
the slices to have reached a relatively high concentration in order 
that hexokinase might react. Blakley’s investigation (437) was 
also made prior to the discovery of ketohexokinase (433) which with 
a low for fructose is more likely in liver slices to catalyze 
fructose phosphorylation (to fructose 1-phosphate) than hexokinase 
(p. 33).
There is little doubt, however, that sorbitol can be oxidized 
in the liver by sorbitol dehydrogenase to fructose (437, 444, 446) 
and that this is the first step in the metabolism of oral loads of 
the hexitol, which are given to diabetics, and of small amounts of 
sorbitol of endogenous origin or of dietary origin. As regards the 
reverse reaction, i.e. fructose to sorbitol, sorbitol dehydrogenase 
possesses a high (100-200 mM) for fructose and, hence, it is 
difficult to envisage any role for this enzyme in the metabolism of 
fructose under normal tissue concentration of this ketose. The 
reasons for the very high levels of sorbitol dehydrogenase in liver 
and the significant sex difference in the levels therefore remain 
obscure.
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Tlie metabolism of D-glyceraldehyde, an intermediate 
(produced by aldolase) in the metabolism of fructose, may 
proceed via at least three pathways: one of these is the 
phosphorylation of the aldehyde to glyceraldehyde 3-phosphate 
catalyzed by the enzyme triokinase. The problem of the D- 
glyceraldehyde 'cross roads' has been reviewed (see p. 62).
The spectrophotometric method adopted by Heinz and 
Lamprecht (112) has been extensively used for measuring the 
specific activity of triokinase and in this present study the 
same method has been employed. The principle of the assay is 
to follow the phosphorylation of glyceraldehyde by coupled re­
actions with triosephosphate isomerase and glycerol 3-phosphate 
dehydrogenase, measuring the loss of NADH at 340nm:
D-Glyceraldehyde + ATP  ^riokinase _^ ^^giyceraidehyde 3-phosphate + ADP
Mg^+
D-Glyceraldehyde 3-phosphate— " ^ igp^erase^^^^ dihydroxyacetone phosphate
Dihydroxyacetone phosphate + NADH — ^ phosphate^ 3_
dehydrogenase phosphate + NAD'
The specific activities of triokinase in livers from male 
and female rats on different diets has been investigated and the 
results are shown in Table Via. They demonstrate that sex differ­
ences in the levels of this enzyme are only evident with those 
animals on the high-carbohydrate, low-fat, Dixon 86 diet with males 
having statistically significant (Table VIb) higher levels than 
females.
As regards male rats on Dixon CDD[r ] diet alone, the results 
are in a good agreement with the specific activities published by 
Adelman et (46) based on liver weight, although they appear to
be somewhat lower than those quoted by Heinz et al. (218).
Comparisons of the specific activities of triokinase in rats 
fed on the two commercial diets, Dixon 86 and CDD[r ], reveal that 
the levels of the enzyme are always higher in those animals on 
Dixon 86 and this is almost certainly due to the fact that Dixon 86 
contains appreciable amounts of molasses (sucrose). This is further 
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TABLE VIb. Statistical analysis (Student t-test) of the
data in Table Via.
Group Comparison No. of 
Animals
Significance
86 J vs. ? 19 P <0.01
CDD[r] S v s .  ? 16 NS
CDD[r]+S S v s .  ? 10 NS
CDD[r]+G S v s .  ¥ 10 NS
86 S vs. CDD[r] S 18 P <0.01
86 ¥ vs. CDD[r ] ¥ 17 P <0.05
cdd[r] s v s .  cdd[r]+s <? 13 P <0.01
cdd[r] s v s .  cdd[r]+g S 13 NS
cdd[r]+s s v s .  cdd[r]+g S 10 P <0.01
CDD[r ] ¥ vs. CDD[r ]+S ¥ 13 P <0.01
CDD[r ] ¥ vs. CDD[r ]+G ¥ 13 NS
CDD[r ]+S ¥ vs. CDD[r ]+G ¥ 10 P <0.01
Dixon 86 = 86; Dixon CDD[r ] = CDD[r ];
Sucrose = S; Glucose = G; Not significant = NS
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sucrose produces higher specific activities in both sexes than 
an unsupplemented diet or a diet supplemented with glucose.
Adelman ej^  al. (46) also showed that with rats initially on a 
normal commercial diet, the level of triokinase was decreased 
by fasting (48 hr) and that it could be restored back to normal 
levels by refeeding a fructose-, but not a glucose-rich diet 
for a short period (70% for 24 hr). It is interesting to note 
that triokinase levels are raised by dietary supplements of 
sucrose or fructose but not glucose and this presumably reflects 
the importance of the enzyme for fructose metabolism (see also 
Heinz, 198).
In addition to glyceraldehyde, dihydroxyacetone phosphate 
is also produced in the liver by the joint action of ketohexo­
kinase and aldolase on fructose. This triose phosphate may:
(1), be converted to glyceraldehyde 3-phosphate and enter the 
glycolytic pathway which eventually leads to acetate and (2), 
serve as an important source of triglyceride-glycerol. As regards 
the latter, dihydroxyacetone phosphate carbon can enter trigly­
ceride either via the dihydroxyacetone phosphate pathway or via 
the glycerol 3-phosphate pathway: the glycerol 3-phosphate path­
way is believed to be the more important in liver (p. 53).
The reduction of dihydroxyacetone phosphate to glycerol 3- 
phosphate can, in vitro, be catalyzed by two different enzymes.
One is the cytosolic NAD-linked glycerol 3-phosphate dehydrogenase, 
and the other the mitochondrial enzyme which utilizes FAD as a 
hydrogen carrier. The two enzymes, acting in concert, are thought 
to provide one of the mechanisms in the cell for the reoxidation 
of extramitochondrially-generated NADH via the respiratory chain 
with the cytosolic dehydrogenase reducing dihydroxyacetone phos­
phate to glycerol 3-phosphate and the mitochondrial enzyme catalyz­
ing the reverse reaction (239).
At physiological pH values the equilibrium for the cytosolic 
enzyme-catalyzed reaction greatly favours glycerol 3-phosphate 
formation and it is difficult to demonstrate the reverse reaction 
in vitro without raising the pH to a strongly alkaline condition 
and 'trapping out' the dihydroxyacetone phosphate product with 
hydrazine.
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As glycerol 3-phosphate dehydrogenase is important for the 
provision of glycerol for the synthesis of hepatic triglycerides, 
it was decided to examine rat liver for sex differences in the 
levels of the enzyme.
Glycerol 3-phosphate dehydrogenase activity has been assayed 
spectrophotometrically by measuring the rate of formation or 
disappearance of NADH at 340nm which accompanies the oxidation of 
glycerol 3-phosphate at pH 10 or the reduction of dihydroxyacetone 
phosphate at pH 7.5, respectively (265). In the present study the 
spectrophotometric method reported by Lee and Graine (265) was 
adopted using glycerol 3-phosphate as substrate:
Glycerol 3-phosphate + NAD^ _ glycerol^3^phosphate^ dihydroxyacetone
phosphate + NADH + H^
The specific activity (see Table Vila) of the hepatic enzyme 
from male animals on chow (CDD[r ]) diet agrees with the results 
of Baquer (448). It was stressed earlier (p. 81) that it
would be difficult to define exactly the effects of the different 
diets on enzyme activities. However, it would appear that the two 
basic chow diets had affected the dehydrogenase activities in both 
male and female rats quite differently with Dixon CDD[r ] being 
associated with a significantly higher specific activity (Table Vllb). 
With the exception of male animals ingesting CDD[r ] with a glucose 
supplement, this was also apparent with all the CDD[R]-containing 
diets. This result may be a function of the higher fat content of 
the CDd [r ] diet as compared with the 86. In this connection Harding 
et al. (449), using chicken, have demonstrated that the specific 
activity of hepatic glycerol 3-phosphate dehydrogenase is decreased 
by a high-carbohydrate, low-fat diet and increased with a high-fat, 
low-carbohydrate regimen. The low specific activities obtained 
with the Dixon 86 diet were probably not a function of either the 
relatively high total carbohydrate content of this diet or the high 
sucrose content otherwise low activities would have been obtained 
with the CDD[r ] supplemented diets. In other studies (266, 450) it 
has been claimed that in the short term, both glucose- and fructose- 
enriched diets increase hepatic glycerol 3-phosphate dehydrogenase 
in male rats (but not female; see De Gomez et (451)) and
Mukherjee and co-workers (340) state that dietary sucrose or fructose 
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TABLE Vllb. Statistical analysis (Student t-test) of the data
in Table Vila
Group Comparison No. of 
Animals
Signif icance
86 S vs. ? 16 NS
CDD[r] S v s .  ? 16 P <0.05
CDD[r ] + S <? vs. ? 10 NS
CDD[r]+G S v s .  ? 10 P <0.02
86 S vs. CDD[r] S 16 P <0.01
86 ? vs. CDD[r ] ? 16 P <0.01
cdd[r] s v s .  cdd[r]+s <? 13 NS
cdd[r] s vs. cdd[r]+g S 13 P <0.01
cdd[r]+s s v s .  cdd[r]+g S 10 P <0.01
CDD[r ] ? vs. CDD[r ]+S ? 13 NS
CDD[r ] ? vs. CDD[r ]+G ? 13 P <0.01
c d d [r ]+s ? vs. c d d [r ]+g  ? 10 P <0.01
Dixon 86 = 86; 
Glucose = G;
Dixon CDD[r ] = CDD[r ]; 
Not significant = NS
Sucrose = S;
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In the present long term study, it is also clear that the 
relationship between sucrose and glucose in both male and female 
rats is similar to that reported by Mukherjee _et (340) i.e.
dietary sucrose raises the dehydrogenase activity more than 
dietary glucose. It is also of interest that a sex difference 
in the levels of glycerol 3-phosphate dehydrogenase exists in the 
case of animals ingesting CDD[r ] and CDD[r ] and glucose supplement 
(? >  (?) but that this does not occur with rats taking a sucrose- 
enriched diet. It should also be noted that there is no sex 
difference with the rats on Dixon 86 which is rich in molasses.
Vernon and Walker (241) observed no sex differences in dehydrogen­
ase activities with rats feeding on a commercial pelleted diet but 
in female kidney tissue the activity was significantly higher than 
in the corresponding male tissue.
Although there is some controversy over the further metabolism 
of glyceraldehyde (pp. 49, 50) the consensus of opinion is that it 
is first phosphorylated by triokinase. It should be noted, however, 
that this theory is derived from metabolic studies on the conversion 
of the aldehyde to glucose and the possibility still exists that it 
is, instead, reduced to glycerol or oxidized to glycerate (111).
There appears to be no clear evidence that one or both of these 
reactions is not involved to some degree in triglyceride synthesis.
In the former case the resulting glycerol could readily be converted 
to glycerol 3-phosphate by glycerol kinase and this metabolite is 
the major precursor of triglyceride-glycerol. Glycerol of dietary 
origin or produced by lipolysis, is also metabolized in the same way.
Two main methods have been used for measuring glycerol kinase 
activity in soluble fractions from rat liver. The first procedure, 
is the radiochemical method described by Newsholme et (458),
which is based on the conversion of ^cjglycerol to [^^c]glycerol 
3-phosphate and adsorption of the latter on DEAE-cellulose paper 
discs. The radioactivity adhering to the paper is then measured in 
a liquid scintillation counter. A second method for measuring 
glycerol kinase activity was published by Bublitz and Wieland (459) 
and in this assay the glycerol kinase reaction is coupled with the 
glycerol 3-phosphate dehydrogenase reaction in the presence of 
hydrazine to 'trap out' dihydroxyacetone phosphate. The formation 
of NADH during the oxidation of glycerol 3-phosphate is then measured
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spectrophotometrically at 340nm.
Glycerol + ATP ------glycerol kinase ^ glycerol 3-phosphate + ADP
Mg
Glycerol 3-phosphate + NAD^ — glycerol 3-phosphate^ dihydroxyacetone
dehydrogenase  ^ '
phosphate + NADH +
In the present investigation, glycerol kinase was assayed by 
the latter method (459) which is more rapid and convenient than 
the procedure of Newsholme and co-workers (458).
The specific activities of glycerol kinase in livers from male 
and female rats on different diets are shown in Table Villa. As 
regards male rats on Dixon CDD[r ] diet alone, the results are in a 
good agreement with the specific activities published by Heinz (214)and 
Heinz, Lamprecht and Kirsch (218) but lower by a factor of three 
than those published by Vernon and Walker (241). The results also 
demonstrate clearly that male livers have a higher activity than 
female livers with rats on Dixon 86 or Dixon CDD[r ] diets alone or 
CDD[r ] diet supplemented with sucrose but, interestingly, this sex 
difference is not evident in the case of animals ingesting the 
glucose supplement. This latter phenomenon was also observed with 
glycerol 3-phosphate dehydrogenase (Table Vila ) and sorbitol 
dehydrogenase (Table Va). Similar sex differences in the specific 
activities of hepatic glycerol kinase with rats on normal chow 
diets have also been reported by Fathipour and Pridhara (258) and 
Vernon and Walker (241) but no attempt to examine the effect of 
diet was made by these workers. Unlike the liver, the level of 
glycerol kinase activity in female rat kidney is higher than in the 
male (241).
Comparisons of the specific activities of hepatic glycerol 
kinase (Table Vlllb) in rats fed on the two commercial diets,
Dixon 86 and CDD[r], reveal that the levels of the enzyme, in both 
sexes, are always higher in those animals on Dixon CDD[r] (the 
high-fat, low-carbohydrate diet) with or without carbohydrate 
supplements, and, as with glycerol 3-phosphate dehydrogenase, this 
is probably due to the fact that Dixon CDD[r] contains a higher fat 
content than 86. This result is supported by observations made by 
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TABLE VlIIb. Statistical analysis (Student t-test) of the
data in Table Villa
Group Comparison No. of 
Animals
Significance
86 a' vs. ? 16 P <0.01
c d d [r ] a' vs. ¥ 16 P <0.01
c d d [r ]+s a' vs. ¥ 10 P <0.01
CDD[r]+G S' vs. ¥ 10 NS
86 a' vs. cdd[r] S 16 P <0.01
86 ? vs. CDD[r ] ¥ 16 P <0.01
cdd[r] S vs. c d d [r ]+s s 13 NS
cdd[r] S vs. c d d [r ]+g s 13 NS
cdd[r]+s S vs. c d d [r ]+g s 10 NS
c d d [r ] ? vs. c d d [r ]+s ¥ 13 NS
c d d [r ] ? vs. c d d [r ]+g ¥ 13 P <0.02
c d d [r ]+s ? vs. c d d [r ]+g ¥ 10 NS
Dixon 86 = 86; 
Glucose = G;
Dixon CDD[r ]; Sucrose = S;
Not significant = NS
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with chickens. Both of these groups found that hepatic glycerol 
kinase activities were increased by feeding high-fat, low-carbo- 
hydrate diets and decreased by low-fat, high-carbohydrate diets. 
Again, as with glycerol 3-phosphate dehydrogenase, the low 
specific activities obtained with the Dixon 86 diet were probably 
not a function of either the relatively high total carbohydrate 
content of this diet or the high sucrose content otherwise low 
activities should have been obtained with the CDD[r ] supplemented 
diets.
With a view to using hepatocytes to investigate the effects, 
in vitro, of sex hormones on glycerol kinase activity, lactate 
dehydrogenase was examined as a marker enzyme for hepatocyte 
viability. This enzyme was of further interest as a possible 
’control enzyme' without male/female differences in activity, 
which could be assayed easily, and which could be studied in 
parallel to glycerol kinase. Initially, a difference in the level 
of the dehydrogenase was considered to be a possibility because of 
reports by Kerr and Frankel (see p. 73; (390)) and Tay (431) that 
the concentration of lactate in male rat liver was approximately 
60% higher than that present in female tissues when the animals 
were ingesting a sucrose-enriched diet. There was no difference 
in the case of rats on an unsupplemented chow (Dixon CDD[r ]) diet, 
however.
In this present study lactate dehydrogenase was assayed spectro- 
photometrically by the method of Bergmeyer and Bernt (460) which is 
based on the reduction of pyruvate by NADH which is monitored at 
340nm:
pyruvate + NADH + h " lactate dehydrogenase .i^ctate + NAD^
The results in Tables IXa, b, show that there was no significant 
difference in the specific activities of the dehydrogenase from male 
or female rat livers no matter which diet the animals were ingesting. 
This result does not help to explain the sex difference in hepatic 
lactate concentration reported by Kerr and Frankel (390) and Tay (431) 
the answer to this problem may perhaps lie in differences in the rate 
of lactate excretion and/or the rate of pyruvate production.
The enzyme was, therefore, considered to be suitable for use as 
a 'control' in an ^  vitro investigation of the effects of steroid 
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TABLE IXb. Statistical analysis (Student t-test) of the
data in Table IXa
Group Comparison No. of 
Animals
Significance
CDD[r] S v s .  ? 16 NS
CDD[r ] + S <? vs. ? 10 NS
CDD[r]+G S v s .  ? 10 NS
cdd[r] s v s .  cdd[r]+s S 13 NS
cdd[r] s v s .  cdd[r]+g S 13 NS
cdd[r]+s s v s .  cdd[r]+g S 10 NS
CDD[r ] ? vs. CDD[r ]+S ? 13 NS
CDD[r ] ¥ vs. CDD[r ]+G ¥ 13 NS
CDD[r ]+S ¥ vs. CDD[r ]+G ¥ 10 NS
Dixon CDD[r ] = CDD[r ]; 
Glucose = G;
Sucrose = S;
Not significant = NS
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It had previously been reported by Vernon and Walker (241) 
and Fathipour and Pridham (258) that the specific activity of 
hepatic glycerol kinase was higher in male than in female rats: 
Vernon and Walker (241) also found no differences between the 
sexes in the case of immature rats. Fathipour and Pridham (258) 
examined the effect of sex hormones on the activity of glycerol 
kinase in rat liver both vivo and ^  vitro. They found that 
testosterone injection had little effect on the activity of the 
enzyme in normal male animals whilst a similar treatment of 
castrated male rats resulted in a significant increase in the 
kinase activity. The hormone was administered in relatively high 
concentrations (0.5 - 5.0 mg/kg body weight) in corn oil although 
injections were subcutaneous and, therefore, the plasma level of 
the steroid may not have been far beyond the physiological range.
In, vitro, studies using liver slices Fathipour and Pridham 
(258) also found that testosterone had an activating effect on the 
enzyme in slices from female rats and from both normal and castrated 
male animals.
In the present study an attempt was made to ellucidate the 
mechanism of androgen activation of hepatic glycerol kinase using 
isolated hepatocytes from male and female rats as an vitro 
system. The rats used for this work were fed on unsupplemented 
Dixon CDD[r ] diet with water to drink ^  lib.
Over the past few years, suspensions of isolated hepatocytes 
have become generally accepted as an important system for studying 
hepatic metabolism and its control and hepatocyte preparations are 
now normally used instead of liver slices because experimental 
condition can be carefully controlled and ischaemia prevented.
Liver slices consist mainly of, apparently, intact cells but they 
serve as poor material for ^  vitro studies because essential 
elements of liver metabolism become greatly impaired during the 
slicing procedure. Thus the capacity for gluconeogenesis from 
lactate and amino acids, for oxidizing fatty acids to ketone bodies 
and for maintaining normal concentrations of the adenine nucleotides 
is largely lost. Hepatocytes, however, are comparable to perfused 
liver in a variety of biochemical parameters including gluconeo­
genesis and protein synthesis (461).
There were many attempts during the past 40 years to produce 
viable, isolated liver cells (462). Early methods depended on the
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use of mechanical force to dissociate the cells from the liver 
(463). Later, various chelating agents (citrate, tetraphenyl 
boron and EDTA) in conjunction with mechanical disruption were 
used to separate the cells (464), inevitably resulting in 
damage to cell membranes.
Shortly after 1964 when Rodbell (465) had demonstrated that 
adipocytes could be isolated by incubating fat tissue with 
collagenase, Howard ejt (466) described a similar method for
isolating liver cells by incubating liver slices with collagenase 
and hyaluronidase. These enzymically prepared cells appeared to 
be morphologically intact and metabolically active. In 1969,
Berry and Friend (467) reported that Howard’s method could be 
modified by perfusing the liver with collagenase and hyaluronidase 
in situ in a recirculating liver perfusion apparatus. This modi­
fication greatly increased cell yields and improved the integrity 
of the isolated liver cells. In 1973, Krebs and co-workers (468) 
described a number of modifications of the original procedure of 
Berry and Friend (467). The most recent procedure, that of Wagle 
and Ingebretsen (469), exposes the liver to low concentrations of 
collagenase (10-20 mg/100ml) and for only a short period of time 
(10-15 min).
In the present study, the method adopted for the isolation 
of hepatocytes was that which was originally devised by Berry and 
Friend (467) and later modified by Krebs e^ (468). In this
procedure the perfusate used is Krebs-Ringer bicarbonate solution
2+ 2+ 
initially without Ca ions. In the later stage of perfusion Ca
ions have to be added to activate the collagenase. No hyaluroni­
dase is used with this technique.
The biochemical properties of hepatocytes do vary with 
different batches of cells and it is necessary to be able to use 
preparations with similar viabilities in order to compare the 
results of experiments carried out with different preparations.
During the isolation of hepatocytes, the cells can be damaged 
by removal of Ca^*, by the action of lytic enzymes and by mechanical 
stress. Thus suitable criteria for estimating their viability have 
to be considered*, for example, fine structure, permeability of the 
plasma membrane, permeability to substances of high molecular, 
weight, ability to respire, the adenine nucleotide content and the 
ability to synthesize glucose from lactate have all been used.
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The trypan blue exclusion test is widely used as an index 
of cell viability. Some workers claim viabilities of 90-100% 
for hepatocyte preparations in the presence of albumin using 
this dye as the only measure of cell viability (469). Baur ejt al. 
(54) have demonstrated clearly that reversible, pH-dependent 
staining of cells by the dye can occur with maximum penetration 
of the hepatocytes at low pH values.
Bovine serum albumin is commonly added to the medium to aid 
cell suspension and to prevent clumping which results in the loss 
of metabolic activity (468) and it has been shown by Tay (431) 
that the viability of hepatocytes, as tested by the ability to 
exclude trypan blue, can be changed by the presence of this 
protein. Albumin decreases the number of cells stained by the 
dye probably because trypan blue binds to albumin preferentially 
(467). In addition, some investigators believe that cells with 
stained nuclei but not cytosol are still viable and consider the 
cells to be 'dead' only when both nuclei and cytosol are stained 
(9). Some controversy, therefore, exists about the definition of 
the term 'viability' with respect to hepatocytes and the use of 
the trypan blue exclusion test. In spite of this, most authors 
have confined themselves to the use of the test as a measure of 
viability.
In this present study it was of importance to be able to 
define the viability of cell preparations because of both the 
need to compare results obtained with hepatocytes from animals of 
both sexes and to determine whether sex hormones affected cell 
viability. Hence, initially, a number of methods for determining 
hepatocyte viability were compared using preparations with 
similar cell concentrations (ca 8-10 x 10^ cells/ml) and containing 
bovine serum albumin and Ca^* ions. In all cases cells were 
gassed continuously with an O^/CO^ mixture and incubated in a 
shaking water bath at 37°.
The leakage of from hepatocytes into the medium can be , 
used as a measure of the integrity of the cells (467, 468, 469) 
and likewise the leakage of lactate dehydrogenase (9, 54, 467, 468, 
469).
The results of a comparison of these methods together with the 
trypan blue exclusion test is given in Fig. 7. Cells from both 
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I n c u b a t i o n  t i m e  ( h r )  * * *
A comparison of different viability tests using 
hepatocytes from male and female rats.
k "*” leakage is corrected for ions initially 
present in the incubation medium.
LDH leakage is given as the activity in the medium 
expressed as a % of the total activity in the 
medium plus the cells.
Cells were preincubated for 1hr at 37° prior to 
the tests.
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medium, incubated for varying times and then examined. The 
graphs show that cells from male and female rat livers can be 
prepared with similar viabilities and loss of viability in both 
cases occurs at the same rate when examined by any one of the 
three procedures. The decrease in the unstained 'viable' cells 
(from c_a 70% to 55%) over a 4hr incubation period is accompanied 
by leakage of both K ions and lactate dehydrogenase into the 
medium. The rate of loss of enzyme from the cells is relatively 
low which suggests that in both preparations cell membranes are 
not grossly damaged. The total ions lost from the hepatocytes 
during 4hr was not measured in this study but an approximate value 
of only 4% is probable if the data on the k "*" content of hepatocyte 
preparations given by Krebs and his associates (468) is used as a 
basis for the calculation.
As a further test of the integrity of the hepatocyte prepara­
tions used in this study the rate of gluconeogenesis from 
lactate was also examined using the procedure described by Claus 
et al. (69) and isolating the products by the method of Exton and 
Park (70).
The results shown in Fig. 8 demonstrate that the rate of glu­
coneogenesis from lactate by the isolated liver cells from male rats 
is linear with time for up to 60 min. The rate of lOpmol glucose/g 
hepatocyte/hr obtained with 2mM lactate in this study, can be 
equated with the values reported by several other groups of workers 
(69, 431, 468, 469), bearing in mind that the rate has been shown 
to be linear with lactate concentrations up to lOmM (431, 469). It 
can also be seen in Fig. 8 that glucagon (lOnM) stimulates the 
gluconeogenic rate by approximately 30% over a period of 1 hr (cf 
69, 71, 73, 87).
It is clear, therefore, from all the data that the technique 
used for hepatocyte isolation produced high quality cells as judged 
by the apparent low degree of membrane disorganisation and the exis­
tence of an intact gluconeogenesis pathway under hormonal control.
The viability tests were extended to examine whether the 
addition of sex steroid hormones (5a-dihydrotestosterone and 
estradiol-17P) to isolated male and female cells would affect cell 
viability after an incubation period of 3hr at 37°. From the results 
in Fig. 9 and 10 where trypan blue exclusion and K^ and lactate 
dehydrogenase leakage tests have been carried out, it appears that
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Fig. 8. The rate of gluconeogenesis from L-[U- Cjlactate
Isolated hepatocytes (3.2 x 10 cells/ml) from
fed male rats were preincubated for Ihr without
r 14-1
substrate and then with L-[U- Cjlactate (2mM) 
for various times. Glucagon (1QnM) was added at 
zero time. Experimental details are described in 







D ihydr otestosterone  ( M)
Fie. 9, The effect on viability of incubating hepatocytes from male 
and female rats with dihydrotestosterone for 3hr at 37°.
Cells were preincubated for Ihr at 37° prior to the tests.
leakage is corrected for ions initially present in 
the incubation medium.
LDH leakage is given as the activity in the medium expressed 
as a % of the total activity in the medium plus the cells.
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E s t r a d i o l  ( m )
The effect on viability of incubating hepatocytes from 
male and female rats with estradiol for 3hr at 37°.
Cells were preincubated for Ihr at 37° prior to the tests,
leakage is corrected for ions initially present in 
the incubation medium.
LDH leakage is given as the activity in the medium 
expressed as a % of the total activity in the medium plus 
the cells.
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addition of eitlier dihydrotestosterone or estradiol at concen- 
— 3
trations up to 10 M and incubation for 3hr, has no apparent 
effect on cell viability according to the three measured para­
meters.
The specific activities of glycerol kinase were examined in 
hepatocytes prepared from adult male and female rats to ensure 
that the sex difference found with soluble preparations from livers 
was reflected by the cell preparations. The levels of lactate 
dehydrogenase in hepatocytes from both sexes were also assayed.
The specific activity values for both enzymes were expressed as 
pmol min  ^ g  ^ liver assuming that approximately 1.38 x 10^ cells 
were equivalent to 1g wet liver (468): the values represent the 
total activity in the cells plus the medium.
In Table X it can be seen that the specific activity of 
glycerol kinase was significantly higher (22%) in hepatocyte 
preparations from male than from female rats and that castration 
produced a marked decrease in activity (30%), compared with intact 
animals, which exceeded that reported by Fathipour and Pridham 
(13%) (258) who measured glycerol kinase activity in soluble super­
natants from livers of intact and orchidectomized rats. The ob­
served difference in activities in Table X are probably not due to 
differences in viabilities of the cells as in all preparations the 
viability range was 80-90% as shown by the trypan blue exclusion 
test.
The results in Table XI also show (as in the case of the 
soluble liver preparations (Table IXa)) that there is no significant 
sex difference in lactate dehydrogenase activity in the hepatocytes.
The effects of sex hormones on the activity of glycerol kinase 
in hepatocyte preparations from male and female rats were next 
investigated in an attempt to demonstrate hormonal control of glycerol 
kinase at the cellular level. For this study, the hormones were 
dispersed in the hepatocyte bathing medium by following a method used 
with testosterone and estradiol-17p by Schweppe and Jungman (120).
In this method, the hormones are dissolved in propan 2-ol to give the 
required concentrations (for full description see Section VI.B.5.C., 
p.147). The final concentrations of the hormone in the incubation 
flasks ranged from 10~^ to 10~^M. Hepatocyte preparations were pre­
incubated for Ihr at 37° before incubation with the hormone which was
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for either 3hr or 'zero lir* (hormone was added to the cells and 
the cells were separated from the incubation medium by centrifu­
gation for 10 rain). In the case of both incubation times a total 
period of about 70 min was required after incubation to obtain a 
soluble supernatant preparation for the enzyme assay.
It was reported by Bruchovsky and Wilson (298, 299) that 5a- 
dihydrotestosterone was the main metabolite of testosterone in 
rat prostate, both vivo and i^ vitro, and that 5a-dihydro- 
testosterone was more firmly bound than testosterone to nuclear 
chromatin material in androgen target tissues such as prostate.
It was also shown by Hansson ejt a^. (317) that after intravenous 
administration of [^H]5a-dihydrotestosterone to adult castrated 
male rats, the highest levels of the hormone were found in the 
prostate and in the liver. These authors believe that 5a-dihydro- 
testosterone is the active intracellular androgen and that testos­
terone is the main transport form of the androgen in blood. In 
view of these reports it was decided to use 5a-dihydrotestosterone 
instead of testosterone in the present experiments.
The effect of incubating hepatocytes from male rats with 
different concentrations of 5a-dihydrotestosterone on the activities 
of glycerol kinase and lactate dehydrogenase are presented in Fig. 11. 
The results demonstrate clearly that dihydrotestosterone, at con­
centrations of 10 ^ and 10 ^M, has no apparent effect on glycerol
-4 -3
kinase activity but at higher hormone concentrations, 10 and 10 M, 
thereis a statistically significant increase in the activity of the
_ 3
kinase (ca 65%, after 3hr incubation)with 10 M hormone compared 
with the controls containing no steroid. This 'activation' appears 
to be instantaneous as there are no significant differences between 
the zero and 3hr incubations in either case.
No statistically significant differences in the levels of lactate 
dehydrogenase are apparent when hepatocytes are incubated with or 
without dihydrotestosterone.
The effect of 5a-dihydrotestosterone on glycerol kinase activity 
in hepatocytes from castrated male rats was also examined because it 
was believed that in the absence or at a low level of endogenous 
hormone, stimulation of the enzyme by exogenous steroid would be 
greater. The results of this experiment (Fig. 12) show that, as 
with intact male rats (Fig. 11), relatively high concentrations of


































Fig. 11. The effect of incubating hepatocytes from male rats
with different concentrations of dihydrotestosterone 
on the activities of glycerol kinase and lactate 
dehydrogenase. For experimental details see Section 
VI.B.5. (p. 145).
(see Appendix 2 for numerical data).
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Fig. 12. The effect of incubating hepatocytes from castrated
male rats with different concentrations of dihydro­
testosterone on the activities of glycerol kinase 
and lactate dehydrogenase. For experimental details 
see Section VI.B.5. (p. 145).
(see Appendix 3 for numerical data).
— I —
5a-dihydrotestosterone raise the level of the kinase activity 
and the difference (90%) between the activities in the absence
_ 3
and presence of the hormone (10 M) is somewhat higher than in 
the experiment with cells from intact animals (Fig. 11). Again, 
zero time and 3hr incubations gave very similar values for each 
hormone concentration indicating that the activation was rapid.
With lactate dehydrogenase activities (Fig. 12) in hepato­
cytes from castrated animals there was, again, no evidence of 
hormone effects.
In further studies the effect of estrogen was investigated 
by incubating hepatocytes from intact male rats with different 
concentrations of e s t r a d i o l - 1 ( F i g .  13). Unlike the results 
obtained with 5a-dihydrotestosterone, increasing concentrations 
of estradiol have no significant effects on glycerol kinase 
activity if either the * zero time' or the 3hr incubations are 
compared with the control (no hormone). However, with the 3hr 
incubations there does appear to be a trend towards decreasing 
activities with increasing estrogen concentration. This may be 
correlated with an increasing difference in activity between 
the zero and 3hr incubations with increasing hormone levels.
Estradiol had no significant effect on lactate dehydrogenase 
activity at any of the steroid concentrations used.
The experiments described using hepatocytes from male rat 
livers were repeated using cells from the livers of intact female 
animals. The results which are given in Fig. 14, show no signifi­
cant changes in lactate dehydrogenase activity with increasing 5a- 
dihydrotestesterone levels but, with glycerol kinase, the results 
are very similar to those obtained with male hepatocytes (Fig. 11). 
That is, the specific activity increased with increasing steroid 
concentrations and, again, the activation was rapid and was apparent 
in the 'zero hour* incubation mixtures.
With estradiol and female hepatocytes (Fig. 15) there were no 
significant changes with either of the enzymes and, in the case of 
glycerol kinase, there was no trend of increasing inactivation with 
increasing hormone levels using a 3hr incubation period as was found 
with male cells (Fig- 13).
In view of the apparent activation of glycerol kinase produced 
by incubating either male or female hepatocytes with 5a-dihydrotes- 
tosterone, it was decided to examine the direct effect of the hormone 













































Fig. 13. The effect of incubating hepatocytes from male rats
with different concentrations of estradiol on the 
activities of glycerol kinase and lactate dehydrog­
enase. For experimental details see Section VI.B.5, 
(p. 145).








































D i hyd rotestosterone
Fig. 14. The effect of incubating hepatocytes from female rats
with different concentrations of dihydrotestosterone 
on the activities of glycerol kinase and lactate dehy­
drogenase. For experimental details see Section VI.B.5, 
(p.145).






































E s t  radio!
Fig. 15. The effect of incubating hepatocytes from female rats
with different concentrations of estradiol on the 
activities of glycerol kinase and lactate dehydrogenase 
For experimental details see Section VI.B.5. (p. 145). 
(see Appendix 6 for numerical data)
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Male hépatocytes were, therefore, sonicated and the prepar­
ation centrifuged at 100,000 x g for 1 hr. Dihydrotestosterone 
was added to the supernatant at various concentrations and assays 
of glycerol kinase then carried out both immediately and after a 
3hr incubation at 37°. The results (Table XII) showed no changes 
in activity resulting from the direct addition of steroid. It 
appears, therefore, that the apparent activation of glycerol kinase 
by androgen is a function of the steroid acting on intact hépato­
cytes and does not result from a direct interaction of the hormone 
with the enzyme protein.
In theory, a steroid hormone might increase enzyme activity in 
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The vitro study described above does not support a 
mechanism involving a direct activation of the enzyme by dihydro­
testosterone (E) or inactivation of a theoretical inhibitor of 
the kinase (A) unless it is assumed that breaking the hepatocytes 
in some way changes the enzyme or the inhibitor (perhaps a con­
formational change) so that the steroid cannot combine.
The other postulated controls in the Scheme above all rely 
on dihydrotestosterone activating the machinery of protein 
synthesis. In (C) enzyme protein is synthesized in response to 
the hormone, in (D) a protein is synthesized which in turn activates 
the enzyme and in (B) a protein is synthesized which either directly 
or indirectly inhibits the enzyme inhibitor.
Sex hormones ^  vivo are believed to normally influence the 
rate of biochemical reactions by stimulating protein synthesis in 
the target tissue. The process starts immediately after the entry 
of the hormone into the cell where it is bound to a specific hormone 
receptor in the cytosol. The resulting hormone-receptor complex is 
then translocated to the nucleus in an 'activated' form. Once in 
the nucleus, it undergoes an interaction with the DNA-nucleoprotein 
complex (chromatin) and the target cells respond by synthesizing mRNA 
(transcription). The mRNA is then moves into the cytosol where it 
stimulates the polysomes (translation) and the process ends by the 
release of newly synthesized protein into the cell (453).
Most of the studies concerning sex hormone receptors and their 
role in macromolecular synthesis have been limited primarily to the 
reproductive tissues and until recently, hepatic tissue was generally 
considered as a 'non-target' for sex hormones. However, in 1975 
androgen uptake by the liver was demonstrated after intraperitoneal 
administration of tritiated testosterone to castrated male rats (368). 
Cytosolic sex hormone receptors were also later identified in livers 
from male and female rats (see also p. 69) (318, 319, 320).
The apparent activation of glycerol kinase by incubating hepato­
cytes with dihydrotestosterone occurred very rapidly: with the 'zero 
time' incubations the hormone was only in contact with the intact 
cells for about 10 min. In addition, no amino acids or other exogenous 
factors which are normally required for protein synthesis, were present 
in the hepatocyte incubation media. It seems unlikely, therefore, 
that protein synthesis giving rise to increased levels of glycerol 
kinase was responsible for steroid activation of the enzyme.
- 129 -
Nevertheless, it was decided to try and eliminate the possibility 
that dihydrotestosterone was stimulating glycerol kinase synthesis 
either directly or indirectly.
For this study, hepatocytes from male rats were prepared and
- 3
incubated with 5a-dihydrotestosterone (10~ M) in the presence and 
absence of specific protein synthesis inhibitors (cycloheximide or 
puromycin). The inhibitors were added to the cells during the pre­
incubation period, i.e. 1 hr prior to the addition of the hormone, 
to allow sufficient time for penetration of the tissues by the 
inhibitors which could have been slow, relative to the rate of 
entry of testosterone. Amino acid mixtures, including [^H]iso- 
leucine, were also added to the incubation media. Glycerol kinase 
activities were then assayed and also total protein synthesis by 
the method of Mans and Novelli (454) which is based on measuring 
the incorporation of label from [^H]isoleucine into trichloroacetic 
acid-insoluble material (see Section VI.B.5.e. p. 148).
[ w i t h  similar preparations of male hepatocytes it has been 
shown that the rates of total protein synthesis and albumin and 
globulin synthesis are linear for periods up to 6hr: the rate of 
a^^globulin synthesis was reported to be 0.15pg/hr/10^ cells 
(D. Settachan, unpublished results). This latter value is comparable 
to the rates found by other workers using perfused liver systems or 
intact animals (455, 456)].
The experiment showed that 10 M dihydrotestosterone activated 
glycerol kinase in the presence and absence of the two protein 
synthesis inhibitors (Table XIII). In addition, both cycloheximide 
and puromycin inhibited total protein synthesis by 82% and 96%, 
respectively (Table XIV) and, hence, particularly with reference to 
cycloheximide, it is unlikely that protein synthesis is involved in 
the activation phenomenon.
From Figs. 11, 12 and 14 it could be concluded that the apparent 
activation of glycerol kinase was related to the stability of the 
enzyme. For example, glycerol kinase inside the hepatocytes could 
be more stable than outside and dihydrotestosterone could perhaps 
stabilize the cells and allow less cellular disruption during incu­
bations. Thus, incubations in the absence of dihydrotestosterone 
could lead to more dénaturation of glycerol kinase as it is released 
into the medium, than incubations in the presence of the hormone. 
However, Fig. 9 suggests that there is little difference in the via­
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TABLE XIV. The rate of incorporation of [ Hjisoleucine





























* Hepatocytes were preincubated for Ihr in the presence or absence 
of the protein inhibitor prior to the addition of [^Hjisoleucine 
(276)
** The incorporation rates are means of four samples taken from each 
incubation mixture
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in the presence or absence of dihydrotestosterone at concentrations
_3
up to 10 M. Therefore, presumably, the rate of leakage of 
glycerol kinase from the cells would be similar in both cases.
Fig. 16 also shows that there is only a small total loss of 
glycerol kinase activity when hepatocytes are incubated for 2-3 hr 
and the proportion of the activity in the cells and in the medium 
remains the same. None of this data, therefore, supports the idea 
that the apparent activation of glycerol kinase by dihydrotestosterone 
is merely due to a decrease in the dénaturation of the enzyme particu­
larly if it is remembered that the apparent activation was observed 
after only a few minutes exposure of the hepatocytes to the hormone.
The mode of activation of glycerol kinase by dihydrotestosterone 
is, therefore, not clear. Intact hepatocytes appear to be a pre­
requisite so it is possible that some intermediary glycerol kinase 
effector, which is lost or which changes conformation when the cells 
are disrupted, is needed. The phenomenon also exhibits a degree of 
specificity in that estradiol is not an activator of the enzyme.
From a physiological point of view the observed effect of dihydro­
testosterone may be unimportant in view of the high concentrations 
of hormone (10 ^ - 10 ^ M) needed to bring about activation. However, 
in vivo, localized high concentrations of hormone within cells or 
particular parts of cells are always possible.
The present investigation and studies by other workers in the 
field (discussed in Section IV.B. p.72) when considered together (see 
Fig. 17) now provide data on the activities of the majority of the 
enzymes in male and female rat livers involved in triose synthesis 
from fructose and many of the enzymes concerned with the conversion 
of trioses to triglycerides.
A first, important point to recognize is that sex differences in 
enzyme activities may be diet-dependent. Although no reversal of 
such differences has been observed in the present study there were 
instances where a sex difference found with animals on one diet was 
nullified in the case of those on another diet. Thus with glycerol 
3-phosphate dehydrogenase, for example (Table Vila), no sex differ­
ences were apparent with animals ingesting Dixon 86 diet or CDD[r ] 
supplemented with sucrose but with CDD[r ] alone or supplemented with 
glucose, enzyme activity was significantly higher in the female livers. 

























\  3.0 
c
Ë




M a i e
Female
1 3
□ Total  
o Medium  
•  Cel Is
-o-
Incubation t im e  [hrl
Fig. 16. The effect of incubating hepatocytes from male



















































6. Fatty acid synthase
Fig. 17. Sex differences in enzymes involved in the conversion of
fructose to triglyceride
Figures in parenthesis are specific activities (nmol/min/ 
mg protein) of the liver enzymes from rats fed Dixon CDD[r ] 
diet (258, 322)
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triokinase (Table Via) and glycerol kinase (Table Villa). These 
results were, of course, obtained by long-term feeding and the 
effect of short-term carbohydrate supplement or intermittent 
carbohydrate loading may be different.
The general conclusion to be gained from liver perfusion 
studies (Section IV.C. p.74) is that female rat livers have a 
greater potential for producing triglyceride than male livers 
although no comparisons using fructose as a substrate have been 
made. This ability is firstly reflected in the higher activities 
in the female liver of a number of key enzymes involved in fatty 
acid synthesis from triose i.e. pyruvate kinase, glucose 6-phosphate 
and 6-phosphogluconate dehydrogenases, acetyl-CoA carboxylase and 
fatty acid synthase.
The sex differential in these activities can, at least in 
part, be accounted for by differing hormonal controls of the enzymes 
in male and female rats involving sex steroids and pancreatic hormones.
In the first place, insulin and glucagon, have been shown to effect 
lipogenesis. This process is enhanced by insulin in hepatocytes (470,
471) and in perfused liver (308, 310, 472, 473). Several reports also 
show that glucagon antagonizes the effect of insulin with respect to 
lipogenesis (470, 471, 473, 474) and triglyceride output (303, 308). 
Insulin may achieve these effects by increasing the activities of 
pyruvate kinase (349, 351), acetyl-CoA carboxylase and fatty acid synthase 
(397, 475), glucose 6-phosphate dehydrogenase (416) and, possibly, 6- 
phosphogluconate dehydrogenase (420). Estrogen injections have also 
been shown to activate fatty acid synthase, acetyl-CoA carboxylase 
(403, 421) and 6-phosphogluconate dehydrogenase (385). Glucagon, on 
the other hand, has been reported to inhibit pyruvate kinase (349, 351), 
fatty acid synthase (476) and glucose 6-phosphate dehydrogenase (417) 
in rats and acetyl-CoA carboxylase (471) in mouse hepatocytes.
Mandour, Kissebah and Wynn (421) showed that estrogen increases 
the insulin/glucagon ratio in ovariectomized female rats and this 
observation suggests that sex differences in the levels of the lipogenic 
enzymes may, to some degree, be a function of sex hormone control 
mediated by insulin and glucagon. In this connection, it is interesting 
to note that female rats have higher insulin levels than males both in 
a fasting state and particularly after feeding a carbohydrate-enriched 
diet (59). (Women have also been reported to have a higher insulin 
level than men (381)).
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All of the lipogenic enzymes listed above would be involved 
in fatty acid production from trioses arising from fructose and, 
thus even in the absence of sex differences in the rate of triose 
formation, female livers would presumably convert fructose more 
efficiently to triglyceride than male livers. However, there do 
appear to be quantitative sex differences in the way triose is
produced from fructose in rat liver.
Inspection of the enzyme activities in Fig. 17 suggests that 
the passage of carbon from fructose to triglyceride-glycerol, at 
least, may be more facile in the female rat liver. For example,
with fructose 1-phosphate aldolase, the specific activity of the
hepatic enzyme in the female is about 25% higher than in the male 
(S.A. Hashemi, unpublished results) and this difference has been 
observed with rats on diets of chow with or without carbohydrate 
supplementation. The greatest sex difference was found with sucrose 
supplementation of the diet. This enzyme-catalyzed step may also be 
rate-limiting and controlled by ATP degradation products (see Section 
III, p . 61).
In addition, one of the products of aldolase, dihydroxyacetone 
phosphate, can presumably be rapidly metabolized to glycerol 3- 
phosphate, an intermediate in triglyceride synthesis, as there are 
relatively high levels of glycerol 3-phosphate dehydrogenase in rat 
liver. This enzyme has a low (0.075mM) for its substrate dihy­
droxyacetone phosphate, and, again, the specific activity in female 
liver is significantly higher than in male (Table Vila). Hence, 
relatively low levels of dihydroxyacetone phosphate which may be 
produced from fructose by the coupled ketohexokinase-aldolase system 
can probably be more readily converted in the female than the male 
to triglyceride via the glycerol 3-phosphate dehydrogenase-catalyzed 
reaction.
Of course, other factors besides enzyme levels such as availa­
bility of coenzymes, other reactions utilizing fructose metabolites 
such as glycolysis and gluconeogenesis, and hormone effects will also 
influence the rate of formation of triglyceride-glycerol. In addition, 
glycerol 3-phosphate dehydrogenase levels are diet-dependent and long­
term feeding, at least, of a sucrose supplement appears to nullify 
the sex difference.
Dihydroxyacetone phosphate can also be converted to triglyceride-fatty
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acid via triosephosphate isomerase which initially yields glycer- 
aldehyde 3-phosphate and this in turn can then be metabolized by 
the glycolytic and lipogenic pathways. This is probably a relatively 
minor pathway as significantly less carbon from [^^cjfructose is 
incorporated into triglyceride-fatty acid than into triglyceride- 
glycerol (see p.58). There is no information concerning possible 
sex differences in triosephosphate isomerase and glycolytic enzymes 
leading as far as phosphoenol pyruvate.
Regarding glyceraldehyde, the second product of aldolase cleavage 
of fructose 1-phosphate, it may be phosphorylated by triokinase to 
glyceraldehyde 3-phosphate in the rat (see Section III, p.62) and 
then there is a facile route to dihydroxyacetone phosphate and thereby 
triglyceride-glycerol, via triosephosphate isomerase. Triokinase is 
present in the liver at relatively low levels and there are no 
apparent sex differences in activity (except, possibly, when animals 
are ingesting a low-fat diet when the male level is 40% higher than 
the female (Table Via)). It is probably, therefore, that the trio- 
kinase-triosephosphate isomerase pathway does not change the sex 
difference in glycerol 3-phosphate production which is attributed to 
glycerol 3-phosphate dehydrogenase variance. Triokinase, however, 
with a high for ATP may not function efficiently at low ATP levels 
perhaps, for example, when fructose phosphorylation is occurring 
(see Section III, p.61 (111, 232)) and in this case the glyceraldehyde- 
glycerol-glycerol 3-phosphate pathway might operate in the rat leading 
glyceraldehyde carbon by a second route to triglyceride-glycerol. 
However, the low activities of all the enzymes on this pathway pre­
sumably means that contributions to the pool of glycerol 3-phosphate 
are smaller from glyceraldehyde than from dihydroxyacetone phosphate.
If this is so then the sex difference (J' 45% >  ?) in hepatic glycerol 
kinase activity which, in theory, would reduce the ability of the 
female liver relative to the male to produce triglyceride-glycerol 
would be of little importance with respect to lipogenesis from fructose.
Triglyceride-fatty acid formation from fructose (which, from 
isotopic tracer studies may be interpreted as occurring less readily 
than triglyceride-glycerol production) can occur from dihydroxyacetone 
phosphate and glyceraldehyde. With regard to sex variations in the 
rates of triglyceride-fatty acid formation from these trioses the 
lipogenic enzymes alone would appear.to control these with little 
part being played by thetriose-metabolizing enzymes.
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All the data on male/fernale differences in enzyme levels so 
far considered support the observations that triglyceride produc­
tion by the liver of female rat (and probably other mammals) is 
higher than that of the male organ. If this is the case then one 
would expect the liver output to be reflected in the serum tri­
glyceride levels but this is not so. Hence, the 'clearing' rates, 
catalyzed by lipoprotein lipase, should presumably play an important 
role in maintaining female serum triglycerides at a lower level than 
that of male.
The specific activity of lipoprotein lipase in human plasma 
is reported to be higher in women than men by about 33% (413). In 
addition, as women normally possess a significantly higher adipose 
tissue/body weight ratio than men (61) the related increased total 
adipose lipoprotein lipase activity in relation to body weight in 
the former should allow a more efficient triglyceride-clearing 
system (cf 413). This assumes that the ratio of other lipoprotein 
lipase-contributing tissues to body weight does not differ signifi­
cantly in males and females.
In rats, the serum triglyceride concentration is, as expected, 
indirectly proportional to the specific activity of the adipose 
lipoprotein lipase (396) and differences in the levels of lipoprotein 
lipase in males and females have also been reported. The data of 
Hamosh and Hamosh (415), for example, show that the specific activity 
of the enzyme (U/g adipose tissue) is higher (ca 30%) in females than 
males, both feeding on chow. A smaller differential (ca 7%) was 
reported by Bruckdorfer et aT. (396) with animals ingesting on a low- 
fat diet supplemented with sucrose. As with humans, the adipose 
tissue/body weight ratio is higher in female rats than in male (431).
Undoubtedly further work on lipoprotein lipase levels in rats is 
needed but if the 'clearing' efficiency in females is greater than 
males, as seems to be the case in humans, it may again relate to the 
insulin/glucagon ratio which, if high, favours lipoprotein lipase 
activity (see p. 67 ). Female rats have higher levels of plasma 
insulin than males (see p . 135) and, hence, it could be postulated 
that the sex difference in lipoprotein lipase activity is a function 
of estrogen control mediated by the insulin/glucagon ratio through 
the following chain of events, as appeared to be the case with the 
lipogenic enzymes (see p . 135):
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Estrogen--------------- ►insulin/glucagon ^T)LPL (see pp.67, 135)
However, this postulated sequence of events is jeopardized by 
reports that ovariectomy of rats increases the lipoprotein lipase 
level (415) and estrogen injection into intact female rats lowers 
the activity of the lipase (412). In the latter case, of course, 
introduction of exogenous hormone would have presumably raised the 
endogenous hormone concentration beyond the physiological level in 
which case toxic effects may have ensued.
In conclusion and in the absence of comparative quantitative 
data on lipogenesis and 'clearing' rates, the postulate must remain 
that the high level of triglyceride in the serum of male rats 
relative to female is very largely controlled by the relatively 
high total lipoprotein lipase activity that the female tissues 
possess which is in excess of the capacity for hepatic lipogenesis.
In the future an accurate determination of the total lipoprotein 
lipase activity in male and female animals in relation to body weight 
is needed for comparison with a measure of total secretion of hepatic 
triglycerides into the serum. In addition, a clearer understanding 
of the effects of hormones and diet on these two processes is required.




All the chemicals used were of Analar grade and all solutions 
were prepared in glass distilled, deionized water. Substrates and 
purified enzymes were purchased from Boehringer Corporation (London) 
Ltd., Lewes, Sussex, U.K., unless otherwise stated.
2. Rats
Male and female rats used in this study were of the Wistar 
strain. The rats were either obtained from Tucks and Son, Rayleigh, 
Essex, U.K. or bred in our laboratory.
3. Diets
Two types of commercial diets were used, Dixon 86 and Dixon 
CDD[r ]. The composition of these diets is shown in Table XVa. The 
calculated percentage composition of these diets and their calorific 
values are presented in Table XVb.
TABLE XVa. Composition of Dixon 86 and Dixon CDD[r ] diets *
Dixon 86 cwt/ton Dixon CDD[r ] cwt/ton
Wheat 10 Wheat 10.3
Barley 5 Maize 1.5
Concentrated meat 1.5 Soya meal 2.5
meal
White fish meal 1.4 White fish meal 3
Grass 1 Milk powder 0.5
Yeast 1 Yeast 0.39
Molasses 1 Shredded suet fat 1.2
Salt 0.2 Salt 0.16
Vitamins 0.022 Vitamins 0.223
Mineral salt 0.25
^Values were obtained from the manufacturer: E. Dixon & Sons 
(Ware) Ltd., Crane Mead Mills, Ware, Herts, U.K.
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TABLE XVb. Calculated percentage partial compositions and
calorie values of Dixon 86 and Dixon CDD[r ] diets
Composition Dixon 86 
(%)
Dixon CDD[r ] 
(%)
Crude Oil 2.03 8.34
Crude protein 19.29 24.18
Crude fibre 3.01 1.88
Digestible crude oil 1.44 7.18
Digestible crude protein 15.73 19.75
Digestible crude fibre 1.90 1.01
Digestible carbohydrate 50.83 42.84
Saturated fatty acids 0.42 2.82
Linoleic acid 0.72 1.98
Other unsaturated fatty acids 0.88 3.52
Kcal/kg
Gross energy 3,942 3,931
Metabolizable energy 3,548 3,538
4. Liver Perfusion Cabinet
The perfusion cabinet consisted of a metal cabinet with glass 
front doors, a fan heater connnected to a thermostat for the control 
of temperature inside the cabinet, a glass 'lung' made to specifi­
cation (240), a Watson-Marlow H.R. flow-inducer (Watson-Marlow, Ltd., 
Marlow, Bucks, U.K.), to pump the perfusion solution, and Swinnex-13 
filter units (Buc, France) to filter the circulating perfusate.
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B. METHODS
1. Long Term Feeding Experiments
Male and female Wistar rats (initial body weight 50 - 5g) 
were fed for 110 days ^  lib, on Dixon 86 or Dixon CDD[r ] diets 
with water to drink or Dixon CDD[r ] diet supplemented with either 
5% (w/v) sucrose or glucose in the drinking water. After 110 days 
the animals were sacrificed by cervical dislocation without fasting 
and the livers were immediately (within 45 sec) removed, washed 
twice in ice-cold saline (0.154 M-NaCl), dried, weighed and stored 
at (-70°).
2. Liver Enzyme Preparations and Enzyme Assays
Livers were homogenized in appropriate ice-cold buffer solutions 
(1:3, w/v), using a Potter-Elvejhem glass homogenizer with a teflon 
pestle (clearance 0.48mm), and 100,000 x g (Ihr) soluble supernatants 
were then prepared (see, however, triokinase Section VI.2.c., p. 144).
In the case of enzymes assayed spectrophotometrically, a Pye- 
Unicam SP.1800 ultraviolet spectrophotometer was normally used. The 
reaction mixtures were contained in quartz cuvettes (1cm light path) 
thermostatically maintained at 30°.
Assays, unless otherwise stated, were initiated by the addition 
of the substrate after preincubation of the homogenate to ensure 
removal of endogenous substrates. The reaction rate as a function 
of substrate concentration for each assay was measured and the K
m
value calculated and compared with literature values: only minor 
differences were observed. All assay reactions were shown to be 
linear with time and proportional to the enzyme concentration.
(a) Ketohexokinase preparations were made in 25mM-phosphate buffer 
(pH 7.4) containing 5mM-EDTA and 0.5mM-dithiothreitol (152). The 
enzyme was assayed by the method of Hers (432, 433) which is based 
on the measurement of fructose disappearance. Fructose was estimated 
by colorimetric method developed by Roe e_t al. (434) and later modi­
fied by Hers £t (435).
The reaction mixture contained; 2mM-fructose, 5mM-ATP, 5mM- 
magnesium acetate, 120mM-potassium acetate. 50mM-Sodium fluoride and 
50mM-N-acetyl D-glucosamine were also added prior to the addition of 
the enzyme (0.2ml). The total volume of the reaction mixture was 1ml. 
The reaction was started by the addition of liver extract to well 
shaken, preheated (37° for 20 min) reaction mixtures. After 10 min
- 144 -
incubation at 37° the reaction was stopped by successive addition 
of 0.15M-zinc sulphate (3ml) and 0.3N-barium hydroxide (3ml) 
solutions. The mixture was shaken and then filtered. Phosphate 
esters are retained on the barium sulphate/zinc hydroxide precipi­
tate and the free fructose can be estimated in the filtrate without 
interference. To the filtrate (2ml), resorcinol-thiourea reagent 
(1ml) and 30% HCl (7ml) were added, the solution was mixed and 
placed for 15 min in a water bath at 75°. After cooling, absorbance 
was measured at 520nm using Pye-Unicam SP.500 ultraviolet spectro­
photometer .
(b) Sorbitol dehydrogenase was prepared in 0.2M-triethanolamine- 
HCl buffer (pH 7.4) (439). The enzyme was measured by the method 
of Gerlach and Hiby (439) using fructose as substrate. The assay 
mixture (final volume 2ml) consisted of: enzyme preparation (0.1ml), 
107mM-triethanolamine-HCl buffer (pH 7.4), 0.4mM-NADH and 400mM- 
fructose. Loss of NADH was measured at 340nm.
(c) Triokinase was obtained by homogenizing rat liver in 0.154 
M-KCl (pH 7.2) and centrifuging at 4,000 x g (20 min). The result­
ant supernatant was again centrifuged (37,000 x g; 2hr) and the 
supernatant dialysed overnight against 0.154 M-KCl (112). Enzyme 
activity was estimated spectrophotometrically by measuring the amount 
of NADH oxidized at 340nm using triosephosphate isomerase and glycerol 
3-phosphate dehydrogenase coupled reactions as adopted by Heinz and 
Lamprecht (112). The reaction mixture (final volume 3ml) consisted 
of: 37mM-triethanolamine-HCl buffer (pH 7.5), 0.45mM-NADH, 2.75mM- 
ATP, 13mM-magnesium chloride, 14.8mM-D-glyceraldehyde, glycerol 3- 
phosphate dehydrogenase (50 p g = r 1 . 8  U), triosephosphate isomerase
(50 pg = 2 2 . 5  U) and liver extract (0.1ml). The reaction was started 
by the addition of ATP to the mixture.
(d) Glycerol 3-phosphate dehydrogenase preparations were obtained 
in lOOmM-Tris (pH 7.2), ImM-EDTA, lmM-2-mercaptoethanol and 1% ethy­
lene glycol (258). The enzyme was assayed by the method reported by 
Lee and Graine (265) using glycerol 3-phosphate as a substrate.
Since, at neutral pH the equilibrium of the reaction favours the 
formation of glycerol 3-phosphate, the reaction was carried out at 
pH 9.8 and a trapping agent (hydrazine) for the dihydroxyacetone 
phosphate produced, was added. The reaction mixture contained: 160mM- 
glycine, 400mM-hydrazine, 0.5mM-NAD, lOmM-glycerol 3-phosphate and
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liver extract (0.02ml). The final volume was 2.0ml and the pH 9.8.
The formation of NADH during the reduction of glycerol 3-phosphate 
to dihydroxyacetone phosphate was measured at 340nm.
(e) Glycerol kinase was prepared in lOOmM-TrisCpH 7.2), ImM-EDTA, 
lmM-2-mercaptoethanol and 1% ethylene glycol (258) and the enzyme 
was assayed by the method of Bublitz and Wieland (459). The form­
ation of NADH produced by the oxidation of glycerol 3-phosphate
was followed spectrophotometrically at 340nm by adding to the reaction 
mixture excess of NAD^ and glycerol 3-phosphate dehydrogenase. The 
reaction mixture contained: 160mM-glycine, 400mM-hydrazine, 1.6mM- 
magnesium chloride, 0.67mM-NAD, 2.5mM-ATP, glycerol 3-phosphate 
dehydrogenase (100pg==4U), liver extract (0.02ml) and 1.66mM- 
glycerol. The final volume of the reaction mixture was 3.0ml and the 
final pH 9.8.
(f) Lactate dehydrogenase preparations were obtained as in the case 
of glycerol kinase and the activity was assayed by measuring the 
conversion of NADH to NAD^ in the presence of pyruvate as a substrate 
according to the method of Bergmeyer and Bernt (460). The reaction 
mixture (final volume 3.0ml) contained: 48mM-phosphate buffer (pH 7.0), 
0.76mM-sodium pyruvate, 0.2mM-NADH and liver extract (0.02ml). The 
formation of NAD was measured at 340nm.
3. Protein Determination
The protein contents of all enzyme preparations were measured 
spectrophotometrically (Pye-Unicam SP.500 ultraviolet spectrophoto­
meter) by the Biuret method (127). Bovine serum albumin was used as 
a standard.
4. Scintillation Counting
Radioactivity was measured with a Packard Tri-Carb liquid scintil­
lation spectrometer. Aqueous samples were assayed in a (1:2, v/v) 
mixture of Triton X-100 and toluene scintillant (5g PPO/1 toluene).
5. In Vitro Experiments
Hepatocytes were prepared according to the method which was 
originally described by Berry and Friend (467) and later modified by 
Krebs £t (468).
In the procedure, rats (fed on Dixon CDd [r ] diet ad lib.) were 
anaesthetized with nembutal [sodium pentobarbitone (60mg/ml, May &
Baker Ltd., Dagenham, Essex, U.K.) O.Iml/IOOg body weight] the 
peritoneal cavity was then opened by two lateral incisions starting
— 14 o —
at the midline of the lower abdomen and proceeding both anteriorly 
and posteriorly exposing the peritoneal cavity. -The gut was 
reclined to the left to expose the portal vein and inferior vena 
cava. Two loose ligatures were applied around the portal vein, 
one anterior to the superior mesentric vein and the other just 
posterior to the splenic vein. A third ligature was then placed 
loosely around the inferior vena cava anterior to the right renal 
vein. The portal vein was then cannulated between the two ligatures 
with a sterile Luer cannula (Braunula sterile Luer; Armour Pharma­
ceutical Co. Ltd., ^Eastbourne, Sussex, U.K.). The two ligatures 
around the portal vein were then tied and the liver perfused with 
Krebs-Ringer bicarbonate <KRB)-buffer (177) without Ca^* ions (37°, 
equilibrated with 0^ and'CO^ (95:5, v/v)) at a rate of.approximately 
25ml/min. ’The inferior vena-cava was-immediately severed below the 
right kidney to prevent the liver' from swelling.and to allow the 
perfusate to flow freely through the organ. -Immediately after this 
step the rib cage was cut open, exposing the thoracic cavity,.and a 
cannula was introduced into the inferior vena cava through the right 
atrium of the heart. - A tight ligature.was placed .around the inferior 
vena cava to hold the cannula in place and.the ligature around the 
_:inferior vena cava in the peritoneal cavity was .then tied.
.When: the livery-appeared pale and the perfusate was. free from 
„blood (usually after 2-5- min), a second perfusion with collagenase 
f (BoehringergCorporation ■ (London) Ltd., Lewes,- Sussex, U.K.) 20mg
2+ T
-:suspended_.-in 100ml oTIKRB (without Ca ions)] was carried out until
-ithe^organ was. -smooth and .swollen -and < the leakage of .the medium from
c.the_liyer was rapid (usually after.15-20 min). . The liver was then
r-removed,- placed In a- plastic.-beaker (250ml capacity).containing KRB
-(50ml> bufXer_-and finely.cut .up.with scissors, and gassed gently with
0 -and CO (95:5,- v/v) .for 1-2.rain. A plastic funnel with a nylon 
2 2—  2 2 '
T^mesh(Nybolt ,,2.No.-y10;' ;1-32 micron; J..,Staniar &. Co..,, Manchester, U.K.)
,,-was -then u sed .to .filter .the xell..suspensions..into centrifuge tubes
2 (50ml ,capacity). -.The .cells .were ..sedimented at-50 x g (.1 min). in a
.^bench ^ centrifuge .and .the .pellet ,then, suspended, ip KRB .buffer and the
.^centrifugation .repeated. ,...The.pelle,t.was, resuspended, in an. appropriate
v o l u m e  ..-of-^ -KRB.,.buffer, c.ontaihing 0.22m. calcium, chloride, gentaraycin
sulphate .,(20.pg/ml).,.and bovine .serum, albumin ,(20mg/ml) (fraction V,
Sigma. (London)-,.Chemical Co. . Ltd. . P o ç l e Por.set, U.-K.). The, hepato-
...cytes^were p o u n  ted, under,,the .microscope. uping -a ha.ematocrit .chamber
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and the concentration of the cells then adjusted accordingly.
hormonal studies were preincubated for 1 hr at 37° to restore the
The hepatocytes used for both the gluconeogenesis and the
m inci
ATP/ADP ratio to normal (69).
r  1 4  -,
(b) Gluconeogenesis from L-|U- Cjlactate
Male rats (200-300g) fed CDD[r ] diet with water to drink
ad lib, were used. Hepatocytes were prepared (see Section VI.B.
5.a.) and preincubated for 1 hr (37° with continuous gassing 0^
and CO (95:5, v/v)). The cell suspension (3.2 x 10^ cells/ml;
r 14 T
1ml) was added to L-[U- Cjlactate (0.025pCi/pmol, 5pl; Radiochemical 
Centre, Ltd., Amersham, Buckinghamshire, U.K.) in plastic tubes 
(glucagon, final concentration lOnM, was also added in some cases) 
and the tubes were incubated in a shaking water bath at 37° (200 
cycles/min) for appropriate times. The reactions were then stopped 
by addition of 0.15 M-zinc sulphate (0.5ml) and 0.3 N-barium 
hydroxide (0.5ml). Water (2ml) was added and the precipitate
r  1 4  -I
removed by centrifugation. |_ CjGlucose was separated from charged
molecules by the procedure of Exton and Park (70): moist Dowex
50W-X8 (H^ form, 200-400 mesh; 200mg) and moist Duolite ES 561
(Dia-prosim, Vitry, Chauny, France; 800mg) were mixed with the
protein free supernatant and shaken for Ihr. This resin treatment
was repeated. The resulting supernatants were then added to Triton
r 1 4 1
X-100 - toluene scintillant (1:2, v/v; 10ml) and analysed for Cj 
glucose in a scintillation counter. This method for measuring 
gluconeogenesis was originally described by Claus £t (69).
(c) Preparation of hormone solutions
Steroid hormones were dispersed in KRB buffer by following a 
method outlined for testosterone and estradiol by Schweppe and 
Jungman (120). Hormones were dissolved in propan 2-ol to give the 
required concentration. Prior to each experiment the appropriate 
amount of hormone solution was pipetted into a 25ml Erlenmeyer flask 
and after evaporation of the alcohol at 37° under a continuous 
stream of nitrogen gas, incubation medium (4ml) (KRB buffer contain­
ing 0.22mM-calcium chloride and bovine serum albumin 2.25mg/ml) was 
added to each flask. The flasks were shaken at 4° for 2hr and then 
left overnight in the cold room (0-4°). Prior to the addition of 
the hepatocytes, the flasks were equilibrated with 0^ and CO^ (95:5, 
v/v) at 37° for 30 min.
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(d) Hormone studies with isolated hepatocytes
Hepatocytes (8-10 x 10^ cells/ml; 1ml), after preincubation 
for Ihr, were added to the hormone solution and the mixture incu­
bated in a shaking water bath at 37° (200 cycles/min) with con­
tinuous gassing with 0^ and CO (95:5, v/v) for 3hr. The cells 
are then centrifuged down in the cold (0-4°) at 6,000 x g (10 min) 
and the supernatants (incubation media) stored at -70°. Prior to 
the determination of the enzyme activities the cells were resus­
pended in buffer solution (1ml) containing lOOmM-Tris (pH 7.2), ImM- 
EDTA, lmM-2-mercaptoethanol and 1% ethylene glycol. The cells were 
sonicated and the supernatants obtained by centrifugation at
100.000 X  g (Ihr). The stated total enzyme activities of hepato­
cytes are the sums of the activities in the cells plus the incu­
bation media.
(e) Estimation of total protein synthesis in isolated hepatocytes
Total protein synthesis was estimated by determining the incor­
poration of radioactivity into trichloroacetic acid (TCA)-insoluble 
material. Hepatocytes (8-10 x 10^ cells/ml; 1ml) after being incu­
bated in the presence of [^hjisoleucine (1pCi/50pmol, lOpl) for 3hr, 
with and without protein inhibitors, were sonicated and centrifuged 
at 6,000 X g (lOmin). When amino acid mixtures were added, the 
final concentrations used were as in Waymouth's medium (477). 
Aliquots (lOOpl) were spotted onto 2.1cm diameter discs of Whatman 
grade 1 paper which were dried and dropped into ice-cold 10% (w/v) 
TCA for 15 min as described by Mans and Novelli (454). The discs 
were then placed in 5% TCA for 30 min at 90°, washed in fresh, cold 
5% TCA and placed in ethanol/ether (3:1, v/v) for 30 min at 37°. 
After washing in fresh ethanol/ether, the discs were placed in ether 
for 15 min at room temperature and then dried. They were then put 
into glass scintillation vials, incubated overnight at 37° with NCS 
solubilizer and then toluene scintillant (10ml) was added to each 
vial and the radioactivity measured.
(f) Estimation of levels in isolated hepatocytes
Hepatocytes (8-10 x 10^ cells/ml; 1ml) were centrifuged at
6.000 X g (10 min) and the level measured in the cell free media 
by flame photometry (EEL, flame photometer) (204).
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6. Statistical Analysis
The following formula (Zivin and Bartko, 478) was used to 
calculate the statistical significance of the data:
Where X = Mean of arithmetric averageXX/N
SD = Standard deviation
N = Number of observations
df = Degrees of freedom (df = n-2)
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